,words,labels,sentence_id,full sentence
316,The,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
317,genetic,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
318,progress,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
319,is,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
320,then,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
321,transferred,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
322,to,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
323,the,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
324,commercial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
325,flocks,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
326,through,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
327,artificial,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
328,insemination,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
329,or,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
330,natural,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
331,-,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
332,mating,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
333,rams,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
334,.,O,8.0,The genetic progress is then transferred to the commercial flocks through artificial insemination or natural - mating rams .
349,Almost,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
350,all,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
351,milk,B,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
352,is,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
353,used,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
354,for,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
355,cheese,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
356,production,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
357,and,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
358,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
359,consequently,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
360,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
361,milk,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
362,content,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
363,traits,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
364,are,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
365,very,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
366,important,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
367,.,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
499,In,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
500,this,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
501,context,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
502,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
503,the,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
504,application,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
505,of,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
506,selection,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
507,schemes,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
508,assisted,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
509,by,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
510,molecular,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
511,information,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
512,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
513,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
514,improve,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
515,either,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
516,traditional,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
517,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
518,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
519,or,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
520,traits,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
521,costly,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
522,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
523,record,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
524,",",O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
525,seems,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
526,to,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
527,be,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
528,attractive,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
529,in,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
530,dairy,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
531,sheep,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
532,.,O,16.0,"In this context , the application of selection schemes assisted by molecular information , to improve either traditional dairy traits or traits costly to record , seems to be attractive in dairy sheep ."
1351,The,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1352,main,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1353,mechanisms,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1354,of,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1355,action,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1356,include,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1357,inducing,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1358,apoptosis,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1359,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1360,inhibiting,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1361,proliferation,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1362,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1363,migration,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1364,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1365,invasion,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1366,of,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1367,tumors,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1368,",",O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1369,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1370,sensitizing,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1371,tumors,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1372,to,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1373,radiotherapy,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1374,and,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1375,chemotherapy,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
1376,.,O,41.0,"The main mechanisms of action include inducing apoptosis , inhibiting proliferation , migration and invasion of tumors , and sensitizing tumors to radiotherapy and chemotherapy ."
2303,After,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2304,16,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2305,weeks,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2306,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2307,ginger,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2308,supplementation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2309,alleviated,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2310,the,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2311,HFD,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2312,-,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2313,induced,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2314,increases,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2315,in,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2316,body,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2317,weight,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2318,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2319,fat,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2320,accumulation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2321,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2322,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2323,levels,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2324,of,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2325,serum,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2326,glucose,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2327,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2328,triglyceride,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2329,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2330,cholesterol,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2331,.,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2408,Additionally,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2409,",",O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2410,stimulation,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2411,of,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2412,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2413,browning,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2414,program,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2415,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2416,ginger,B,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2417,may,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2418,be,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2419,partly,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2420,regulated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2421,by,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2422,the,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2423,sirtuin-1,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2424,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2425,SIRT1)/AMP,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2426,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2427,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2428,protein,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2429,kinase,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2430,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2431,AMPK)/peroxisome,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2432,proliferator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2433,-,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2434,activated,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2435,receptor,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2436,γ,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2437,coactivator,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2438,1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2439,(,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2440,PGC-1α,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2441,),O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2442,pathway,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2443,.,O,78.0,"Additionally , stimulation of the browning program by ginger may be partly regulated by the sirtuin-1 ( SIRT1)/AMP - activated protein kinase ( AMPK)/peroxisome proliferator - activated receptor γ coactivator 1α ( PGC-1α ) pathway ."
2444,Taken,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2445,together,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2446,",",O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2447,these,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2448,results,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2449,indicate,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2450,that,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2451,dietary,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2452,ginger,B,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2453,prevents,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2454,body,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2455,weight,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2456,gain,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2457,by,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2458,remodeling,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2459,whole,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2460,-,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2461,body,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2462,energy,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2463,metabolism,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2464,and,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2465,inducing,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2466,browning,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2467,of,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2468,white,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2469,adipose,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2470,tissue,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2471,(,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2472,WAT,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2473,),O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2474,.,O,79.0,"Taken together , these results indicate that dietary ginger prevents body weight gain by remodeling whole - body energy metabolism and inducing browning of white adipose tissue ( WAT ) ."
2774,The,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2775,goal,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2776,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2777,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2778,First,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2779,Global,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2780,Summit,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2781,on,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2782,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2783,Health,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2784,Effects,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2785,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2786,Yogurt,B,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2787,was,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2788,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2789,review,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2790,and,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2791,evaluate,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2792,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2793,strength,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2794,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2795,current,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2796,scientific,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2797,knowledge,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2798,with,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2799,regard,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2800,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2801,the,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2802,health,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2803,benefits,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2804,of,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2805,yogurt,B,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2806,and,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2807,to,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2808,identify,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2809,areas,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2810,where,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2811,further,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2812,research,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2813,is,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2814,needed,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
2815,.,O,88.0,The goal of the First Global Summit on the Health Effects of Yogurt was to review and evaluate the strength of current scientific knowledge with regard to the health benefits of yogurt and to identify areas where further research is needed .
3116,The,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3117,test,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3118,beverages,B,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3119,(,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3120,except,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3121,water,B,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3122,),O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3123,each,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3124,contained,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3125,12,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3126,g,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3127,digestible,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3128,carbohydrate,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3129,.,O,96.0,The test beverages ( except water ) each contained 12 g digestible carbohydrate .
3428,In,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3429,food,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3430,groups,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3431,",",O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3432,increased,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3433,intake,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3434,of,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3435,soybean,B,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3436,products,I,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3437,was,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3438,associated,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3439,with,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3440,decreased,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3441,risk,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3442,of,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3443,GC,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3444,.,O,107.0,"In food groups , increased intake of soybean products was associated with decreased risk of GC ."
3499,In,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3500,conclusion,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3501,",",O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3502,our,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3503,study,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3504,suggests,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3505,that,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3506,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3507,risk,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3508,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3509,GC,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3510,decreased,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3511,with,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3512,high,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3513,consumption,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3514,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3515,fresh,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3516,vegetables,B,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3517,and,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3518,fruits,B,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3519,",",O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3520,whereas,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3521,high,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3522,consumption,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3523,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3524,foods,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3525,rich,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3526,in,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3527,nitrate,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3528,and,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3529,carcinogenic,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3530,substances,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3531,produced,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3532,during,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3533,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3534,cooking,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3535,process,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3536,increased,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3537,the,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3538,risk,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3539,of,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3540,GC,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3541,.,O,110.0,"In conclusion , our study suggests that the risk of GC decreased with high consumption of fresh vegetables and fruits , whereas high consumption of foods rich in nitrate and carcinogenic substances produced during the cooking process increased the risk of GC ."
3599,Clinical,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3600,status,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3601,and,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3602,changes,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3603,in,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3604,milk,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3605,production,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3606,and,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3607,composition,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3608,were,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3609,compared,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3610,in,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3611,the,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3612,four,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3613,groups,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3614,.,O,113.0,Clinical status and changes in milk production and composition were compared in the four groups .
3980,Endogenous,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3981,and,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3982,exogenous,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3983,LCAT,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3984,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3985,CETP,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3986,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3987,and,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3988,PLTP,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3989,activities,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3990,did,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3991,not,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3992,differ,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3993,in,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3994,hamsters,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3995,fed,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3996,margarine,B,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3997,or,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3998,saturated,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
3999,fat,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4000,diets,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4001,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4002,despite,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4003,lower,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4004,hepatic,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4005,LCAT,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4006,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4007,apo,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4008,A,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4009,-,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4010,I,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4011,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4012,and,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4013,SR,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4014,-,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4015,B1,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4016,mRNA,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4017,abundance,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4018,",",O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4019,suggesting,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4020,that,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4021,changes,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4022,in,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4023,available,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4024,substrate,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4025,and/or,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4026,modification,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4027,to,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4028,the,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4029,LCAT,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4030,protein,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4031,may,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4032,have,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4033,been,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4034,involved,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4035,in,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4036,lipoprotein,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4037,changes,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4038,.,O,127.0,"Endogenous and exogenous LCAT , CETP , and PLTP activities did not differ in hamsters fed margarine or saturated fat diets , despite lower hepatic LCAT , apo A - I , and SR - B1 mRNA abundance , suggesting that changes in available substrate and/or modification to the LCAT protein may have been involved in lipoprotein changes ."
4085,Phenolics,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4086,from,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4087,grapes,B,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4088,and,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4089,wines,B,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4090,can,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4091,play,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4092,a,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4093,role,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4094,against,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4095,oxidation,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4096,and,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4097,development,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4098,of,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4099,atherosclerosis,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4100,.,O,129.0,Phenolics from grapes and wines can play a role against oxidation and development of atherosclerosis .
4118,We,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4119,describe,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4120,a,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4121,method,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4122,for,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4123,the,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4124,direct,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4125,determination,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4126,of,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4127,stilbenes,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4128,in,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4129,several,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4130,red,B,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4131,wines,I,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4132,using,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4133,high,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4134,-,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4135,performance,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4136,liquid,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4137,chromatography,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4138,with,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4139,UV,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4140,detection,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4141,.,O,131.0,We describe a method for the direct determination of stilbenes in several red wines using high - performance liquid chromatography with UV detection .
4233,Isolation,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4234,and,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4235,identification,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4236,of,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4237,delta,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4238,-,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4239,viniferin,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4240,was,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4241,achieved,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4242,by,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4243,NMR,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4244,after,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4245,extraction,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4246,and,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4247,fractionation,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4248,of,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4249,red,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4250,wine,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4251,phenolics,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4252,.,O,134.0,Isolation and identification of delta - viniferin was achieved by NMR after extraction and fractionation of red wine phenolics .
4741,Concluding,B,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4742,",",B,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4743,industrial,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4744,snacks,B,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4745,and,I,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4746,home,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4747,-,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4748,made,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4749,pastries,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4750,high,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4751,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4752,Na,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4753,and,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4754,unhealthy,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4755,fat,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4756,were,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4757,frequent,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4758,in,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4759,Chişinău,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4760,.,O,150.0,"Concluding , industrial snacks and home - made pastries high in Na and unhealthy fat were frequent in Chişinău ."
4782,Long,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4783,chain,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4784,omega,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4785,3,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4786,(,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4787,n-3,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4788,),O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4789,fatty,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4790,acids,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4791,",",O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4792,eicosapentaenoic,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4793,(,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4794,EPA,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4795,),O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4796,and/or,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4797,docosahexaenoic,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4798,acid,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4799,(,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4800,DHA,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4801,),O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4802,",",O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4803,have,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4804,been,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4805,shown,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4806,to,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4807,suppress,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4808,growth,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4809,of,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4810,most,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4811,cancer,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4812,cells,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4813,.,O,152.0,"Long chain omega 3 ( n-3 ) fatty acids , eicosapentaenoic ( EPA ) and/or docosahexaenoic acid ( DHA ) , have been shown to suppress growth of most cancer cells ."
4833,We,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4834,hypothesized,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4835,that,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4836,substituting,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4837,canola,B,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4838,oil,I,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4839,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4840,10,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4841,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4842,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4843,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4844,for,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4845,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4846,corn,B,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4847,oil,I,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4848,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4849,1,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4850,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4851,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4852,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4853,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4854,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4855,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4856,of,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4857,cancer,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4858,bearing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4859,mice,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4860,would,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4861,slow,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4862,tumor,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4863,growth,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4864,by,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4865,increasing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4866,n-3,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4867,fatty,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4868,acids,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4869,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4870,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4871,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4872,.,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4907,The,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4908,dietary,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4909,fat,B,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4910,of,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4911,half,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4912,of,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4913,the,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4914,tumor,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4915,bearing,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4916,mice,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4917,was,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4918,then,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4919,changed,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4920,to,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4921,8,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4922,%,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4923,w,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4924,/,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4925,w,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4926,canola,B,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4927,oil,I,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
4928,.,O,156.0,The dietary fat of half of the tumor bearing mice was then changed to 8 % w / w canola oil .
5049,Epigenetic,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5050,therapy,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5051,induced,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5052,by,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5053,dietary,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5054,components,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5055,has,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5056,become,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5057,a,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5058,strong,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5059,interest,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5060,in,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5061,the,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5062,field,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5063,of,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5064,cancer,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5065,prevention,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5066,.,O,160.0,Epigenetic therapy induced by dietary components has become a strong interest in the field of cancer prevention .
5090,Thus,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5091,",",O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5092,we,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5093,aimed,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5094,to,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5095,investigate,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5096,the,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5097,effect,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5098,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5099,olive,B,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5100,oil,I,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5101,in,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5102,a,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5103,preclinical,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5104,model,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5105,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5106,colon,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5107,cancer,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5108,by,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5109,targeting,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5110,genetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5111,and,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5112,epigenetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5113,mechanisms,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5114,.,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5188,The,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5189,effect,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5190,of,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5191,olive,B,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5192,oil,I,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5193,on,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5194,epigenetic,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5195,alterations,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5196,was,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5197,examined,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5198,by,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5199,detecting,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5200,promoter,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5201,methylation,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5202,with,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5203,MS,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5204,-,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5205,HRM,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5206,and,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5207,dysregulation,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5208,of,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5209,miRNA,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5210,by,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5211,TaqMan,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5212,MicroRNA,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5213,Assay,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5214,.,O,166.0,The effect of olive oil on epigenetic alterations was examined by detecting promoter methylation with MS - HRM and dysregulation of miRNA by TaqMan MicroRNA Assay .
5361,Also,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5362,",",O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5363,some,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5364,intervention,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5365,studies,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5366,have,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5367,shown,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5368,a,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5369,blood,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5370,pressure,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5371,-,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5372,lowering,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5373,effect,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5374,of,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5375,milk,B,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5376,products,I,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5377,and,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5378,dairy,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5379,proteins,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5380,.,O,172.0,"Also , some intervention studies have shown a blood pressure - lowering effect of milk products and dairy proteins ."
5568,Information,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5569,on,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5570,total,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5571,fluid,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5572,intake,I,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5573,was,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5574,derived,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5575,from,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5576,the,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5577,consumption,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5578,of,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5579,specific,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5580,fluids,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5581,including,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5582,water,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5583,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5584,coffee,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5585,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5586,tea,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5587,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5588,alcohol,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5589,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5590,milk,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5591,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5592,juice,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5593,",",O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5594,hot,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5595,chocolate,I,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5596,and,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5597,soda,B,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5598,.,O,181.0,"Information on total fluid intake was derived from the consumption of specific fluids including water , coffee , tea , alcohol , milk , juice , hot chocolate and soda ."
5786,Results,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5787,from,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5788,our,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5789,study,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5790,suggest,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5791,that,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5792,water,B,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5793,intake,I,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5794,may,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5795,be,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5796,associated,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5797,with,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5798,a,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5799,slight,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5800,reduction,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5801,in,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5802,bladder,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5803,cancer,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5804,risk,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5805,.,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
6090,Consumption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6091,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6092,tomato,B,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6093,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6094,tomato,B,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6095,-,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6096,based,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6097,products,I,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6098,contribute,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6099,to,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6100,the,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6101,absorption,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6102,of,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6103,carotenoids,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6104,and,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6105,lycopenes,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6106,in,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6107,human,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6108,serum,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6109,.,O,198.0,Consumption of tomato and tomato - based products contribute to the absorption of carotenoids and lycopenes in human serum .
6353,The,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6354,DGAs,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6355,note,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6356,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6357,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6358,are,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6359,consuming,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6360,100,B,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6361,%,B,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6362,fruit,I,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6363,juice,I,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6364,within,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6365,recommendations,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6366,(,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6367,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6368,is,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6369,",",O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6370,120,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6371,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6372,180,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6373,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6374,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6375,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6376,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6377,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6378,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6379,1,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6380,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6381,6,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6382,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6383,and,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6384,236,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6385,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6386,355,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6387,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6388,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6389,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6390,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6391,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6392,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6393,7,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6394,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6395,18,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6396,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6397,),O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6398,.,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6642,Osteoporosis,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6643,can,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6644,be,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6645,defined,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6646,as,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6647,a,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6648,disease,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6649,characterized,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6650,by,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6651,low,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6652,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6653,mass,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6654,and,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6655,microarchitectural,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6656,deterioration,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6657,of,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6658,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6659,tissue,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6660,",",O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6661,leading,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6662,to,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6663,enhanced,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6664,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6665,fragility,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6666,and,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6667,a,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6668,consequent,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6669,increase,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6670,in,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6671,fracture,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6672,risk,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6673,.,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6830,Discordant,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6831,data,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6832,",",O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6833,mainly,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6834,on,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6835,the,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6836,risk,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6837,of,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6838,fractures,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6839,",",O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6840,provided,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6841,limited,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6842,proof,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6843,of,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6844,the,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6845,unfavorable,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6846,effect,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6847,of,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6848,dairy,B,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6849,intake,I,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
6850,.,O,222.0,"Discordant data , mainly on the risk of fractures , provided limited proof of the unfavorable effect of dairy intake ."
7123,Using,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7124,high,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7125,-,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7126,performance,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7127,liquid,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7128,chromatography,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7129,",",O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7130,the,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7131,concentration,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7132,of,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7133,MG,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7134,in,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7135,various,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7136,coffee,B,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7137,samples,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7138,was,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7139,determined,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7140,.,O,235.0,"Using high - performance liquid chromatography , the concentration of MG in various coffee samples was determined ."
7695,For,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7696,males,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7697,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7698,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7699,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7700,eggs,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7701,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7702,beef,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7703,and,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7704,veal,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7705,significantly,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7706,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7707,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7708,but,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7709,not,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7710,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7711,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7712,pork,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7713,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7714,while,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7715,for,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7716,females,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7717,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7718,there,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7719,was,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7720,a,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7721,non,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7722,-,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7723,significant,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7724,increase,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7725,in,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7726,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7727,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7728,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7729,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7730,eggs,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7731,",",O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7732,no,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7733,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7734,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7735,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7736,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7737,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7738,beef,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7739,or,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7740,veal,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7741,and,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7742,a,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7743,significantly,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7744,increased,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7745,risk,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7746,with,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7747,consumption,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7748,of,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7749,pork,B,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
7750,.,O,256.0,"For males , consumption of eggs , beef and veal significantly increased risk but not consumption of pork , while for females , there was a non - significant increase in risk with consumption of eggs , no increased risk with consumption of beef or veal and a significantly increased risk with consumption of pork ."
8356,Although,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8357,nutrition,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8358,and,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8359,diet,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8360,have,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8361,been,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8362,related,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8363,to,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8364,renal,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8365,cell,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8366,carcinoma,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8367,(,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8368,RCC,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8369,),O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8370,",",O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8371,the,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8372,role,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8373,of,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8374,specific,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8375,foods,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8376,or,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8377,nutrients,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8378,on,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8379,this,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8380,cancer,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8381,is,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8382,still,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8383,controversial,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8384,.,O,278.0,"Although nutrition and diet have been related to renal cell carcinoma ( RCC ) , the role of specific foods or nutrients on this cancer is still controversial ."
8632,The,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8633,results,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8634,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8635,this,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8636,study,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8637,provide,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8638,further,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8639,indications,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8640,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8641,dietary,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8642,correlates,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8643,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8644,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8645,",",O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8646,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8647,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8648,particular,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8649,indicate,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8650,that,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8651,a,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8652,diet,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8653,rich,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8654,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8655,refined,B,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8656,cereals,I,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8657,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8658,poor,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8659,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8660,vegetables,B,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8661,may,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8662,have,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8663,an,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8664,unfavorable,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8665,role,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8666,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8667,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8668,.,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
9038,Lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9039,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9040,lactoferrin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9041,decreased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9042,plasma,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9043,leptin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9044,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9045,insulin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9046,",",O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9047,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9048,lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9049,increased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9050,peptide,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9051,YY,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9052,.,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9262,A,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9263,total,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9264,of,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9265,"1,478",O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9266,incident,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9267,renal,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9268,cell,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9269,cancer,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9270,cases,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9271,were,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9272,identified,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9273,during,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9274,a,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9275,follow,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9276,-,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9277,up,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9278,of,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9279,7,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9280,-,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9281,20,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9282,years,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9283,across,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9284,studies,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9285,.,O,306.0,"A total of 1,478 incident renal cell cancer cases were identified during a follow - up of 7 - 20 years across studies ."
9628,Though,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9629,bioinformatic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9630,analyses,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9631,revealed,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9632,that,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9633,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9634,had,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9635,high,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9636,similarity,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9637,with,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9638,GmFT2a,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9639,",",O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9640,ectopic,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9641,GmFT7,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9642,expression,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9643,in,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9644,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9645,could,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9646,not,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9647,promote,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9648,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9649,or,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9650,rescue,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9651,the,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9652,late,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9653,-,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9654,flowering,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9655,phenotype,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9656,of,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9657,Arabidopsis,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9658,ft-10,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9659,mutant,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9660,.,O,320.0,"Though bioinformatic analyses revealed that GmFT7 had high similarity with GmFT2a , ectopic GmFT7 expression in Arabidopsis could not promote flowering or rescue the late - flowering phenotype of Arabidopsis ft-10 mutant ."
9683,This,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9684,study,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9685,aimed,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9686,to,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9687,determine,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9688,the,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9689,antioxidant,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9690,capacities,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9691,as,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9692,well,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9693,as,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9694,the,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9695,content,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9696,of,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9697,total,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9698,soluble,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9699,phenolics,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9700,",",O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9701,anthocyanins,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9702,",",O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9703,tannins,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9704,",",O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9705,and,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9706,flavonoids,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9707,in,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9708,the,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9709,fruits,B,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9710,and,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9711,leaves,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9712,of,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9713,blueberries,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9714,and,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9715,lingonberries,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9716,growing,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9717,in,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9718,Newfoundland,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9719,.,O,322.0,"This study aimed to determine the antioxidant capacities as well as the content of total soluble phenolics , anthocyanins , tannins , and flavonoids in the fruits and leaves of blueberries and lingonberries growing in Newfoundland ."
9903,The,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9904,greater,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9905,protective,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9906,effect,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9907,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9908,leaf,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9909,extracts,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9910,was,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9911,in,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9912,correlation,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9913,with,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9914,the,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9915,levels,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9916,of,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9917,phenolics,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9918,and,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9919,antioxidant,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9920,capacity,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9921,.,O,332.0,The greater protective effect of leaf extracts was in correlation with the levels of phenolics and antioxidant capacity .
9991,In,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9992,epidemiological,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9993,studies,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9994,frequent,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9995,consumption,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9996,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9997,certain,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9998,fruits,B,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
9999,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10000,vegetables,B,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10001,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10002,in,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10003,laboratory,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10004,experiments,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10005,some,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10006,components,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10007,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10008,fruits,B,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10009,and,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10010,vegetables,B,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10011,",",O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10012,especially,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10013,cruciferous,B,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10014,vegetables,I,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10015,",",O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10016,appear,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10017,to,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10018,decrease,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10019,the,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10020,incidence,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10021,of,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10022,cancers,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10023,at,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10024,various,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10025,sites,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10026,.,O,336.0,"In epidemiological studies frequent consumption of certain fruits and vegetables and in laboratory experiments some components of fruits and vegetables , especially cruciferous vegetables , appear to decrease the incidence of cancers at various sites ."
10370,The,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10371,MOEs,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10372,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10373,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10374,younger,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10375,age,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10376,groups,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10377,indicate,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10378,a,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10379,health,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10380,concern,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10381,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10382,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10383,food,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10384,consumption,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10385,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10386,with,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10387,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10388,highest,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10389,mean,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10390,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10391,",",O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10392,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10393,well,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10394,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10395,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10396,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10397,P95,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10398,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10399,in,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10400,all,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10401,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10402,.,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10867,Random,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10868,effect,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10869,models,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10870,adjusting,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10871,for,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10872,relevant,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10873,confounders,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10874,were,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10875,used,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10876,to,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10877,estimate,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10878,changes,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10879,in,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10880,repetitive,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10881,measures,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10882,of,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10883,FPG,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10884,and,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10885,2h,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10886,-,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10887,PG,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
10888,.,O,365.0,Random effect models adjusting for relevant confounders were used to estimate changes in repetitive measures of FPG and 2h - PG .
11476,As,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11477,a,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11478,result,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11479,",",O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11480,consumption,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11481,of,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11482,a,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11483,Mediterranean,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11484,dietary,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11485,pattern,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11486,favorably,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11487,affects,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11488,numerous,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11489,cardiovascular,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11490,disease,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11491,risk,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11492,factors,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11493,",",O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11494,such,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11495,as,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11496,dyslipidemia,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11497,",",O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11498,hypertension,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11499,",",O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11500,metabolic,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11501,syndrome,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11502,",",O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11503,and,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11504,diabetes,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11505,.,O,383.0,"As a result , consumption of a Mediterranean dietary pattern favorably affects numerous cardiovascular disease risk factors , such as dyslipidemia , hypertension , metabolic syndrome , and diabetes ."
11650,The,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11651,prevalence,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11652,of,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11653,chronic,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11654,respiratory,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11655,symptoms,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11656,was,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11657,significantly,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11658,higher,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11659,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11660,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11661,exposed,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11662,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11663,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11664,in,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11665,the,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11666,control,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11667,workers,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11668,(,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11669,P,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11670,less,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11671,than,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11672,0.01,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11673,),O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11674,.,O,390.0,The prevalence of chronic respiratory symptoms was significantly higher in the exposed workers than in the control workers ( P less than 0.01 ) .
11769,In,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11770,those,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11771,workers,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11772,with,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11773,negative,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11774,skin,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11775,reactions,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11776,only,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11777,FEF50,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11778,and,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11779,FEF25,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11780,reached,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11781,statistical,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11782,significance,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11783,.,O,396.0,In those workers with negative skin reactions only FEF50 and FEF25 reached statistical significance .
11829,These,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11830,data,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11831,suggest,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11832,that,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11833,immunologic,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11834,reactions,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11835,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11836,spices,B,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11837,are,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11838,frequent,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11839,in,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11840,spice,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11841,workers,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11842,and,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11843,may,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11844,be,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11845,related,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11846,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11847,acute,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11848,symptoms,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11849,and,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11850,lung,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11851,function,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11852,changes,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11853,",",O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11854,but,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11855,not,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11856,to,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11857,chronic,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11858,changes,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11859,.,O,398.0,"These data suggest that immunologic reactions to spices are frequent in spice workers and may be related to acute symptoms and lung function changes , but not to chronic changes ."
11896,Pulses,B,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11897,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11898,including,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11899,peas,B,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11900,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11901,are,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11902,a,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11903,good,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11904,source,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11905,of,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11906,protein,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11907,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11908,dietary,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11909,fiber,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11910,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11911,folic,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11912,acid,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11913,",",O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11914,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11915,iron,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11916,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11917,are,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11918,reported,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11919,to,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11920,reduce,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11921,the,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11922,risk,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11923,for,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11924,cardiovascular,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11925,disease,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11926,and,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11927,diabetes,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
11928,.,O,400.0,"Pulses , including peas , are a good source of protein , dietary fiber , folic acid , and iron and are reported to reduce the risk for cardiovascular disease and diabetes ."
12776,There,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12777,is,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12778,limited,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12779,evidence,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12780,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12781,a,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12782,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12783,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12784,preventive,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12785,effect,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12786,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12787,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12788,consumption,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12789,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12790,fruits,B,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12791,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12792,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12793,for,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12794,cancer,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12795,of,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12796,the,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12797,mouth,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12798,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12799,pharynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12800,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12801,esophagus,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12802,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12803,stomach,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12804,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12805,colon,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12806,-,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12807,rectum,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12808,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12809,larynx,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12810,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12811,lung,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12812,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12813,ovary,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12814,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12815,vegetables,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12816,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12817,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12818,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12819,bladder,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12820,(,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12821,fruit,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12822,only,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12823,),O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12824,",",O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12825,and,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12826,kidney,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12827,.,O,426.0,"There is limited evidence for a cancer - preventive effect of the consumption of fruits and vegetables for cancer of the mouth and pharynx , esophagus , stomach , colon - rectum , larynx , lung , ovary ( vegetables only ) , bladder ( fruit only ) , and kidney ."
12885,It,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12886,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12887,important,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12888,to,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12889,recognize,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12890,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12891,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12892,is,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12893,only,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12894,a,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12895,crude,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12896,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12897,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12898,estimates,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12899,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12900,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12901,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12902,proportion,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12903,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12904,cancers,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12905,that,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12906,might,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12907,be,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12908,preventable,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12909,by,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12910,increasing,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12911,fruit,B,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12912,and,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12913,vegetable,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12914,intake,I,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12915,may,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12916,vary,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12917,beyond,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12918,this,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12919,range,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12920,for,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12921,specific,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12922,cancer,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12923,sites,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12924,and,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12925,across,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12926,different,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12927,regions,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12928,of,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12929,the,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12930,world,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
12931,.,O,429.0,It is important to recognize that this is only a crude range of estimates and that the proportion of cancers that might be preventable by increasing fruit and vegetable intake may vary beyond this range for specific cancer sites and across different regions of the world .
13006,The,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13007,prevalence,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13008,of,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13009,hypersensitivity,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13010,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13011,wheat,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13012,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13013,soy,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13014,appears,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13015,similar,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13016,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13017,sesame,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13018,seed,I,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13019,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13020,cashew,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13021,nut,I,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13022,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13023,hazelnut,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13024,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13025,walnut,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13026,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13027,but,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13028,allergy,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13029,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13030,fish,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13031,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13032,brazil,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13033,nut,I,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13034,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13035,shell,B,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13036,fish,I,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13037,are,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13038,uncommon,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13039,.,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13089,Rice,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13090,hypersensitivity,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13091,was,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13092,rare,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13093,in,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13094,both,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13095,Australia,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13096,and,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13097,Asian,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13098,countries,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13099,.,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13100,Milk,B,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13101,consumption,I,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13102,decreases,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13103,inflammatory,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13104,stress,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13105,in,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13106,overweight,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13107,and,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13108,obese,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13109,subjects,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13110,.,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13131,The,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13132,aim,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13133,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13134,the,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13135,present,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13136,study,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13137,was,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13138,to,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13139,compare,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13140,the,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13141,acute,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13142,effect,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13143,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13144,meals,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13145,rich,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13146,in,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13147,casein,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13148,and,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13149,carbohydrate,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13150,and,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13151,a,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13152,combination,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13153,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13154,both,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13155,nutrients,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13156,on,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13157,postprandial,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13158,plasma,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13159,concentrations,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13160,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13161,IL-6,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13162,",",O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13163,a,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13164,marker,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13165,of,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13166,inflammation,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13167,",",O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13168,in,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13169,obese,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13170,women,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13171,.,O,437.0,"The aim of the present study was to compare the acute effect of meals rich in casein and carbohydrate and a combination of both nutrients on postprandial plasma concentrations of IL-6 , a marker of inflammation , in obese women ."
13407,Information,O,445.0,Information concerning gluten intake in the general population is scarce .
13408,concerning,O,445.0,Information concerning gluten intake in the general population is scarce .
13409,gluten,O,445.0,Information concerning gluten intake in the general population is scarce .
13410,intake,O,445.0,Information concerning gluten intake in the general population is scarce .
13411,in,O,445.0,Information concerning gluten intake in the general population is scarce .
13412,the,O,445.0,Information concerning gluten intake in the general population is scarce .
13413,general,O,445.0,Information concerning gluten intake in the general population is scarce .
13414,population,O,445.0,Information concerning gluten intake in the general population is scarce .
13415,is,O,445.0,Information concerning gluten intake in the general population is scarce .
13416,scarce,O,445.0,Information concerning gluten intake in the general population is scarce .
13417,.,O,445.0,Information concerning gluten intake in the general population is scarce .
13594,Oats,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13595,were,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13596,introduced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13597,first,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13598,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13599,rapidly,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13600,outpaced,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13601,by,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13602,wheat,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13603,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13604,the,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13605,intake,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13606,of,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13607,which,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13608,continued,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13609,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13610,increase,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13611,with,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13612,age,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13613,",",O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13614,whereas,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13615,oats,B,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13616,started,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13617,to,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13618,decrease,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13619,at,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13620,12,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13621,months,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
13622,.,O,453.0,"Oats were introduced first , rapidly outpaced by wheat , the intake of which continued to increase with age , whereas oats started to decrease at 12 months ."
27520,The,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27521,dietary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27522,guidelines,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27523,are,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27524,based,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27525,on,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27526,29,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27527,systematic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27528,reviews,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27529,of,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27530,English,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27531,language,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27532,meta,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27533,-,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27534,analyses,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27535,in,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27536,PubMed,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27537,summarizing,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27538,randomized,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27539,controlled,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27540,trials,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27541,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27542,prospective,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27543,cohort,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27544,studies,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27545,on,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27546,nutrients,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27547,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27548,foods,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27549,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27550,food,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27551,patterns,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27552,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27553,the,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27554,risk,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27555,of,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27556,10,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27557,major,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27558,chronic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27559,diseases,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27560,:,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27561,coronary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27562,heart,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27563,disease,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27564,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27565,stroke,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27566,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27567,heart,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27568,failure,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27569,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27570,diabetes,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27571,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27572,breast,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27573,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27574,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27575,colorectal,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27576,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27577,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27578,lung,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27579,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27580,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27581,chronic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27582,obstructive,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27583,pulmonary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27584,disease,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27585,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27586,dementia,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27587,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27588,depression,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27589,.,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27590,The,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27591,committee,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27592,also,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27593,selected,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27594,three,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27595,causal,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27596,risk,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27597,factors,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27598,for,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27599,cardiovascular,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27600,diseases,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27601,or,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27602,diabetes,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27603,:,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27604,systolic,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27605,blood,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27606,pressure,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27607,",",O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27608,low,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27609,-,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27610,density,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27611,lipoprotein,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27612,cholesterol,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27613,and,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27614,body,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27615,weight,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
27616,.,O,935.0,"The committee also selected three causal risk factors for cardiovascular diseases or diabetes : systolic blood pressure , low - density lipoprotein cholesterol and body weight ."
28079,To,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28080,estimate,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28081,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28082,effects,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28083,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28084,consuming,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28085,hot,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28086,beverages,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28087,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28088,including,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28089,mate,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28090,(,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28091,an,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28092,infusion,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28093,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28094,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28095,herb,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28096,Ilex,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28097,paraguayensis,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28098,),O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28099,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28100,tea,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28101,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28102,coffee,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28103,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28104,coffee,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28105,with,I,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28106,milk,I,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28107,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28108,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28109,other,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28110,food,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28111,items,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28112,on,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28113,esophageal,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28114,cancer,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28115,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28116,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28117,we,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28118,analyzed,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28119,data,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28120,from,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28121,830,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28122,cases,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28123,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28124,"1,779",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28125,controls,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28126,participating,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28127,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28128,a,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28129,series,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28130,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28131,5,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28132,hospital,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28133,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28134,based,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28135,case,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28136,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28137,control,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28138,studies,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28139,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28140,squamous,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28141,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28142,cell,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28143,carcinoma,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28144,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28145,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28146,esophagus,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28147,conducted,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28148,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28149,high,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28150,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28151,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28152,areas,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28153,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28154,South,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28155,America,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28156,.,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28406,Our,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28407,study,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28408,further,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28409,confirms,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28410,the,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28411,protective,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28412,effect,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28413,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28414,a,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28415,dietary,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28416,pattern,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28417,characterized,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28418,by,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28419,daily,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28420,consumption,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28421,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28422,fruits,B,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28423,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28424,vegetables,B,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28425,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28426,low,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28427,consumption,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28428,of,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28429,meat,B,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28430,and,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28431,animal,B,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28432,fats,I,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28433,.,O,962.0,Our study further confirms the protective effect of a dietary pattern characterized by daily consumption of fruits and vegetables and low consumption of meat and animal fats .
28888,The,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28889,change,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28890,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28891,form,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28892,of,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28893,milk,B,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28894,offered,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28895,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28896,schools,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28897,to,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28898,lower,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28899,fat,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28900,and,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28901,lower,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28902,added,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28903,sugar,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28904,content,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28905,in,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28906,the,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28907,United,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28908,States,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28909,has,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28910,been,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28911,driven,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28912,by,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28913,government,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28914,-,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28915,mandated,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28916,school,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28917,lunch,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28918,calorie,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28919,and,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28920,fat,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28921,requirements,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
28922,.,O,979.0,The change in form of milk offered in schools to lower fat and lower added sugar content in the United States has been driven by government - mandated school lunch calorie and fat requirements .
29361,However,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29362,",",O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29363,spices,B,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29364,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29365,herbs,B,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29366,cultivated,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29367,mainly,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29368,in,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29369,tropic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29370,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29371,subtropic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29372,areas,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29373,can,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29374,be,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29375,exposed,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29376,to,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29377,contamination,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29378,with,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29379,toxigenic,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29380,fungi,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29381,and,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29382,subsequently,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29383,mycotoxins,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29384,.,O,995.0,"However , spices and herbs cultivated mainly in tropic and subtropic areas can be exposed to contamination with toxigenic fungi and subsequently mycotoxins ."
29517,Overall,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29518,liking,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29519,of,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29520,the,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29521,RF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29522,breakfast,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29523,and,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29524,lunch,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29525,meals,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29526,were,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29527,lower,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29528,than,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29529,the,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29530,FF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29531,and,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29532,RFS,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29533,versions,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29534,(,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29535,breakfast,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29536,:,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29537,6.50,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29538,RF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29539,compared,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29540,with,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29541,6.84,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29542,FF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29543,",",O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29544,P,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29545,=,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29546,0.0061,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29547,;,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29548,6.50,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29549,RF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29550,compared,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29551,with,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29552,6.82,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29553,RFS,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29554,",",O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29555,P,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29556,=,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29557,0.0030,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29558,;,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29559,lunch,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29560,:,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29561,6.35,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29562,RF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29563,compared,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29564,with,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29565,6.94,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29566,FF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29567,",",O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29568,P,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29569,<,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29570,0.0001,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29571,;,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29572,6.35,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29573,RF,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29574,compared,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29575,with,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29576,6.71,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29577,RFS,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29578,",",O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29579,P,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29580,=,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29581,0.0061,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29582,),O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29583,.,O,1001.0,"Overall liking of the RF breakfast and lunch meals were lower than the FF and RFS versions ( breakfast : 6.50 RF compared with 6.84 FF , P = 0.0061 ; 6.50 RF compared with 6.82 RFS , P = 0.0030 ; lunch : 6.35 RF compared with 6.94 FF , P < 0.0001 ; 6.35 RF compared with 6.71 RFS , P = 0.0061 ) ."
29705,Herbs,B,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29706,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29707,spices,B,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29708,may,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29709,be,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29710,useful,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29711,for,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29712,improving,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29713,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29714,liking,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29715,of,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29716,lower,B,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29717,fat,I,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29718,foods,I,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29719,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29720,helping,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29721,Americans,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29722,maintain,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29723,a,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29724,diet,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29725,consistent,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29726,with,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29727,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29728,U.S.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29729,Dietary,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29730,Guidelines,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29731,.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
30063,N,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30064,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30065,terminal,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30066,sequence,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30067,analysis,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30068,of,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30069,the,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30070,14-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30071,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30072,28,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30073,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30074,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30075,pepper,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30076,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30077,23,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30078,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30079,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30080,paprika,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30081,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30082,revealed,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30083,no,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30084,homology,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30085,to,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30086,known,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30087,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30088,.,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30089,The,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30090,28,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30091,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30092,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30093,pepper,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30094,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30095,showed,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30096,homology,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30097,to,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30098,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30099,wheat,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30100,germin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30101,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30102,",",O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30103,and,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30104,the,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30105,23,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30106,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30107,kDa,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30108,paprika,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30109,allergen,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30110,was,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30111,identified,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30112,as,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30113,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30114,homolog,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30115,of,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30116,a,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30117,osmotin,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30118,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30119,like,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30120,or,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30121,pathogenesis,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30122,-,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30123,related,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30124,protein,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30125,in,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30126,tomato,B,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30127,.,O,1019.0,"The 28 - kDa pepper allergen showed homology to a wheat germin protein , and the 23 - kDa paprika allergen was identified as a homolog of a osmotin - like or pathogenesis - related protein in tomato ."
30632,Understanding,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30633,the,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30634,adolescents,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30635,',O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30636,nutrition,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30637,behavior,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30638,during,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30639,COVID-19,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30640,lockdown,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30641,will,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30642,help,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30643,public,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30644,health,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30645,authorities,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30646,reshape,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30647,future,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30648,policies,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30649,on,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30650,their,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30651,nutritional,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30652,recommendations,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30653,",",O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30654,in,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30655,preparation,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30656,for,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30657,future,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30658,pandemics,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
30659,.,O,1037.0,"Understanding the adolescents ' nutrition behavior during COVID-19 lockdown will help public health authorities reshape future policies on their nutritional recommendations , in preparation for future pandemics ."
31538,The,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31539,epidemiologic,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31540,studies,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31541,on,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31542,tea,B,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31543,drinking,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31544,and,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31545,stomach,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31546,cancer,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31547,do,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31548,not,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31549,justify,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31550,claims,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31551,of,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31552,a,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31553,cancer,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31554,-,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31555,protective,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31556,effect,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31557,.,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31558,A,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31559,protective,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31560,effect,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31561,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31562,green,B,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31563,tea,I,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31564,on,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31565,the,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31566,development,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31567,of,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31568,colon,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31569,cancer,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31570,is,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31571,suggested,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31572,.,O,1069.0,A protective effect of green tea on the development of colon cancer is suggested .
31671,The,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31672,disparities,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31673,in,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31674,colon,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31675,cancer,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31676,incidence,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31677,between,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31678,African,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31679,-,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31680,Americans,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31681,and,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31682,other,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31683,U.S.,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31684,ethnic,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31685,groups,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31686,are,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31687,largely,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31688,unexplained,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31689,.,O,1074.0,The disparities in colon cancer incidence between African - Americans and other U.S. ethnic groups are largely unexplained .
31777,Multivariate,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31778,logistic,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31779,regression,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31780,models,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31781,estimated,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31782,energy,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31783,-,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31784,adjusted,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31785,and,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31786,non,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31787,-,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31788,energy,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31789,adjusted,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31790,odds,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31791,ratios,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31792,(,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31793,OR,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31794,),O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
31795,.,O,1078.0,Multivariate logistic regression models estimated energy - adjusted and non - energy adjusted odds ratios ( OR ) .
33216,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33217,availability,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33218,was,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33219,estimated,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33220,using,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33221,FAO,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33222,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33223,Balance,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33224,Sheet,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33225,data,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33226,on,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33227,country,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33228,-,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33229,level,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33230,food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33231,supply,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33232,.,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33310,Literature,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33311,on,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33312,the,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33313,nutritional,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33314,and,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33315,medicinal,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33316,potential,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33317,of,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33318,bamboo,B,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33319,shoots,I,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33320,is,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33321,scarce,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33322,.,O,1131.0,Literature on the nutritional and medicinal potential of bamboo shoots is scarce .
33336,Various,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33337,edible,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33338,species,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33339,and,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33340,exotic,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33341,food,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33342,products,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33343,(,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33344,fermented,B,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33345,shoots,I,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33346,",",O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33347,pickle,B,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33348,",",O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33349,etc,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33350,.,O,1133.0,"Various edible species and exotic food products ( fermented shoots , pickle , etc ."
33506,are,O,1141.0,are now gaining importance .
33507,now,O,1141.0,are now gaining importance .
33508,gaining,O,1141.0,are now gaining importance .
33509,importance,O,1141.0,are now gaining importance .
33510,.,O,1141.0,are now gaining importance .
33528,The,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33529,effects,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33530,of,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33531,feeding,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33532,a,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33533,5,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33534,%,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33535,corn,B,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33536,oil,I,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33537,or,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33538,coconut,B,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33539,oil,I,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33540,diet,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33541,on,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33542,the,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33543,composition,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33544,of,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33545,hepatic,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33546,phospholipid,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33547,fatty,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33548,acids,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33549,and,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33550,on,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33551,hepatic,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33552,mitochondrial,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33553,function,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33554,were,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33555,studied,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33556,.,O,1143.0,The effects of feeding a 5 % corn oil or coconut oil diet on the composition of hepatic phospholipid fatty acids and on hepatic mitochondrial function were studied .
33821,The,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33822,amount,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33823,and,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33824,source,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33825,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33826,fat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33827,was,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33828,varied,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33829,in,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33830,diets,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33831,fed,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33832,to,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33833,anemic,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33834,rats,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33835,for,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33836,assaying,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33837,the,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33838,bioavailability,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33839,of,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33840,iron,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33841,from,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33842,turkey,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33843,meat,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33844,.,O,1155.0,The amount and source of fat was varied in diets fed to anemic rats for assaying the bioavailability of iron from turkey meat .
33916,It,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33917,was,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33918,found,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33919,that,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33920,animals,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33921,fed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33922,beef,B,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33923,fat,I,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33924,were,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33925,most,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33926,efficient,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33927,at,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33928,converting,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33929,iron,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33930,from,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33931,turkey,B,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33932,meat,I,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33933,into,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33934,hemoglobin,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33935,followed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33936,by,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33937,those,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33938,fed,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33939,turkey,B,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33940,fat,I,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33941,",",O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33942,corn,B,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33943,oil,I,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33944,and,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33945,pork,B,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33946,fat,I,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33947,in,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33948,descending,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33949,order,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
33950,.,O,1158.0,"It was found that animals fed beef fat were most efficient at converting iron from turkey meat into hemoglobin followed by those fed turkey fat , corn oil and pork fat in descending order ."
34139,Concerning,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34140,prostatic,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34141,cancer,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34142,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34143,milk,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34144,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34145,1961,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34146,-,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34147,90,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34148,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34149,was,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34150,most,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34151,closely,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34152,correlated,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34153,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34154,r,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34155,=,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34156,0.711,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34157,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34158,with,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34159,its,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34160,incidence,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34161,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34162,followed,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34163,by,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34164,meat,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34165,and,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34166,coffee,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34167,.,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34442,Withdrawal,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34443,periods,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34444,for,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34445,mastitis,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34446,treatments,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34447,averaged,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34448,4.5,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34449,days,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34450,",",O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34451,with,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34452,a,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34453,mean,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34454,incidence,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34455,of,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34456,20,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34457,%,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34458,of,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34459,cows,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34460,in,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34461,a,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34462,herd,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34463,.,O,1175.0,"Withdrawal periods for mastitis treatments averaged 4.5 days , with a mean incidence of 20 % of cows in a herd ."
34624,Nevertheless,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34625,",",O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34626,about,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34627,2,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34628,%,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34629,of,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34630,the,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34631,barley,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34632,global,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34633,production,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34634,is,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34635,utilized,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34636,due,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34637,to,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34638,unacceptable,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34639,organoleptic,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34640,characters,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34641,.,O,1181.0,"Nevertheless , about 2 % of the barley global production is utilized due to unacceptable organoleptic characters ."
34642,Therefore,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34643,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34644,continuous,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34645,modifications,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34646,are,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34647,ongoing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34648,either,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34649,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34650,develop,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34651,new,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34652,cultivars,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34653,for,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34654,different,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34655,purposes,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34656,",",O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34657,or,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34658,novel,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34659,processing,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34660,methods,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34661,to,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34662,improve,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34663,its,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34664,organoleptic,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34665,characters,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34666,.,O,1182.0,"Therefore , continuous modifications are ongoing either to develop new cultivars for different purposes , or novel processing methods to improve its organoleptic characters ."
34734,The,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34735,optimum,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34736,formulation,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34737,for,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34738,mayonnaise,B,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34739,-,B,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34740,type,B,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34741,spreads,I,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34742,containing,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34743,rice,B,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34744,bran,I,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34745,oil,I,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34746,(,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34747,RBO,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34748,),O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34749,and,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34750,soy,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34751,protein,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34752,concentrate,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34753,(,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34754,SPC,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34755,),O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34756,was,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34757,determined,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34758,based,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34759,on,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34760,sensory,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34761,acceptability,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
34762,.,O,1185.0,The optimum formulation for mayonnaise - type spreads containing rice bran oil ( RBO ) and soy protein concentrate ( SPC ) was determined based on sensory acceptability .
35082,The,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35083,aim,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35084,of,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35085,this,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35086,study,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35087,was,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35088,to,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35089,develop,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35090,a,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35091,rapid,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35092,",",O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35093,sensitive,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35094,",",O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35095,and,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35096,specific,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35097,enzyme,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35098,-,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35099,linked,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35100,immunosorbent,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35101,assay,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35102,(,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35103,ELISA,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35104,),O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35105,method,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35106,for,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35107,the,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35108,detection,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35109,of,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35110,walnut,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35111,protein,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35112,residues,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35113,.,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35330,Researchers,O,1204.0,Researchers do not understand what causes ovarian cancer .
35331,do,O,1204.0,Researchers do not understand what causes ovarian cancer .
35332,not,O,1204.0,Researchers do not understand what causes ovarian cancer .
35333,understand,O,1204.0,Researchers do not understand what causes ovarian cancer .
35334,what,O,1204.0,Researchers do not understand what causes ovarian cancer .
35335,causes,O,1204.0,Researchers do not understand what causes ovarian cancer .
35336,ovarian,O,1204.0,Researchers do not understand what causes ovarian cancer .
35337,cancer,O,1204.0,Researchers do not understand what causes ovarian cancer .
35338,.,O,1204.0,Researchers do not understand what causes ovarian cancer .
35656, ,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35657,Another,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35658,problem,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35659,is,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35660,that,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35661,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35662,subsets,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35663,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35664,exposure,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35665,or,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35666,subgroups,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35667,of,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35668,the,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35669,population,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35670,are,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35671,unpredictable,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35672,.,O,1219.0,  Another problem is that the subsets of exposure or subgroups of the population are unpredictable .
35837,Over,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35838,a,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35839,12,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35840,-,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35841,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35842,period,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35843,",",O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35844,cows,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35845,were,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35846,ruminally,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35847,infused,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35848,with,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35849,1,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35850,L,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35851,/,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35852,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35853,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35854,water,B,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35855,or,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35856,water,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35857,containing,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35858,8,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35859,mg,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35860,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35861,perchlorate,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35862,.,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
36015,The,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36016,overall,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36017,finding,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36018,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36019,mastitis,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36020,results,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36021,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36022,lower,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36023,milk,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36024,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36025,concentrations,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36026,suggests,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36027,that,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36028,changes,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36029,in,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36030,udder,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36031,health,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36032,do,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36033,not,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36034,necessitate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36035,increased,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36036,screening,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36037,of,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36038,milk,B,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36039,for,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36040,perchlorate,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36041,.,O,1234.0,The overall finding that mastitis results in lower milk perchlorate concentrations suggests that changes in udder health do not necessitate increased screening of milk for perchlorate .
36133,Short,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36134,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36135,chain,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36136,fatty,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36137,acid,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36138,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36139,SCFA,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36140,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36141,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36142,hydrogen,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36143,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36144,H2,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36145,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36146,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36147,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36148,methane,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36149,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36150,CH4,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36151,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36152,productions,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36153,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36154,neutral,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36155,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36156,detergent,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36157,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36158,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36159,NDF,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36160,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36161,digestibility,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36162,differed,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36163,significantly,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36164,with,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36165,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36166,source,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36167,.,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36405,There,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36406,were,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36407,significant,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36408,reductions,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36409,in,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36410,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36411,intake,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36412,of,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36413,table,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36414,fat,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36415,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36416,high,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36417,-,I,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36418,fat,I,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36419,milk,I,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36420,products,I,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36421,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36422,pork,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36423,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36424,sausages,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36425,(,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36426,containing,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36427,greater,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36428,than,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36429,11,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36430,%,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36431,fat,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36432,),O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36433,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36434,eggs,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36435,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36436,rice,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36437,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36438,pasta,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36439,",",O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36440,cakes,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36441,and,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36442,chocolate,B,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36443,for,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36444,the,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36445,intervention,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36446,group,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36447,.,O,1245.0,"There were significant reductions in the intake of table fat , high - fat milk products , pork and sausages ( containing greater than 11 % fat ) , eggs , rice , pasta , cakes and chocolate for the intervention group ."
36755,Such,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36756,a,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36757,nutritional,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36758,state,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36759,reflects,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36760,avoiding,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36761,excess,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36762,adiposity,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36763,through,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36764,healthy,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36765,dietary,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36766,patterns,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36767,rich,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36768,in,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36769,plant,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36770,foods,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36771,(,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36772,legumes,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36773,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36774,wholegrains,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36775,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36776,pulses,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36777,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36778,vegetables,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36779,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36780,fruits,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36781,),O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36782,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36783,with,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36784,modest,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36785,meat,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36786,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36787,fish,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36788,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36789,dairy,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36790,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36791,low,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36792,in,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36793,alcohol,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36794,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36795,salt,B,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36796,preserved,I,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36797,foods,I,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36798,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36799,and,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36800,an,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36801,active,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36802,way,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36803,of,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36804,life,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36805,",",O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36806,avoiding,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36807,sedentary,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36808,behaviours,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36809,.,O,1258.0,"Such a nutritional state reflects avoiding excess adiposity through healthy dietary patterns rich in plant foods ( legumes , wholegrains , pulses , vegetables and fruits ) , with modest meat , fish and dairy , low in alcohol and salt preserved foods , and an active way of life , avoiding sedentary behaviours ."
36810,Less,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36811,is,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36812,known,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36813,about,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36814,the,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36815,impact,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36816,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36817,nutritional,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36818,interventions,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36819,in,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36820,people,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36821,with,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36822,a,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36823,diagnosis,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36824,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36825,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36826,",",O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36827,but,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36828,nutrition,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36829,including,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36830,adiposity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36831,and,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36832,physical,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36833,activity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36834,predict,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36835,breast,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36836,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36837,outcome,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36838,.,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36839,Promoting,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36840,healthy,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36841,ways,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36842,of,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36843,life,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36844,requires,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36845,public,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36846,information,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36847,and,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36848,education,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36849,",",O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36850,but,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36851,alone,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36852,these,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36853,do,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36854,not,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36855,generate,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36856,change,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36857,;,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36858,a,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36859,socio,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36860,-,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36861,political,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36862,and,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36863,cultural,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36864,environment,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36865,that,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36866,is,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36867,conducive,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36868,to,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36869,adopting,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36870,healthy,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36871,behaviours,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36872,is,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36873,needed,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36874,.,O,1260.0,"Promoting healthy ways of life requires public information and education , but alone these do not generate change ; a socio - political and cultural environment that is conducive to adopting healthy behaviours is needed ."
36938,There,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36939,are,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36940,many,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36941,kinds,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36942,of,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36943,diseases,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36944,of,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36945,the,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36946,liver,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36947,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36948,caused,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36949,by,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36950,viruses,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36951,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36952,such,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36953,as,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36954,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36955,A,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36956,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36957,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36958,B,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36959,and,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36960,hepatitis,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36961,C,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36962,",",O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36963,or,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36964,by,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36965,certain,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36966,drugs,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36967,and,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36968,poisons,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36969,including,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36970,excessive,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36971,alcohol,B,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36972,consumption,I,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36973,.,O,1264.0,"There are many kinds of diseases of the liver , caused by viruses , such as hepatitis A , hepatitis B and hepatitis C , or by certain drugs and poisons including excessive alcohol consumption ."
36974,Many,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36975,herbal,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36976,medicines,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36977,are,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36978,used,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36979,in,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36980,traditional,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36981,medicine,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36982,for,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36983,their,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36984,protective,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36985,and,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36986,therapeutic,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36987,properties,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36988,against,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36989,liver,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36990,diseases,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
36991,.,O,1265.0,Many herbal medicines are used in traditional medicine for their protective and therapeutic properties against liver diseases .
37465,Against,O,1282.0,"Against this background , emerging data on potassium are presented ."
37466,this,O,1282.0,"Against this background , emerging data on potassium are presented ."
37467,background,O,1282.0,"Against this background , emerging data on potassium are presented ."
37468,",",O,1282.0,"Against this background , emerging data on potassium are presented ."
37469,emerging,O,1282.0,"Against this background , emerging data on potassium are presented ."
37470,data,O,1282.0,"Against this background , emerging data on potassium are presented ."
37471,on,O,1282.0,"Against this background , emerging data on potassium are presented ."
37472,potassium,O,1282.0,"Against this background , emerging data on potassium are presented ."
37473,are,O,1282.0,"Against this background , emerging data on potassium are presented ."
37474,presented,O,1282.0,"Against this background , emerging data on potassium are presented ."
37475,.,O,1282.0,"Against this background , emerging data on potassium are presented ."
37505,Potassium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37506,was,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37507,inversely,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37508,associated,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37509,with,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37510,both,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37511,urinary,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37512,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37513,excretion,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37514,and,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37515,intestinal,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37516,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37517,absorption,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37518,",",O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37519,yielding,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37520,no,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37521,significant,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37522,net,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37523,change,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37524,in,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37525,calcium,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37526,balance,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37527,.,O,1284.0,"Potassium was inversely associated with both urinary calcium excretion and intestinal calcium absorption , yielding no significant net change in calcium balance ."
37996,Results,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37997,suggest,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37998,that,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
37999,NOC,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38000,from,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38001,dietary,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38002,bacon,B,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38003,would,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38004,not,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38005,enhance,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38006,colon,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38007,carcinogenesis,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38008,in,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38009,rats,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38010,.,O,1304.0,Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats .
38725,Our,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38726,study,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38727,included,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38728,22,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38729,case,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38730,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38731,control,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38732,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38733,cohort,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38734,studies,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38735,with,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38736,a,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38737,total,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38738,of,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38739,2548,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38740,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38741,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38742,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38743,lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38744,cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38745,patients,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38746,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38747,9362,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38748,never,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38749,-,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38750,smoking,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38751,controls,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38752,from,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38753,North,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38754,America,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38755,",",O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38756,Europe,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38757,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38758,Asia,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38759,within,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38760,the,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38761,International,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38762,Lung,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38763,Cancer,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38764,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38765,(,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38766,ILCCO,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38767,),O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38768,and,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38769,SYNERGY,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38770,Consortium,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
38771,.,O,1333.0,"Our study included 22 case - control and cohort studies with a total of 2548 never - smoking lung cancer patients and 9362 never - smoking controls from North America , Europe and Asia within the International Lung Cancer Consortium ( ILCCO ) and SYNERGY Consortium ."
39021,Crossed,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39022,line,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39023,immunoelectrophoresis,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39024,(,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39025,CLIE,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39026,),O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39027,was,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39028,used,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39029,to,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39030,show,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39031,that,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39032,a,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39033,minor,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39034,allergen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39035,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39036,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39037,birch,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39038,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39039,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39040,another,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39041,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39042,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39043,timothy,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39044,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39045,shared,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39046,common,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39047,epitopes,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39048,with,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39049,antigens,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39050,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39051,apple,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39052,",",O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39053,carrot,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39054,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39055,celery,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39056,tuber,I,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39057,.,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39135,In,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39136,crossed,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39137,radioimmunoelectrophoresis,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39138,(,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39139,CRIE,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39140,),O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39141,none,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39142,of,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39143,the,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39144,precipitates,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39145,could,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39146,be,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39147,shown,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39148,to,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39149,act,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39150,as,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39151,an,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39152,allergen,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
39153,.,O,1346.0,In crossed radioimmunoelectrophoresis ( CRIE ) none of the precipitates could be shown to act as an allergen .
40658,A,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40659,higher,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40660,percentage,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40661,of,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40662,the,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40663,obese,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40664,group,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40665,reported,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40666,skipping,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40667,one,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40668,meal,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40669,and,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40670,eating,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40671,no,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40672,snack,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40673,at,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40674,school,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40675,.,O,1394.0,A higher percentage of the obese group reported skipping one meal and eating no snack at school .
40920,Intestinal,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40921,epitheliolysis,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40922,measured,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40923,as,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40924,alkaline,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40925,phosphatase,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40926,activity,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40927,in,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40928,fecal,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40929,water,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40930,was,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40931,lowered,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40932,comparably,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40933,to,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40934,the,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40935,reduction,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40936,in,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40937,cytotoxicity,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40938,by,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40939,supplemental,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40940,calcium,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40941,phosphate,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
40942,.,O,1403.0,Intestinal epitheliolysis measured as alkaline phosphatase activity in fecal water was lowered comparably to the reduction in cytotoxicity by supplemental calcium phosphate .
41295,Strategies,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41296,that,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41297,decrease,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41298,postprandial,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41299,glucose,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41300,excursions,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41301,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41302,including,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41303,digestive,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41304,enzyme,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41305,inhibition,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41306,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41307,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41308,low,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41309,glycemic,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41310,index,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41311,diets,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41312,result,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41313,in,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41314,lower,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41315,diabetes,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41316,incidence,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41317,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41318,coronary,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41319,heart,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41320,disease,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41321,(,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41322,CHD,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41323,),O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41324,risk,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41325,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41326,possibly,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41327,through,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41328,lower,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41329,postprandial,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41330,oxidative,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41331,damage,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41332,to,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41333,lipids,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41334,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41335,proteins,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41336,.,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41726,Cox,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41727,proportional,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41728,hazards,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41729,regression,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41730,was,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41731,used,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41732,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41733,calculate,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41734,hazard,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41735,ratios,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41736,for,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41737,incident,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41738,diabetes,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41739,according,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41740,to,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41741,categories,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41742,of,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41743,total,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41744,flavonoids,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41745,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41746,anthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41747,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41748,flavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41749,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41750,flavanones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41751,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41752,flavonols,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41753,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41754,flavan-3,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41755,-,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41756,ol,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41757,monomers,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41758,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41759,isoflavones,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41760,",",O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41761,and,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41762,proanthocyanidins,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41763,.,O,1431.0,"Cox proportional hazards regression was used to calculate hazard ratios for incident diabetes according to categories of total flavonoids and anthocyanidins , flavones , flavanones , flavonols , flavan-3 - ol monomers , isoflavones , and proanthocyanidins ."
41903,The,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41904,suggestive,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41905,evidence,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41906,of,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41907,a,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41908,protective,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41909,effect,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41910,of,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41911,regular,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41912,red,B,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41913,wine,I,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41914,consumption,I,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41915,is,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41916,shared,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41917,with,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41918,an,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41919,inverse,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41920,association,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41921,between,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41922,alcohol,B,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41923,drinks,I,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41924,in,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41925,general,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41926,and,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41927,diabetes,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41928,risk,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41929,and,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41930,may,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41931,reflect,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41932,the,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41933,effects,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41934,of,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41935,nonflavonoid,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41936,constituents,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41937,that,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41938,are,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41939,common,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41940,to,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41941,all,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41942,alcohol,B,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41943,drinks,I,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
41944,.,O,1437.0,The suggestive evidence of a protective effect of regular red wine consumption is shared with an inverse association between alcohol drinks in general and diabetes risk and may reflect the effects of nonflavonoid constituents that are common to all alcohol drinks .
42777,Whilst,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42778,dietary,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42779,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42780,have,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42781,been,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42782,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42783,subject,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42784,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42785,breast,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42786,cancer,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42787,risk,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42788,-,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42789,reduction,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42790,",",O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42791,this,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42792,review,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42793,will,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42794,focus,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42795,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42796,the,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42797,clinical,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42798,effects,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42799,of,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42800,polyphenols,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42801,on,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42802,reducing,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42803,recurrence,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
42804,.,O,1467.0,"Whilst dietary polyphenols have been the subject of breast cancer risk - reduction , this review will focus on the clinical effects of polyphenols on reducing recurrence ."
43037,Red,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43038,pepper,I,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43039,had,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43040,the,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43041,highest,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43042,total,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43043,antioxidant,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43044,activity,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43045,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43046,followed,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43047,by,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43048,broccoli,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43049,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43050,carrot,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43051,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43052,spinach,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43053,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43054,cabbage,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43055,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43056,yellow,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43057,onion,I,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43058,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43059,celery,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43060,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43061,potato,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43062,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43063,lettuce,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43064,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43065,and,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43066,cucumber,B,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43067,.,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
44022,Death,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44023,attributed,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44024,to,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44025,cardiovascular,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44026,and,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44027,coronary,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44028,heart,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44029,diseases,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44030,showed,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44031,strong,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44032,and,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44033,consistent,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44034,reductions,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44035,with,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44036,increasing,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44037,nut,B,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44038,/,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44039,peanut,I,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44040,butter,I,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44041,consumption,I,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44042,.,O,1516.0,Death attributed to cardiovascular and coronary heart diseases showed strong and consistent reductions with increasing nut / peanut butter consumption .
44193,In,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44194,analyses,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44195,focusing,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44196,on,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44197,nutrients,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44198,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44199,rather,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44200,than,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44201,foods,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44202,",",O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44203,polyunsaturated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44204,fats,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44205,were,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44206,positively,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44207,and,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44208,vitamin,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44209,E,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44210,inversely,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44211,associated,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44212,with,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44213,prostate,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44214,cancer,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44215,.,O,1522.0,"In analyses focusing on nutrients , rather than foods , polyunsaturated fats were positively and vitamin E inversely associated with prostate cancer ."
44448,He,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44449,was,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44450,previously,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44451,diagnosed,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44452,as,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44453,having,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44454,allergy,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44455,to,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44456,coconut,B,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44457,",",O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44458,banana,B,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44459,",",O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44460,and,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44461,kiwi,B,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44462,and,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44463,allergic,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44464,rhinitis,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44465,to,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44466,horse,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44467,",",O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44468,cat,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44469,",",O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44470,dog,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44471,",",O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44472,and,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44473,cow,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
44474,.,O,1532.0,"He was previously diagnosed as having allergy to coconut , banana , and kiwi and allergic rhinitis to horse , cat , dog , and cow ."
45112,A,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45113,bacon,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45114,-,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45115,based,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45116,diet,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45117,appears,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45118,to,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45119,protect,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45120,against,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45121,carcinogenesis,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45122,",",O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45123,perhaps,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45124,because,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45125,bacon,B,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45126,contains,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45127,5,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45128,%,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45129,NaCl,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45130,and,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45131,increased,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45132,the,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45133,rats,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45134,',O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45135,water,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45136,intake,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45137,.,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45649,These,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45650,associations,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45651,warrant,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45652,further,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45653,investigation,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45654,and,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45655,",",O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45656,if,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45657,confirmed,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45658,",",O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45659,they,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45660,might,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45661,have,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45662,important,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45663,public,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45664,health,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45665,implications,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45666,for,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45667,the,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45668,reduction,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45669,of,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45670,melanoma,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45671,incidence,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45672,through,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45673,dietary,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45674,modification,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45675,.,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45883,Based,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45884,on,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45885,these,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45886,results,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45887,",",O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45888,the,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45889,glycolipids,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45890,fraction,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45891,from,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45892,spinach,B,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45893,is,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45894,potentially,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45895,a,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45896,source,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45897,of,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45898,food,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45899,material,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45900,for,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45901,a,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45902,novel,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45903,anticancer,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45904,activity,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
45905,.,O,1588.0,"Based on these results , the glycolipids fraction from spinach is potentially a source of food material for a novel anticancer activity ."
46327,Other,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46328,contributions,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46329,have,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46330,included,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46331,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46332,value,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46333,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46334,nut,B,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46335,consumption,I,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46336,for,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46337,prevention,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46338,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46339,coronary,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46340,artery,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46341,disease,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46342,",",O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46343,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46344,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46345,roles,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46346,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46347,red,B,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46348,meat,I,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46349,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46350,dairy,B,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46351,products,I,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46352,in,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46353,the,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46354,etiologies,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46355,of,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46356,cardiovascular,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46357,disease,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46358,and,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46359,cancer,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46360,.,O,1601.0,"Other contributions have included the value of nut consumption for prevention of coronary artery disease , and the roles of red meat and dairy products in the etiologies of cardiovascular disease and cancer ."
46504,The,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46505,unusually,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46506,wide,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46507,range,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46508,of,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46509,milk,B,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46510,consumption,I,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46511,in,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46512,Adventists,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46513,will,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46514,be,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46515,particularly,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46516,informative,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46517,with,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46518,regard,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46519,to,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46520,these,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46521,relations,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46522,.,O,1608.0,The unusually wide range of milk consumption in Adventists will be particularly informative with regard to these relations .
46649,In,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46650,order,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46651,to,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46652,increase,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46653,the,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46654,sustainability,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46655,of,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46656,a,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46657,cardio,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46658,-,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46659,protective,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46660,diet,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46661,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46662,consumers,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46663,can,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46664,choose,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46665,nuts,B,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46666,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46667,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46668,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46669,walnuts,B,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46670,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46671,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46672,oils,B,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46673,(,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46674,e.g.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46675,",",O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46676,sunflower,B,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46677,),O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46678,with,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46679,lower,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46680,water,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46681,footprints,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46682,and,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46683,sustainably,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46684,produced,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46685,fish,B,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46686,.,O,1613.0,"In order to increase the sustainability of a cardio - protective diet , consumers can choose nuts ( e.g. , walnuts ) and oils ( e.g. , sunflower ) with lower water footprints and sustainably produced fish ."
46877,The,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46878,highest,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46879,oxalate,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46880,content,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46881,was,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46882,demonstrated,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46883,for,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46884,wheat,B,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46885,bran,I,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46886,(,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46887,457.4,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46888,mg/100,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46889,g,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46890,),O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
46891,.,O,1620.0,The highest oxalate content was demonstrated for wheat bran ( 457.4 mg/100 g ) .
47682,During,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47683,11,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47684,years,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47685,of,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47686,follow,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47687,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47688,up,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47689,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47690,899,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47691,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47692,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47693,316,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47694,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47695,-,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47696,related,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47697,deaths,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47698,",",O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47699,569,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47700,CVD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47701,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47702,and,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47703,301,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47704,CHD,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47705,events,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47706,occurred,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47707,.,O,1648.0,"During 11 years of follow - up , 899 deaths , 316 CVD - related deaths , 569 CVD events and 301 CHD events occurred ."
47956,The,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47957,serum,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47958,insulin,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47959,area,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47960,response,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47961,was,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47962,3.6,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47963,-,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47964,fold,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47965,greater,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47966,following,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47967,ingestion,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47968,of,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47969,cottage,B,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47970,cheese,I,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47971,compared,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47972,with,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47973,egg,B,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47974,white,I,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47975,(,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47976,309,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47977,v,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47978,86,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47979,pmol,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47980,/,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47981,L.h,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47982,),O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
47983,.,O,1657.0,The serum insulin area response was 3.6 - fold greater following ingestion of cottage cheese compared with egg white ( 309 v 86 pmol / L.h ) .
48613,Consumers,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48614,disliked,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48615,samples,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48616,with,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48617,a,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48618,strong,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48619,raw,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48620,potato,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48621,aroma,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48622,.,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48655,These,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48656,findings,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48657,imply,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48658,acceptance,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48659,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48660,sodium,B,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48661,-,I,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48662,reduced,I,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48663,potato,I,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48664,chips,I,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48665,and,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48666,puffed,B,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48667,rice,I,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48668,is,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48669,possible,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48670,by,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48671,focusing,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48672,on,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48673,these,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48674,identified,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48675,drivers,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48676,of,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48677,liking,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
48678,.,O,1682.0,These findings imply acceptance of sodium - reduced potato chips and puffed rice is possible by focusing on these identified drivers of liking .
49176,Overall,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49177,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49178,MedDiets,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49179,have,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49180,direct,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49181,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49182,mono,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49183,-,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49184,unsaturated,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49185,fatty,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49186,acids,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49187,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49188,MUFAs,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49189,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49190,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49191,tocopherols,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49192,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49193,polyphenols,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49194,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49195,and,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49196,indirect,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49197,(,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49198,low,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49199,saturated,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49200,fats,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49201,",",O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49202,well,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49203,-,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49204,balanced,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49205,linoleic,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49206,/,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49207,alpha,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49208,linolenic,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49209,acid,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49210,),O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49211,effects,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49212,on,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49213,the,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49214,immune,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49215,system,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49216,and,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49217,inflammatory,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49218,responses,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49219,.,O,1699.0,"Overall , MedDiets have direct ( mono - unsaturated fatty acids ( MUFAs ) , tocopherols , polyphenols ) and indirect ( low saturated fats , well - balanced linoleic / alpha linolenic acid ) effects on the immune system and inflammatory responses ."
49422,The,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49423,milk,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49424,prolactin,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49425,level,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49426,in,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49427,early,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49428,lactation,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49429,was,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49430,measured,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49431,",",O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49432,and,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49433,the,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49434,relation,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49435,with,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49436,NAS,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49437,IMI,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49438,was,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49439,determined,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49440,.,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49507,Our,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49508,data,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49509,suggest,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49510,that,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49511,IMI,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49512,with,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49513,NAS,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49514,(,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49515,as,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49516,a,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49517,group,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49518,),O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49519,present,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49520,shortly,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49521,after,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49522,calving,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49523,do,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49524,not,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49525,have,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49526,an,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49527,adverse,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49528,effect,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49529,on,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49530,later,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49531,production,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49532,.,O,1709.0,Our data suggest that IMI with NAS ( as a group ) present shortly after calving do not have an adverse effect on later production .
49533,The,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49534,milk,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49535,prolactin,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49536,concentrations,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49537,were,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49538,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49539,dissimilar,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49540,between,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49541,NAS,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49542,-,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49543,infected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49544,and,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49545,noninfected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49546,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49547,and,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49548,thus,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49549,can,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49550,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49551,explain,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49552,why,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49553,NAS,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49554,-,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49555,infected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49556,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49557,do,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49558,not,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49559,produce,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49560,less,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49561,than,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49562,noninfected,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49563,quarters,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
49564,.,O,1710.0,The milk prolactin concentrations were not dissimilar between NAS - infected and noninfected quarters and thus can not explain why NAS - infected quarters do not produce less than noninfected quarters .
51444,The,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51445,goal,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51446,of,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51447,the,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51448,present,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51449,study,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51450,was,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51451,to,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51452,provide,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51453,biochemical,B,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51454,and,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51455,genetic,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51456,evidence,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51457,that,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51458,sorghum,B,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51459,is,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51460,safe,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51461,for,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51462,celiac,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51463,patients,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51464,.,O,1766.0,The goal of the present study was to provide biochemical and genetic evidence that sorghum is safe for celiac patients .
51465,In,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51466,silico,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51467,analysis,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51468,of,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51469,the,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51470,recently,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51471,published,B,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51472,sorghum,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51473,genome,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51474,predicts,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51475,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51476,sorghum,B,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51477,does,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51478,not,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51479,contain,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51480,peptides,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51481,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51482,are,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51483,toxic,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51484,for,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51485,celiac,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51486,patients,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51487,.,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
52436,The,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52437,Mediterranean,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52438,diet,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52439,is,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52440,a,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52441,healthy,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52442,eating,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52443,pattern,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52444,with,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52445,protective,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52446,effects,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52447,on,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52448,chronic,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52449,diseases,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52450,.,O,1799.0,The Mediterranean diet is a healthy eating pattern with protective effects on chronic diseases .
52759,Seven,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52760,culinary,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52761,spices,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52762,including,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52763,black,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52764,pepper,I,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52765,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52766,cayenne,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52767,pepper,I,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52768,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52769,cinnamon,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52770,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52771,ginger,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52772,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52773,Mediterranean,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52774,oregano,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52775,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52776,rosemary,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52777,",",O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52778,and,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52779,turmeric,B,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52780,were,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52781,extracted,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52782,with,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52783,boiling,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52784,water,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52785,.,O,1810.0,"Seven culinary spices including black pepper , cayenne pepper , cinnamon , ginger , Mediterranean oregano , rosemary , and turmeric were extracted with boiling water ."
52843,A,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52844,total,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52845,of,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52846,14,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52847,phenolic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52848,compounds,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52849,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52850,a,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52851,piperine,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52852,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52853,cinnamic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52854,acid,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52855,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52856,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52857,cinnamaldehyde,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52858,were,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52859,identified,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52860,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52861,quantitated,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52862,.,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52910,Cinnamon,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52911,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52912,oregano,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52913,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52914,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52915,rosemary,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52916,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52917,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52918,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52919,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52920,Fusobacterium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52921,strains,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52922,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52923,cinnamon,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52924,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52925,rosemary,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52926,",",O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52927,and,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52928,turmeric,B,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52929,were,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52930,active,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52931,against,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52932,selected,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52933,Clostridium,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52934,spp,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
52935,.,O,1818.0,"Cinnamon , oregano , and rosemary were active against selected Fusobacterium strains and cinnamon , rosemary , and turmeric were active against selected Clostridium spp ."
53137,Capillary,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53138,blood,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53139,samples,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53140,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53141,then,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53142,drawn,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53143,for,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53144,2,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53145,h,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53146,",",O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53147,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53148,glucose,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53149,and,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53150,insulin,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53151,were,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53152,analysed,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53153,.,O,1826.0,"Capillary blood samples were then drawn for 2 h , and glucose and insulin were analysed ."
53259,However,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53260,",",O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53261,the,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53262,insulinaemic,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53263,response,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53264,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53265,mashed,B,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53266,potato,I,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53267,with,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53268,chicken,B,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53269,breast,I,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53270,and,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53271,rapeseed,B,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53272,oil,I,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53273,was,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53274,lower,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53275,than,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53276,that,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53277,to,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53278,mashed,B,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53279,potato,I,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53280,alone,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53281,.,O,1832.0,"However , the insulinaemic response to mashed potato with chicken breast and rapeseed oil was lower than that to mashed potato alone ."
53511,Patients,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53512,with,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53513,more,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53514,aggressive,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53515,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53516,presented,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53517,a,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53518,lower,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53519,adherence,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53520,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53521,MD,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53522,according,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53523,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53524,PREDIMED,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53525,categories,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53526,in,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53527,comparison,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53528,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53529,G1,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53530,",",O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53531,localized,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53532,and,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53533,free,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53534,/,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53535,stable,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53536,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53537,status,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53538,.,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53950,Water,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53951,deficit,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53952,strategies,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53953,generate,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53954,hydroSOStainable,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53955,almonds,B,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53956,",",O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53957,raised,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53958,under,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53959,water,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53960,stress,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53961,conditions,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53962,",",O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53963,with,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53964,high,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53965,content,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53966,of,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53967,bioactive,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53968,compounds,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
53969,.,O,1859.0,"Water deficit strategies generate hydroSOStainable almonds , raised under water stress conditions , with high content of bioactive compounds ."
54042,The,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54043,Japan,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54044,Collaborative,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54045,Cohort,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54046,Study,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54047,was,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54048,established,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54049,in,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54050,1988,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54051,-,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54052,1990,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54053,and,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54054,consisted,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54055,of,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54056,"47,997",O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54057,men,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54058,and,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54059,"66,520",O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54060,women,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54061,observed,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54062,until,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54063,the,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54064,end,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54065,of,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54066,1999,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54067,.,O,1863.0,"The Japan Collaborative Cohort Study was established in 1988 - 1990 and consisted of 47,997 men and 66,520 women observed until the end of 1999 ."
54371,Food,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54372,hypersensitivity,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54373,was,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54374,reported,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54375,by,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54376,23,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54377,patients,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54378,(,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54379,27.3,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54380,%,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54381,),O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54382,allergic,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54383,to,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54384,Artemisia,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54385,.,O,1877.0,Food hypersensitivity was reported by 23 patients ( 27.3 % ) allergic to Artemisia .
54531,The,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54532,relation,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54533,between,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54534,vegetable,B,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54535,and,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54536,fruit,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54537,consumption,I,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54538,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54539,colorectal,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54540,cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54541,risk,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54542,was,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54543,comprehensively,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54544,assessed,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54545,in,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54546,the,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54547,Netherlands,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54548,Cohort,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54549,Study,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54550,on,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54551,Diet,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54552,and,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54553,Cancer,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54554,using,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54555,a,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54556,validated,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54557,150,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54558,-,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54559,item,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54560,food,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54561,frequency,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54562,questionnaire,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54563,.,O,1883.0,The relation between vegetable and fruit consumption and colorectal cancer risk was comprehensively assessed in the Netherlands Cohort Study on Diet and Cancer using a validated 150 - item food frequency questionnaire .
54587,Using,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54588,case,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54589,-,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54590,cohort,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54591,analysis,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54592,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54593,the,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54594,authors,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54595,calculated,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54596,rate,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54597,ratios,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54598,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54599,95,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54600,%,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54601,confidence,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54602,intervals,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54603,adjusted,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54604,for,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54605,age,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54606,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54607,alcohol,B,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54608,intake,I,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54609,",",O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54610,and,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54611,family,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54612,history,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54613,of,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54614,colorectal,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54615,cancer,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54616,.,O,1885.0,"Using case - cohort analysis , the authors calculated rate ratios and 95 % confidence intervals adjusted for age , alcohol intake , and family history of colorectal cancer ."
54692,Among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54693,women,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54694,and,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54695,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54696,to,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54697,a,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54698,lesser,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54699,extent,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54700,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54701,among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54702,men,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54703,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54704,inverse,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54705,associations,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54706,were,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54707,stronger,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54708,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54709,distal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54710,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54711,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54712,than,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54713,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54714,proximal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54715,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54716,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54717,.,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
56375,Oxidized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56376,starches,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56377,have,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56378,been,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56379,utilized,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56380,in,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56381,many,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56382,coating,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56383,applications,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56384,for,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56385,their,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56386,adhesion,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56387,ability,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56388,.,O,1946.0,Oxidized starches have been utilized in many coating applications for their adhesion ability .
56389,However,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56390,",",O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56391,it,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56392,is,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56393,not,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56394,known,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56395,if,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56396,they,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56397,perform,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56398,similarly,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56399,in,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56400,bake,B,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56401,-,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56402,only,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56403,products,I,1947.0,"However , it is not known if they perform similarly in bake - only products ."
56404,.,O,1947.0,"However , it is not known if they perform similarly in bake - only products ."
57353,Three,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57354,-,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57355,fourths,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57356,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57357,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57358,participants,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57359,had,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57360,a,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57361,family,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57362,history,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57363,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57364,at,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57365,least,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57366,one,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57367,of,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57368,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57369,life,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57370,-,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57371,style,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57372,diseases,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57373,addressed,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57374,by,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57375,the,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57376,course,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57377,.,O,1983.0,Three - fourths of the participants had a family history of at least one of the life - style diseases addressed by the course .
57479,Diabetes,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57480,is,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57481,one,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57482,of,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57483,the,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57484,main,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57485,health,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57486,problems,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57487,among,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57488,Saharawi,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57489,refugees,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57490,living,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57491,in,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57492,Algerian,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57493,camps,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57494,",",O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57495,especially,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57496,for,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57497,women,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
57498,.,O,1987.0,"Diabetes is one of the main health problems among Saharawi refugees living in Algerian camps , especially for women ."
58085,This,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58086,study,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58087,had,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58088,a,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58089,randomised,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58090,",",O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58091,controlled,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58092,",",O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58093,non,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58094,-,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58095,blind,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58096,",",O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58097,cross,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58098,-,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58099,over,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58100,design,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58101,in,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58102,which,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58103,fifteen,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58104,healthy,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58105,Chinese,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58106,male,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58107,participants,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58108,were,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58109,required,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58110,to,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58111,come,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58112,on,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58113,non,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58114,-,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58115,consecutive,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58116,days,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58117,.,O,2003.0,"This study had a randomised , controlled , non - blind , cross - over design in which fifteen healthy Chinese male participants were required to come on non - consecutive days ."
58209,RWF,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58210,and,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58211,RWE,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58212,had,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58213,significantly,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58214,higher,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58215,insulin,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58216,response,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58217,",",O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58218,but,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58219,no,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58220,significant,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58221,increase,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58222,was,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58223,observed,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58224,in,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58225,RWT,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58226,and,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58227,RWC,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58228,when,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58229,compared,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58230,with,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58231,the,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58232,control,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58233,(,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58234,P<0·05,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58235,),O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58236,.,O,2007.0,"RWF and RWE had significantly higher insulin response , but no significant increase was observed in RWT and RWC when compared with the control ( P<0·05 ) ."
58385,We,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58386,used,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58387,data,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58388,from,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58389,the,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58390,Mexican,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58391,Teachers,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58392,',O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58393,Cohort,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58394,including,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58395,64,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58396,934,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58397,disease,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58398,-,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58399,free,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58400,women,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58401,aged,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58402,≥25,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58403,years,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58404,at,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58405,baseline,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58406,.,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged ≥25 years at baseline .
58794,Whether,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58795,these,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58796,milk,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58797,bioactive,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58798,components,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58799,will,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58800,replace,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58801,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58802,entirely,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58803,in,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58804,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58805,immediate,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58806,future,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58807,is,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58808,still,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58809,unclear,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58810,",",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58811,but,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58812,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58813,increasing,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58814,appreciation,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58815,of,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58816,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58817,drug,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58818,foods,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58819,"""",O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58820,or,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58821,nutraceuticals,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58822,plays,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58823,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58824,complementary,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58825,rather,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58826,than,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58827,a,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58828,substitutional,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58829,role,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58830,to,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58831,the,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58832,synthetic,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58833,pharmacological,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58834,drugs,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
58835,.,O,2032.0,"Whether these milk bioactive components will replace drugs entirely in the immediate future is still unclear , but the increasing appreciation of "" drug foods "" or nutraceuticals plays a complementary rather than a substitutional role to the synthetic pharmacological drugs ."
59020,Beer,B,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59021,consumption,I,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59022,contributed,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59023,to,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59024,9·6,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59025,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59026,5·3,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59027,%,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59028,inter,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59029,-,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59030,individual,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59031,variation,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59032,in,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59033,GI,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59034,and,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59035,GL,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59036,",",O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59037,respectively,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59038,.,O,2042.0,"Beer consumption contributed to 9·6 and 5·3 % inter - individual variation in GI and GL , respectively ."
59071,The,O,2044.0,The results were more pronounced in men than in women .
59072,results,O,2044.0,The results were more pronounced in men than in women .
59073,were,O,2044.0,The results were more pronounced in men than in women .
59074,more,O,2044.0,The results were more pronounced in men than in women .
59075,pronounced,O,2044.0,The results were more pronounced in men than in women .
59076,in,O,2044.0,The results were more pronounced in men than in women .
59077,men,O,2044.0,The results were more pronounced in men than in women .
59078,than,O,2044.0,The results were more pronounced in men than in women .
59079,in,O,2044.0,The results were more pronounced in men than in women .
59080,women,O,2044.0,The results were more pronounced in men than in women .
59081,.,O,2044.0,The results were more pronounced in men than in women .
59234,Both,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59235,diets,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59236,were,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59237,low,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59238,glycemic,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59239,",",O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59240,low,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59241,fat,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59242,",",O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59243,and,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59244,high,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59245,plant,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59246,protein,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59247,diets,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59248,;,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59249,the,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59250,diet,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59251,for,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59252,the,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59253,TD,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59254,group,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59255,contained,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59256,an,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59257,additional,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59258,0.5,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59259,servings,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59260,of,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59261,protein,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59262,.,O,2050.0,"Both diets were low glycemic , low fat , and high plant protein diets ; the diet for the TD group contained an additional 0.5 servings of protein ."
59517,In,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59518,addition,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59519,",",O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59520,olives,B,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59521,(,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59522,Olea,B,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59523,europaea,I,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59524,L.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59525,),O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59526,and,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59527,olive,B,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59528,oils,I,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59529,provide,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59530,a,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59531,rich,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59532,source,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59533,of,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59534,natural,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59535,antioxidants,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59536,.,O,2060.0,"In addition , olives ( Olea europaea L. ) and olive oils provide a rich source of natural antioxidants ."
59841,Demographic,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59842,and,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59843,history,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59844,data,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59845,were,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59846,collected,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59847,from,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59848,"128,934",O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59849,adults,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59850,undergoing,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59851,health,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59852,evaluations,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59853,in,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59854,1978,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59855,-,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59856,1985,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59857,",",O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59858,with,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59859,subsequent,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59860,death,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59861,ascertained,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59862,by,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59863,an,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59864,automated,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59865,linkage,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59866,system,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59867,.,O,2071.0,"Demographic and history data were collected from 128,934 adults undergoing health evaluations in 1978 - 1985 , with subsequent death ascertained by an automated linkage system ."
59940,Similar,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59941,risk,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59942,reductions,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59943,were,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59944,associated,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59945,with,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59946,red,B,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59947,wine,I,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59948,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59949,white,B,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59950,wine,I,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59951,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59952,other,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59953,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59954,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59955,wine,B,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59956,",",O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59957,and,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59958,combinations,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59959,of,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59960,wine,B,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59961,types,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
59962,.,O,2075.0,"Similar risk reductions were associated with red wine , white wine , other types of wine , and combinations of wine types ."
60269,Information,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60270,on,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60271,demographic,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60272,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60273,lifestyle,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60274,factors,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60275,was,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60276,collected,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60277,using,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60278,mailed,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60279,questionnaires,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60280,between,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60281,2002,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60282,and,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60283,2003,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60284,.,O,2087.0,Information on demographic and lifestyle factors was collected using mailed questionnaires between 2002 and 2003 .
60349,Hazard,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60350,ratio,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60351,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60352,HR,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60353,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60354,estimates,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60355,for,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60356,consuming,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60357,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60358,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60359,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60360,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60361,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60362,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60363,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60364,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60365,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60366,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60367,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60368,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60369,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60370,but,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60371,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60372,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60373,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60374,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60375,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60376,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60377,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60378,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60379,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60380,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60381,drink,B,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60382,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60383,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60384,were,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60385,0.89,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60386,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60387,95,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60388,%,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60389,confidence,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60390,interval,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60391,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60392,0.74,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60393,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60394,1.07,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60395,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60396,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60397,0.99,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60398,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60399,0.83,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60400,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60401,1.17,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60402,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60403,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60404,0.88,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60405,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60406,0.70,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60407,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60408,1.12,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60409,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60410,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60411,respectively,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60412,.,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60422,The,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60423,lack,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60424,of,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60425,association,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60426,for,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60427,red,B,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60428,wine,I,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60429,intake,I,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60430,was,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60431,consistently,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60432,observed,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60433,when,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60434,we,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60435,restricted,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60436,the,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60437,analyses,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60438,to,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60439,those,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60440,with,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60441,and,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60442,without,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60443,a,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60444,history,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60445,of,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60446,PSA,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60447,screening,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60448,.,O,2093.0,The lack of association for red wine intake was consistently observed when we restricted the analyses to those with and without a history of PSA screening .
60961,Glucose,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60962,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60963,urea,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60964,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60965,triglycerides,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60966,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60967,TG,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60968,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60969,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60970,total,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60971,cholesterol,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60972,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60973,beta,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60974,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60975,hydroxibutyrate,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60976,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60977,BHBA,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60978,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60979,",",O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60980,and,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60981,gamma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60982,-,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60983,glutamyl,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60984,transferase,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60985,(,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60986,GGT,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60987,),O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60988,in,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60989,plasma,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60990,were,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60991,unaffected,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60992,by,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60993,treatment,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
60994,.,O,2115.0,"Glucose , urea , triglycerides ( TG ) , total cholesterol , beta - hydroxibutyrate ( BHBA ) , and gamma - glutamyl transferase ( GGT ) in plasma were unaffected by treatment ."
61045,Blood,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61046,and,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61047,milk,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61048,parameters,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61049,do,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61050,not,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61051,indicate,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61052,any,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61053,adverse,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61054,effects,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61055,of,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61056,feeding,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61057,this,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61058,natural,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61059,compound,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61060,.,O,2118.0,Blood and milk parameters do not indicate any adverse effects of feeding this natural compound .
61093,However,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61094,",",O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61095,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61096,molecular,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61097,mechanisms,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61098,responsible,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61099,for,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61100,this,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61101,preventive,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61102,activity,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61103,and,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61104,whether,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61105,cocoa,B,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61106,exerts,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61107,potential,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61108,beneficial,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61109,effects,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61110,on,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61111,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61112,insulin,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61113,signaling,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61114,pathway,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61115,in,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61116,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61117,liver,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61118,remain,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61119,largely,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61120,unknown,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61121,.,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61304,Moreover,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61305,",",O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61306,cocoa,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61307,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61308,rich,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61309,diet,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61310,suppressed,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61311,c,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61312,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61313,Jun,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61314,N,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61315,-,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61316,terminal,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61317,kinase,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61318,and,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61319,p38,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61320,activation,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61321,caused,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61322,by,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61323,insulin,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61324,resistance,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61325,.,O,2127.0,"Moreover , cocoa - rich diet suppressed c - Jun N - terminal kinase and p38 activation caused by insulin resistance ."
61349,Many,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61350,countries,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61351,set,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61352,quantitative,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61353,targets,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61354,for,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61355,added,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61356,sugars,B,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61357,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61358,justifying,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61359,this,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61360,by,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61361,expressing,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61362,concern,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61363,about,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61364,the,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61365,likely,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61366,impact,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61367,of,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61368,sugar,B,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61369,on,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61370,weight,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61371,control,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61372,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61373,dental,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61374,health,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61375,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61376,diet,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61377,quality,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61378,",",O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61379,or,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61380,metabolic,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61381,syndrome,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
61382,.,O,2129.0,"Many countries set quantitative targets for added sugars , justifying this by expressing concern about the likely impact of sugar on weight control , dental health , diet quality , or metabolic syndrome ."
62144,A,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62145,lower,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62146,risk,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62147,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62148,colon,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62149,cancer,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62150,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62151,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62152,with,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62153,higher,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62154,self,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62155,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62156,reported,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62157,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62158,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62159,fruit,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62160,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62161,vegetable,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62162,combined,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62163,(,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62164,HR,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62165,Q4,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62166,vs.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62167,Q1,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62168,0.87,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62169,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62170,95,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62171,%,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62172,CI,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62173,0.75,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62174,-,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62175,1.01,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62176,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62177,p,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62178,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62179,trend,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62180,0.02,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62181,),O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62182,",",O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62183,but,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62184,no,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62185,consistent,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62186,association,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62187,was,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62188,observed,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62189,for,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62190,separate,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62191,consumption,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62192,of,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62193,fruits,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62194,and,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62195,vegetables,B,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62196,.,O,2156.0,"A lower risk of colon cancer was observed with higher self - reported consumption of fruit and vegetable combined ( HR Q4 vs. Q1 0.87 , 95 % CI 0.75 - 1.01 , p for trend 0.02 ) , but no consistent association was observed for separate consumption of fruits and vegetables ."
62207,The,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62208,few,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62209,observed,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62210,associations,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62211,for,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62212,some,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62213,fruit,B,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62214,and,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62215,vegetable,B,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62216,subtypes,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62217,with,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62218,colon,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62219,cancer,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62220,risk,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62221,may,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62222,have,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62223,been,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62224,due,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62225,to,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62226,chance,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62227,.,O,2158.0,The few observed associations for some fruit and vegetable subtypes with colon cancer risk may have been due to chance .
62780,When,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62781,extracts,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62782,from,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62783,nonthermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62784,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62785,thermally,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62786,processed,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62787,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62788,were,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62789,subjected,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62790,to,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62791,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62792,RBL,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62793,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62794,cell,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62795,mediator,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62796,release,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62797,assay,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62798,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62799,these,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62800,sera,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62801,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62802,an,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62803,inverse,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62804,ranking,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62805,was,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62806,obtained,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62807,with,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62808,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62809,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62810,heated,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62811,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62812,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62813,and,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62814,anti,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62815,-,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62816,native,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62817,celeriac,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62818,IgE,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62819,",",O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62820,respectively,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62821,.,O,2180.0,"When extracts from nonthermally and thermally processed celeriac were subjected to an RBL - cell mediator release assay with these sera , an inverse ranking was obtained with anti - heated celeriac IgE and anti - native celeriac IgE , respectively ."
62836,Since,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62837,all,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62838,parameters,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62839,were,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62840,tested,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62841,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62842,model,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62843,experiments,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62844,with,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62845,either,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62846,human,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62847,or,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62848,murine,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62849,IgE,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62850,",",O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62851,their,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62852,relevance,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62853,has,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62854,to,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62855,be,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62856,proven,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62857,in,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62858,further,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62859,clinical,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62860,investigations,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
62861,.,O,2182.0,"Since all parameters were tested in model experiments with either human or murine IgE , their relevance has to be proven in further clinical investigations ."
63461,High,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63462,GI,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63463,food,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63464,can,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63465,be,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63466,detrimental,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63467,to,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63468,diabetics,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63469,since,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63470,they,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63471,can,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63472,rapidly,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63473,increase,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63474,the,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63475,glucose,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63476,level,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63477,in,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63478,blood,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63479,during,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63480,digestion,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63481,.,O,2203.0,High GI food can be detrimental to diabetics since they can rapidly increase the glucose level in blood during digestion .
63760,Therefore,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63761,",",O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63762,preparation,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63763,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63764,an,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63765,instant,B,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63766,rice,I,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63767,product,I,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63768,with,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63769,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63770,lower,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63771,GI,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63772,would,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63773,ensure,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63774,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63775,product,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63776,was,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63777,beneficial,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63778,to,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63779,a,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63780,wider,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63781,range,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63782,of,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63783,the,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63784,population,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
63785,.,O,2213.0,"Therefore , preparation of an instant rice product with a lower GI would ensure the product was beneficial to a wider range of the population ."
64013,The,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64014,root,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64015,mean,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64016,square,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64017,error,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64018,approximation,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64019,from,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64020,the,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64021,confirmatory,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64022,factor,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64023,analysis,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64024,was,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64025,0.08,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64026,.,O,2224.0,The root mean square error approximation from the confirmatory factor analysis was 0.08 .
64211,This,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64212,article,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64213,provides,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64214,an,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64215,overview,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64216,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64217,the,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64218,health,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64219,benefits,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64220,associated,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64221,with,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64222,fruit,B,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64223,and,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64224,vegetable,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64225,consumption,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64226,for,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64227,each,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64228,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64229,these,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64230,conditions,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64231,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64232,including,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64233,brief,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64234,discussions,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64235,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64236,underlying,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64237,protective,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64238,mechanisms,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64239,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64240,identifies,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64241,key,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64242,scientific,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64243,findings,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64244,regarding,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64245,the,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64246,health,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64247,benefits,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64248,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64249,fruit,B,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64250,and,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64251,vegetable,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64252,consumption,I,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64253,",",O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64254,and,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64255,outlines,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64256,applications,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64257,of,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64258,these,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64259,findings,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64260,for,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64261,dietetics,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64262,professionals,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64263,.,O,2233.0,"This article provides an overview of the health benefits associated with fruit and vegetable consumption for each of these conditions , including brief discussions of underlying protective mechanisms , identifies key scientific findings regarding the health benefits of fruit and vegetable consumption , and outlines applications of these findings for dietetics professionals ."
64436,Our,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64437,hypothesis,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64438,was,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64439,that,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64440,cold,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64441,milk,B,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64442,drunk,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64443,at,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64444,high,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64445,speed,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64446,would,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64447,cause,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64448,insufficient,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64449,closure,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64450,of,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64451,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64452,esophageal,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64453,groove,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64454,and,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64455,hence,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64456,milk,B,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64457,in,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64458,the,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64459,rumen,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64460,.,O,2240.0,Our hypothesis was that cold milk drunk at high speed would cause insufficient closure of the esophageal groove and hence milk in the rumen .
64567,Starting,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64568,with,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64569,a,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64570,low,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64571,number,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64572,of,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64573,subjects,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64574,and,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64575,increasing,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64576,this,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64577,number,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64578,with,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64579,increasing,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64580,design,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64581,levels,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64582,reduces,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64583,the,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64584,sample,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64585,size,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64586,without,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64587,reducing,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64588,the,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64589,statistical,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64590,power,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64591,.,O,2245.0,Starting with a low number of subjects and increasing this number with increasing design levels reduces the sample size without reducing the statistical power .
64962,A,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64963,case,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64964,-,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64965,control,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64966,study,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64967,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64968,cancer,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64969,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64970,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64971,colon,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64972,and,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64973,rectum,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64974,was,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64975,conducted,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64976,in,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64977,the,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64978,Marseilles,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64979,region,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64980,of,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64981,southern,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64982,France,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
64983,.,O,2261.0,A case - control study of cancer of the colon and rectum was conducted in the Marseilles region of southern France .
65050,The,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65051,cases,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65052,reported,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65053,lower,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65054,consumption,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65055,of,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65056,vegetables,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65057,and,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65058,oil,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65059,than,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65060,controls,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65061,",",O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65062,but,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65063,no,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65064,differences,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65065,were,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65066,seen,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65067,in,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65068,the,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65069,consumption,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65070,of,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65071,meat,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65072,",",O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65073,bread,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65074,",",O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65075,eggs,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65076,or,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65077,butter,B,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65078,.,O,2264.0,"The cases reported lower consumption of vegetables and oil than controls , but no differences were seen in the consumption of meat , bread , eggs or butter ."
65107,However,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65108,",",O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65109,when,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65110,all,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65111,these,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65112,nutrients,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65113,were,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65114,analysed,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65115,jointly,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65116,and,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65117,adjusted,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65118,one,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65119,for,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65120,the,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65121,other,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65122,",",O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65123,only,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65124,potassium,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65125,retained,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65126,a,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65127,significant,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65128,effect,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65129,.,O,2266.0,"However , when all these nutrients were analysed jointly and adjusted one for the other , only potassium retained a significant effect ."
65406,Although,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65407,corn,B,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65408,is,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65409,often,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65410,cited,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65411,as,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65412,an,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65413,allergenic,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65414,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65415,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65416,very,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65417,few,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65418,studies,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65419,have,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65420,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65421,devoted,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65422,to,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65423,the,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65424,identification,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65425,of,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65426,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65427,allergens,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65428,and,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65429,corn,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65430,allergy,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65431,has,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65432,been,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65433,rarely,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65434,confirmed,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65435,by,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65436,double,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65437,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65438,blind,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65439,",",O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65440,placebo,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65441,-,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65442,controlled,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65443,food,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65444,challenge,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65445,(,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65446,DBPCFC,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65447,),O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
65448,.,O,2281.0,"Although corn is often cited as an allergenic food , very few studies have been devoted to the identification of corn allergens and corn allergy has been rarely confirmed by double - blind , placebo - controlled food challenge ( DBPCFC ) ."
66011,These,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66012,results,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66013,implicate,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66014,a,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66015,new,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66016,class,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66017,of,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66018,compounds,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66019,in,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66020,diet,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66021,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66022,induced,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66023,obesity,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66024,-,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66025,C18,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66026,epoxide,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66027,and,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66028,diol,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66029,oxylipins,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66030,.,O,2302.0,These results implicate a new class of compounds in diet - induced obesity - C18 epoxide and diol oxylipins .
66156,Cerebral,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66157,ischemia,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66158,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66159,reperfusion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66160,(,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66161,I,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66162,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66163,R,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66164,),O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66165,injury,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66166,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66167,expression,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66168,of,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66169,adhesion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66170,molecules,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66171,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66172,pro-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66173,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66174,anti,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66175,-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66176,inflammatory,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66177,cytokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66178,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66179,chemokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66180,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66181,microglial,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66182,activation,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66183,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66184,neutrophil,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66185,infiltration,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66186,were,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66187,evaluated,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66188,.,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66425,Furthermore,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66426,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66427,strawberry,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66428,extracts,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66429,have,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66430,been,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66431,shown,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66432,to,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66433,inhibit,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66434,COX,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66435,enzymes,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66436,in,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66437,vitro,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66438,",",O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66439,which,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66440,would,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66441,modulate,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66442,the,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66443,inflammatory,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66444,process,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66445,.,O,2319.0,"Furthermore , strawberry extracts have been shown to inhibit COX enzymes in vitro , which would modulate the inflammatory process ."
66446,Individual,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66447,compounds,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66448,in,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66449,strawberries,B,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66450,have,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66451,demonstrated,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66452,anticancer,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66453,activity,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66454,in,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66455,several,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66456,different,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66457,experimental,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66458,systems,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66459,",",O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66460,blocking,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66461,initiation,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66462,of,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66463,carcinogenesis,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66464,",",O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66465,and,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66466,suppressing,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66467,progression,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66468,and,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66469,proliferation,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66470,of,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66471,tumors,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66472,.,O,2320.0,"Individual compounds in strawberries have demonstrated anticancer activity in several different experimental systems , blocking initiation of carcinogenesis , and suppressing progression and proliferation of tumors ."
66507,The,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66508,agents,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66509,capable,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66510,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66511,causing,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66512,damage,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66513,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66514,genetic,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66515,material,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66516,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66517,known,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66518,as,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66519,genotoxins,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66520,and,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66521,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66522,according,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66523,to,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66524,their,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66525,mode,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66526,of,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66527,action,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66528,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66529,are,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66530,classified,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66531,into,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66532,mutagens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66533,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66534,carcinogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66535,",",O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66536,or,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66537,teratogens,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66538,.,O,2323.0,"The agents capable of causing damage to genetic material are known as genotoxins and , according to their mode of action , are classified into mutagens , carcinogens , or teratogens ."
66709,An,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66710,association,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66711,between,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66712,alcohol,B,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66713,consumption,I,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66714,and,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66715,prostate,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66716,cancer,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66717,risk,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66718,remains,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66719,uncertain,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
66720,.,O,2329.0,An association between alcohol consumption and prostate cancer risk remains uncertain .
67542,A,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67543,significant,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67544,reduction,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67545,in,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67546,risk,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67547,was,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67548,linked,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67549,to,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67550,daily,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67551,tea,B,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67552,drinking,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67553,among,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67554,women,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67555,",",O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67556,but,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67557,not,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67558,among,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67559,men,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67560,.,O,2359.0,"A significant reduction in risk was linked to daily tea drinking among women , but not among men ."
67612,There,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67613,is,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67614,emerging,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67615,epidemiology,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67616,data,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67617,supporting,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67618,the,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67619,connection,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67620,between,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67621,increased,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67622,tomato,B,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67623,consumption,I,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67624,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67625,reduced,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67626,risk,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67627,for,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67628,both,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67629,cardiovascular,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67630,disease,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67631,and,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67632,prostate,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67633,cancer,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67634,.,O,2362.0,There is emerging epidemiology data supporting the connection between increased tomato consumption and reduced risk for both cardiovascular disease and prostate cancer .
67903,In,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67904,recent,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67905,years,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67906,and,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67907,due,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67908,to,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67909,their,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67910,well,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67911,-,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67912,known,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67913,high,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67914,nutritional,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67915,value,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67916,and,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67917,potential,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67918,health,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67919,benefits,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67920,",",O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67921,these,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67922,pseudocereals,B,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67923,have,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67924,received,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67925,much,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67926,attention,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67927,as,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67928,ideal,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67929,candidates,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67930,for,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67931,gluten,B,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67932,-,I,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67933,free,I,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67934,products,I,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67935,.,O,2372.0,"In recent years and due to their well - known high nutritional value and potential health benefits , these pseudocereals have received much attention as ideal candidates for gluten - free products ."
67963,Fermentation,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67964,is,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67965,one,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67966,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67967,the,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67968,most,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67969,antique,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67970,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67971,economical,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67972,methods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67973,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67974,producing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67975,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67976,preserving,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67977,foods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67978,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67979,can,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67980,be,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67981,easily,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67982,employed,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67983,for,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67984,cereal,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67985,processing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67986,.,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
68007,This,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68008,review,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68009,provides,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68010,an,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68011,overview,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68012,on,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68013,pseudocereal,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68014,fermentation,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68015,by,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68016,LAB,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68017,emphasizing,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68018,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68019,capacity,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68020,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68021,these,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68022,bacteria,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68023,to,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68024,decrease,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68025,antinutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68026,factors,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68027,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68028,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68029,phytic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68030,acid,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68031,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68032,increase,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68033,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68034,functional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68035,value,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68036,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68037,phytochemicals,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68038,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68039,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68040,phenolic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68041,compounds,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68042,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68043,and,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68044,produce,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68045,nutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68046,ingredients,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68047,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68048,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68049,B,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68050,-,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68051,group,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68052,vitamins,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68053,.,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68553,A,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68554,100,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68555,mg,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68556,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68557,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68558,dietary,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68559,cholesterol,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68560,per,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68561,4184,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68562,kJ,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68563,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68564,or,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68565,1000,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68566,kcal,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68567,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68568,was,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68569,associated,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68570,with,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68571,a,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68572,14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68573,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68574,increase,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68575,in,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68576,the,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68577,risk,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68578,of,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68579,diabetes,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68580,(,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68581,HR,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68582,1·14,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68583,;,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68584,95,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68585,%,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68586,CI,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68587,1·02,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68588,",",O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68589,1·26,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68590,),O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68591,.,O,2392.0,"A 100 mg increase of dietary cholesterol per 4184 kJ ( or 1000 kcal ) was associated with a 14 % increase in the risk of diabetes ( HR 1·14 ; 95 % CI 1·02 , 1·26 ) ."
68841,A,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68842,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68843,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68844,one,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68845,serving,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68846,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68847,SSBs,B,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68848,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68849,375,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68850,mL,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68851,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68852,had,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68853,the,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68854,greatest,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68855,potential,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68856,impact,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68857,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68858,terms,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68859,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68860,weight,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68861,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68862,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68863,particularly,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68864,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68865,ages,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68866,19,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68867,-,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68868,24,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68869,years,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68870,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68871,mean,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68872,0.31,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68873,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68874,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68875,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68876,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68877,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68878,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68879,0.23,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68880,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68881,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68882,0.37,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68883,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68884,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68885,and,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68886,overall,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68887,healthcare,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68888,cost,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68889,savings,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68890,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68891,AUD,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68892,793.4,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68893,million,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68894,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68895,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68896,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68897,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68898,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68899,589.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68900,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68901,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68902,976.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68903,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68904,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68905,.,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68975,The,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68976,results,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68977,demonstrate,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68978,that,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68979,small,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68980,reductions,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68981,in,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68982,discretionary,B,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68983,food,I,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68984,consumption,I,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68985,are,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68986,likely,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68987,to,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68988,have,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68989,substantial,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68990,health,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68991,benefits,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68992,at,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68993,the,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68994,population,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68995,level,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
68996,.,O,2403.0,The results demonstrate that small reductions in discretionary food consumption are likely to have substantial health benefits at the population level .
69217,Six,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69218,starch,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69219,-,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69220,rich,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69221,foods,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69222,were,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69223,tested,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69224,alone,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69225,and,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69226,in,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69227,an,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69228,isoglucido,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69229,-,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69230,lipido,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69231,-,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69232,protidic,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69233,meal,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69234,in,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69235,18,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69236,NIDDs,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69237,and,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69238,compared,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69239,with,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69240,a,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69241,glucose,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69242,challenge,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69243,.,O,2413.0,Six starch - rich foods were tested alone and in an isoglucido - lipido - protidic meal in 18 NIDDs and compared with a glucose challenge .
69442,Nigeria,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69443,is,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69444,a,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69445,multicultural,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69446,country,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69447,with,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69448,a,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69449,diverse,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69450,cultural,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69451,food,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69452,.,O,2420.0,Nigeria is a multicultural country with a diverse cultural food .
69453,Most,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69454,Nigerians,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69455,',O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69456,cultural,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69457,diet,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69458,is,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69459,based,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69460,on,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69461,staple,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69462,food,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69463,accompanied,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69464,by,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69465,stew,B,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
69466,.,O,2421.0,Most Nigerians ' cultural diet is based on staple food accompanied by stew .
70005,The,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70006,latter,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70007,societies,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70008,have,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70009,a,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70010,higher,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70011,incidence,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70012,of,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70013,these,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70014,cancers,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70015,than,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70016,Asians,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70017,and,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70018,vegetarians,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70019,.,O,2439.0,The latter societies have a higher incidence of these cancers than Asians and vegetarians .
70360,Age,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70361,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70362,duration,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70363,of,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70364,diabetes,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70365,",",O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70366,or,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70367,insulin,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70368,regimen,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70369,did,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70370,not,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70371,correlate,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70372,with,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70373,subjects,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70374,',O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70375,responses,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70376,to,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70377,fruit,B,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70378,.,O,2451.0,"Age , duration of diabetes , or insulin regimen did not correlate with subjects ' responses to fruit ."
70379,We,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70380,investigated,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70381,the,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70382,dietary,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70383,effects,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70384,of,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70385,egg,B,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70386,white,I,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70387,(,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70388,EW,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70389,),O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70390,and,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70391,its,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70392,hydrolysate,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70393,(,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70394,EWH,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70395,),O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70396,on,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70397,fat,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70398,metabolism,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70399,in,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70400,rats,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70401,.,O,2452.0,We investigated the dietary effects of egg white ( EW ) and its hydrolysate ( EWH ) on fat metabolism in rats .
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,I,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70899,During,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70900,8,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70901,years,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70902,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70903,follow,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70904,-,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70905,up,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70906,",",O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70907,we,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70908,documented,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70909,710,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70910,cases,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70911,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70912,invasive,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70913,breast,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70914,cancer,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70915,.,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
71057,The,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71058,multivariate,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71059,RR,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71060,(,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71061,95,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71062,%,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71063,CI,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71064,),O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71065,",",O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71066,comparing,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71067,the,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71068,highest,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71069,category,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71070,(,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71071,2,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71072,or,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71073,more,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71074,times,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71075,a,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71076,week,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71077,),O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71078,of,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71079,cumulative,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71080,average,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71081,beans,B,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71082,or,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71083,lentils,B,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71084,intake,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71085,with,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71086,the,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71087,lowest,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71088,category,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71089,(,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71090,less,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71091,than,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71092,once,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71093,a,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71094,month,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71095,),O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71096,",",O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71097,was,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71098,0.76,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71099,(,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71100,0.57,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71101,",",O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71102,1.00,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71103,;,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71104,p,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71105,-,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71106,value,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71107,for,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71108,test,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71109,of,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71110,trend=0.03,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71111,),O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71112,.,O,2475.0,"The multivariate RR ( 95 % CI ) , comparing the highest category ( 2 or more times a week ) of cumulative average beans or lentils intake with the lowest category ( less than once a month ) , was 0.76 ( 0.57 , 1.00 ; p - value for test of trend=0.03 ) ."
71319,Moreover,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71320,",",O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71321,recent,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71322,results,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71323,suggest,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71324,that,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71325,bacterial,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71326,and,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71327,fungal,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71328,metabolites,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71329,produced,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71330,by,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71331,cocobiota,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71332,have,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71333,a,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71334,significant,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71335,anti,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71336,-,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71337,infective,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71338,potential,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71339,.,O,2481.0,"Moreover , recent results suggest that bacterial and fungal metabolites produced by cocobiota have a significant anti - infective potential ."
71483,Two,O,2487.0,Two distinct dietary patterns were identified .
71484,distinct,O,2487.0,Two distinct dietary patterns were identified .
71485,dietary,O,2487.0,Two distinct dietary patterns were identified .
71486,patterns,O,2487.0,Two distinct dietary patterns were identified .
71487,were,O,2487.0,Two distinct dietary patterns were identified .
71488,identified,O,2487.0,Two distinct dietary patterns were identified .
71489,.,O,2487.0,Two distinct dietary patterns were identified .
71799,In,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71800,the,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71801,second,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71802,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71803,",",O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71804,soybean,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71805,hulls,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71806,were,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71807,replaced,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71808,with,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71809,50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71810,g,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71811,of,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71812,CH,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71813,/,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71814,d,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71815,(,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71816,CH50,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71817,group,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71818,),O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71819,.,O,2497.0,"In the second group , soybean hulls were replaced with 50 g of CH / d ( CH50 group ) ."
71891,Milk,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71892,fat,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71893,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71894,protein,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71895,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71896,casein,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71897,",",O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71898,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71899,somatic,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71900,cell,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71901,count,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71902,concentration,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71903,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71904,curd,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71905,-,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71906,firming,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71907,time,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71908,showed,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71909,a,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71910,significant,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71911,interaction,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71912,between,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71913,treatment,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71914,and,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71915,sampling,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71916,date,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
71917,.,O,2501.0,"Milk fat , protein , casein , and somatic cell count concentration and curd - firming time showed a significant interaction between treatment and sampling date ."
72648,Among,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72649,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72650,minerals,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72651,analysed,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72652,",",O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72653,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72654,leaves,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72655,of,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72656,M.,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72657,balsamina,I,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72658,had,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72659,higher,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72660,values,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72661,than,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72662,those,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72663,reported,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72664,for,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72665,the,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72666,exotic,B,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72667,vegetables,I,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72668,",",O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72669,except,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72670,for,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72671,sodium,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
72672,.,O,2525.0,"Among the minerals analysed , the leaves of M. balsamina had higher values than those reported for the exotic vegetables , except for sodium ."
73048,Garlic,B,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73049,has,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73050,long,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73051,been,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73052,the,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73053,focus,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73054,of,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73055,experimental,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73056,and,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73057,clinical,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73058,attentions,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73059,due,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73060,to,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73061,its,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73062,promising,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73063,lipid,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73064,-,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73065,lowering,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73066,effects,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73067,.,O,2536.0,Garlic has long been the focus of experimental and clinical attentions due to its promising lipid - lowering effects .
73143,It,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73144,should,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73145,be,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73146,noted,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73147,that,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73148,the,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73149,doses,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73150,of,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73151,garlic,B,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73152,used,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73153,in,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73154,clinical,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73155,trials,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73156,were,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73157,usually,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73158,far,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73159,lower,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73160,than,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73161,those,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73162,used,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73163,in,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73164,animal,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73165,studies,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73166,",",O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73167,which,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73168,might,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73169,cover,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73170,its,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73171,potential,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73172,effects,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73173,.,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73926,Perinatal,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73927,outcomes,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73928,were,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73929,collected,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73930,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73931,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73932,with,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73933,birth,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73934,weight,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73935,data,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73936,calculated,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73937,into,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73938,percentiles,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73939,to,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73940,assess,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73941,small,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73942,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73943,large,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73944,for,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73945,gestational,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73946,age,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73947,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73948,preterm,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73949,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73950,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73951,<,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73952,37,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73953,wk,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73954,.,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
74509,A,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74510,history,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74511,of,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74512,previous,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74513,surgery,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74514,was,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74515,found,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74516,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74517,5/10,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74518,positive,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74519,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74520,latex,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74521,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74522,SPT,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74523,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74524,",",O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74525,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74526,63/316,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74527,negative,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74528,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74529,latex,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74530,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74531,SPT,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74532,atopic,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74533,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74534,(,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74535,P,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74536,<,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74537,0.05,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74538,),O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74539,",",O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74540,and,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74541,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74542,23/127,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74543,nonatopic,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74544,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74545,.,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74560,Associated,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74561,fruit,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74562,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74563,specific,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74564,IgE,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74565,(,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74566,SPT,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74567,and/or,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74568,RAST,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74569,),O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74570,were,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74571,found,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74572,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74573,all,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74574,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74575,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74576,symptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74577,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74578,and,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74579,in,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74580,2/5,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74581,latex,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74582,-,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74583,asymptomatic,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74584,children,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74585,.,O,2590.0,Associated fruit - specific IgE ( SPT and/or RAST ) were found in all latex - symptomatic children and in 2/5 latex - asymptomatic children .
74601,Only,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74602,one,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74603,patient,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74604,with,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74605,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74606,allergy,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74607,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74608,latex,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74609,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74610,positive,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74611,skin,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74612,tests,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74613,to,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74614,fruits,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74615,had,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74616,a,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74617,history,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74618,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74619,clinical,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74620,symptoms,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74621,after,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74622,ingestion,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74623,of,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74624,kiwi,B,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74625,and,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74626,orange,B,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74627,.,O,2592.0,Only one patient with clinical allergy to latex and positive skin tests to fruits had a history of clinical symptoms after ingestion of kiwi and orange .
74701,To,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74702,date,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74703,",",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74704,over,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74705,"10,000",O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74706, ,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74707,PAs,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74708,poisoning,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74709,cases,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74710,have,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74711,been,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74712,reported,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74713,worldwide,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
74714,.,O,2596.0,"To date , over 10,000   PAs poisoning cases have been reported worldwide ."
75149,In,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75150,addition,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75151,",",O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75152,sodium,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75153,dodecyl,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75154,sulfate,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75155,-,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75156,PAGE,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75157,analysis,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75158,indicated,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75159,a,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75160,formation,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75161,of,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75162,high,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75163,-,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75164,molecular,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75165,weight,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75166,complexes,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75167,through,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75168,MR,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75169,.,O,2612.0,"In addition , sodium dodecyl sulfate - PAGE analysis indicated a formation of high - molecular weight complexes through MR ."
75275,Therefore,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75276,",",O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75277,these,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75278,results,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75279,suggest,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75280,that,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75281,the,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75282,MRP,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75283,from,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75284,milk,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75285,protein,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75286,reacting,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75287,with,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75288,sugars,B,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75289,possess,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75290,effective,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75291,antioxidant,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75292,activity,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75293,and,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75294,have,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75295,a,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75296,protective,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75297,ability,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75298,against,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75299,oxidative,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75300,damage,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75301,.,O,2617.0,"Therefore , these results suggest that the MRP from milk protein reacting with sugars possess effective antioxidant activity and have a protective ability against oxidative damage ."
75616,Since,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75617,1976,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75618,",",O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75619,a,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75620,decrease,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75621,in,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75622,cardiovascular,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75623,disease,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75624,(,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75625,CVD,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75626,),O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75627,mortality,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75628,in,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75629,males,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75630,and,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75631,females,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75632,has,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75633,been,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75634,observed,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75635,",",O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75636,and,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75637,standardized,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75638,CHD,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75639,mortality,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75640,rates,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75641,have,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75642,fallen,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
75643,.,O,2629.0,"Since 1976 , a decrease in cardiovascular disease ( CVD ) mortality in males and females has been observed , and standardized CHD mortality rates have fallen ."
76624,By,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76625,December,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76626,31,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76627,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76628,2001,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76629,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76630,238,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76631,cases,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76632,had,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76633,occurred,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76634,in,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76635,which,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76636,HER-2,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76637,status,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76638,was,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76639,known,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76640,.,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
77064,People,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77065,in,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77066,the,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77067,high,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77068,-,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77069,risk,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77070,region,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77071,preserve,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77072,their,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77073,meat,B,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77074,by,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77075,sun,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77076,drying,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77077,",",O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77078,and,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77079,a,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77080,higher,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77081,proportion,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77082,of,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77083,households,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77084,in,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77085,this,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77086,region,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77087,keep,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77088,the,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77089,preserved,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77090,food,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77091,for,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77092,longer,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77093,periods,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77094,of,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77095,time,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77096,.,O,2675.0,"People in the high - risk region preserve their meat by sun drying , and a higher proportion of households in this region keep the preserved food for longer periods of time ."
77187,But,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77188,",",O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77189,environmental,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77190,contamination,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77191,due,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77192,to,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77193,drugs,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77194,or,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77195,medicines,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77196,used,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77197,for,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77198,different,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77199,purposes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77200,in,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77201,humans,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77202,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77203,animals,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77204,goes,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77205,unseen,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77206,largely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77207,and,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77208,can,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77209,affect,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77210,the,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77211,health,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77212,of,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77213,living,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77214,system,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77215,severely,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77216,.,O,2679.0,"But , environmental contamination due to drugs or medicines used for different purposes in humans and animals goes unseen largely and can affect the health of living system severely ."
77543,The,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77544,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77545,mortality,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77546,rates,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77547,from,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77548,ischemic,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77549,heart,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77550,disease,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77551,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77552,cancer,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77553,are,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77554,thought,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77555,to,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77556,reflect,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77557,the,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77558,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77559,prevalence,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77560,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77561,obesity,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77562,in,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77563,Japan,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77564,;,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77565,low,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77566,intake,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77567,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77568,red,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77569,meat,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77570,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77571,specifically,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77572,saturated,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77573,fatty,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77574,acids,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77575,;,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77576,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77577,high,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77578,intakes,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77579,of,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77580,fish,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77581,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77582,specifically,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77583,n-3,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77584,polyunsaturated,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77585,fatty,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77586,acids,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77587,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77588,plant,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77589,foods,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77590,such,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77591,as,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77592,soybeans,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77593,",",O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77594,and,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77595,nonsugar,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77596,-,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77597,sweetened,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77598,beverages,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77599,such,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77600,as,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77601,green,B,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77602,tea,I,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
77603,.,O,2692.0,"The low mortality rates from ischemic heart disease and cancer are thought to reflect the low prevalence of obesity in Japan ; low intake of red meat , specifically saturated fatty acids ; and high intakes of fish , specifically n-3 polyunsaturated fatty acids , plant foods such as soybeans , and nonsugar - sweetened beverages such as green tea ."
80726,No,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80727,association,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80728,was,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80729,observed,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80730,between,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80731,consumption,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80732,of,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80733,meat,B,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80734,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80735,spicy,B,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80736,food,I,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80737,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80738,turmeric,B,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80739,",",O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80740,pulses,B,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80741,or,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80742,with,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80743,any,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80744,other,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80745,oil,B,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80746,as,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80747,a,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80748,cooking,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80749,medium,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80750,.,O,2794.0,"No association was observed between consumption of meat , spicy food , turmeric , pulses or with any other oil as a cooking medium ."
80792,The,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80793,prevailing,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80794,view,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80795,holds,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80796,that,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80797,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80798,integrity,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80799,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80800,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80801,cell,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80802,wall,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80803,structure,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80804,is,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80805,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80806,primary,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80807,determinant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80808,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80809,energy,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80810,and,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80811,nutrient,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80812,extraction,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80813,from,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80814,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80815,cells,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80816,as,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80817,they,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80818,pass,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80819,through,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80820,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80821,gastrointestinal,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80822,(,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80823,GI,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80824,),O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80825,tract,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80826,.,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80891,Walnuts,B,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80892,produced,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80893,a,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80894,significantly,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80895,larger,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80896,particle,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80897,size,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80898,post,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80899,-,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80900,mastication,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80901,compared,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80902,with,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80903,almonds,B,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80904,.,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
81044,Evidence,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81045,from,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81046,epidemiological,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81047,and,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81048,experimental,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81049,studies,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81050,suggests,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81051,a,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81052,protective,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81053,effect,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81054,against,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81055,the,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81056,development,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81057,of,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81058,coronary,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81059,heart,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81060,disease,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81061,with,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81062,moderate,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81063,consumption,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81064,of,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81065,wine,B,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81066,and,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81067,especially,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81068,red,B,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81069,wine,I,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81070,.,O,2808.0,Evidence from epidemiological and experimental studies suggests a protective effect against the development of coronary heart disease with moderate consumption of wine and especially red wine .
81176,More,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81177,specifically,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81178,",",O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81179,polar,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81180,lipids,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81181,from,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81182,four,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81183,wines,B,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81184,and,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81185,three,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81186,musts,B,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81187,were,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81188,fractionated,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81189,by,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81190,thin,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81191,-,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81192,layer,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81193,chromatography,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81194,",",O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81195,and,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81196,fractions,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81197,were,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81198,tested,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81199,in,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81200,vitro,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81201,for,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81202,their,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81203,ability,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81204,to,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81205,inhibit,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81206,PAF,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81207,and,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81208,thrombin,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81209,-,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81210,induced,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81211,washed,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81212,rabbit,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81213,platelet,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81214,aggregation,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81215,and/or,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81216,to,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81217,cause,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81218,platelet,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81219,aggregation,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81220,.,O,2813.0,"More specifically , polar lipids from four wines and three musts were fractionated by thin - layer chromatography , and fractions were tested in vitro for their ability to inhibit PAF and thrombin - induced washed rabbit platelet aggregation and/or to cause platelet aggregation ."
81221,On,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81222,the,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81223,basis,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81224,of,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81225,the,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81226,above,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81227,results,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81228,",",O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81229,a,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81230,white,B,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81231,wine,I,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81232,from,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81233,the,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81234,principal,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81235,Greek,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81236,grape,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81237,Rompola,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81238,and,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81239,its,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81240,respective,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81241,must,B,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81242,with,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81243,and,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81244,without,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81245,extra,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81246,yeast,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81247,were,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81248,chosen,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81249,for,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81250,further,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81251,high,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81252,-,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81253,performance,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81254,liquid,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81255,chromatography,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81256,separation,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81257,.,O,2814.0,"On the basis of the above results , a white wine from the principal Greek grape Rompola and its respective must with and without extra yeast were chosen for further high - performance liquid chromatography separation ."
81309,However,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81310,",",O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81311,the,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81312,extent,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81313,to,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81314,which,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81315,food,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81316,intake,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81317,varies,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81318,according,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81319,to,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81320,salt,B,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81321,",",O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81322,fat,B,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81323,and,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81324,sugar,B,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81325,content,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81326,is,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81327,imperfectly,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81328,known,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81329,.,O,2817.0,"However , the extent to which food intake varies according to salt , fat and sugar content is imperfectly known ."
81385,Every,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81386,other,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81387,week,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81388,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81389,they,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81390,were,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81391,served,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81392,lunches,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81393,composed,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81394,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81395,among,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81396,other,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81397,items,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81398,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81399,of,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81400,green,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81401,beans,I,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81402,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81403,pasta,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81404,with,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81405,varying,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81406,salt,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81407,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81408,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81409,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81410,0·6,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81411,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81412,1·2,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81413, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81414,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81415,added,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81416,salt,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81417,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81418,or,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81419,fat,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81420,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81421,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81422,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81423,2·5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81424,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81425,5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81426, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81427,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81428,added,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81429,butter,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81430,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81431,levels,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81432,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81433,afternoon,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81434,snacks,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81435,composed,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81436,of,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81437,fruit,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81438,purée,I,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81439,varying,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81440,in,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81441,sugar,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81442,level,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81443,(,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81444,0,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81445,",",O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81446,5,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81447,and,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81448,10,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81449, ,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81450,%,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81451,added,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81452,sugar,B,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81453,),O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81454,.,O,2820.0,"Every other week , they were served lunches composed , among other items , of green beans and pasta with varying salt ( 0 , 0·6 and 1·2   % added salt ) or fat ( 0 , 2·5 and 5   % added butter ) levels and afternoon snacks composed of fruit purée varying in sugar level ( 0 , 5 and 10   % added sugar ) ."
81496,On,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81497,the,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81498,contrary,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81499,",",O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81500,no,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81501,impact,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81502,of,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81503,added,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81504,fat,B,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81505,or,I,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81506,added,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81507,sugar,B,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81508,levels,I,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81509,was,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81510,observed,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81511,.,O,2824.0,"On the contrary , no impact of added fat or added sugar levels was observed ."
81628,Specific,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81629,serum,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81630,IgE,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81631,was,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81632,measured,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81633,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81634,four,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81635,different,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81636,commercially,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81637,available,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81638,tests,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81639,and,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81640,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81641,an,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81642,inhouse,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81643,Maxisorp,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81644,RAST,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81645,using,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81646,freshly,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81647,prepared,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81648,food,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81649,extracts,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81650,.,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81701,Among,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81702,commercially,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81703,available,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81704,test,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81705,allergens,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81706,",",O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81707,egg,B,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81708,white,I,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81709,gave,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81710,the,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81711,most,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81712,consistent,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81713,results,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81714,in,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81715,levels,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81716,and,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81717,class,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81718,scores,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81719,",",O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81720,and,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81721,the,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81722,highest,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81723,degree,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81724,of,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81725,concordance,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81726,with,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81727,DBPCFC,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81728,",",O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81729,whereas,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81730,egg,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81731,yolk,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81732,and,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81733,milk,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81734,varied,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81735,more,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81736,.,O,2832.0,"Among commercially available test allergens , egg white gave the most consistent results in levels and class scores , and the highest degree of concordance with DBPCFC , whereas egg yolk and milk varied more ."
81737,Applying,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81738,freshly,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81739,prepared,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81740,food,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81741,extracts,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81742,in,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81743,Maxisorp,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81744,RAST,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81745,did,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81746,not,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81747,improve,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81748,diagnostic,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81749,value,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
81750,.,O,2833.0,Applying freshly prepared food extracts in Maxisorp RAST did not improve diagnostic value .
82344,Quantification,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82345,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82346,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82347,intracellular,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82348,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82349,concentration,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82350,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82351,human,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82352,gastric,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82353,tumor,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82354,cells,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82355,(,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82356,HGT-1,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82357,),O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82358,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82359,a,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82360,well,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82361,-,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82362,established,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82363,indicator,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82364,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82365,proton,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82366,secretion,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82367,and,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82368,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82369,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82370,turn,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82371,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82372,stomach,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82373,acid,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82374,formation,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82375,in,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82376,vivo,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82377,",",O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82378,confirmed,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82379,the,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82380,stronger,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82381,effect,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82382,of,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82383,red,B,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82384,wine,I,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82385,as,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82386,compared,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82387,to,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82388,white,B,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82389,wine,I,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82390,.,O,2854.0,"Quantification of the intracellular proton concentration in human gastric tumor cells ( HGT-1 ) , a well - established indicator of proton secretion and , in turn , stomach acid formation in vivo , confirmed the stronger effect of red wine as compared to white wine ."
82497,Dietary,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82498,fibre,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82499,has,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82500,been,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82501,shown,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82502,to,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82503,have,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82504,important,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82505,health,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82506,implications,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82507,in,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82508,the,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82509,prevention,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82510,of,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82511,risks,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82512,of,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82513,chronic,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82514,diseases,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82515,.,O,2859.0,Dietary fibre has been shown to have important health implications in the prevention of risks of chronic diseases .
82675,Groundnuts,B,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82676,have,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82677,the,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82678,lowest,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82679,Fe,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82680,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82681,1.3,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82682,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82683,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82684,1.1,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82685,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82686,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82687,",",O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82688,Zn,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82689,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82690,7.9,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82691,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82692,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82693,1.3,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82694,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82695,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82696,and,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82697,Ca,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82698,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82699,14.6,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82700,(,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82701,sem,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82702,2.8,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82703,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82704,),O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82705,availability,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
82706,.,O,2864.0,"Groundnuts have the lowest Fe ( 1.3 ( sem 1.1 ) ) , Zn ( 7.9 ( sem 1.3 ) ) and Ca ( 14.6 ( sem 2.8 ) ) availability ."
83363,The,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83364,observed,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83365,metal,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83366,concentration,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83367,in,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83368,the,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83369,Borgo,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83370,area,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83371,is,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83372,compatible,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83373,with,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83374,the,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83375,presence,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83376,in,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83377,Taranto,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83378,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83379,a,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83380,military,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83381,dockyard,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83382,and,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83383,a,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83384,reported,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83385,increase,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83386,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83387,lung,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83388,cancer,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83389,risk,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83390,among,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83391,residents,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83392,of,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83393,that,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83394,area,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83395,.,O,2889.0,The observed metal concentration in the Borgo area is compatible with the presence in Taranto of a military dockyard and a reported increase of lung cancer risk among residents of that area .
83521,Ethyl,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83522,acetate,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83523,extract,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83524,showed,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83525,higher,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83526,activity,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83527,compared,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83528,with,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83529,other,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83530,extracts,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83531,.,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83768,In,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83769,conclusion,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83770,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83771,these,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83772,findings,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83773,demonstrate,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83774,that,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83775,U.S.,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83776,consumers,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83777,',O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83778,acceptability,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83779,of,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83780,Seolgitteok,B,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83781,varies,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83782,not,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83783,only,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83784,by,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83785,sensory,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83786,attributes,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83787,such,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83788,as,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83789,rice,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83790,flavor,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83791,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83792,sweetness,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83793,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83794,and,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83795,chewiness,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83796,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83797,but,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83798,also,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83799,by,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83800,nonsensory,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83801,factors,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83802,such,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83803,as,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83804,gender,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83805,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83806,sensation,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83807,-,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83808,seeking,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83809,characteristics,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83810,",",O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83811,and,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83812,personality,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83813,traits,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
83814,.,O,2905.0,"In conclusion , these findings demonstrate that U.S. consumers ' acceptability of Seolgitteok varies not only by sensory attributes such as rice flavor , sweetness , and chewiness , but also by nonsensory factors such as gender , sensation - seeking characteristics , and personality traits ."
84137,Data,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84138,were,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84139,observed,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84140,and,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84141,recorded,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84142,in,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84143,diaries,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84144,by,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84145,caregivers,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84146,at,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84147,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84148,day,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84149,nursery,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84150,and,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84151,by,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84152,parents,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84153,at,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84154,home,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84155,on,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84156,days,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84157,that,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84158,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84159,children,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84160,attended,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84161,the,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84162,daycare,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84163,center,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84164,.,O,2917.0,Data were observed and recorded in diaries by caregivers at the day nursery and by parents at home on days that the children attended the daycare center .
84242,The,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84243,children,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84244,used,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84245,mostly,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84246,(,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84247,semi-)skimmed,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84248,milk,I,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84249,products,I,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84250,and,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84251,non,B,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84252,-,I,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84253,refined,I,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84254,bread,I,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84255,and,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84256,cereals,B,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84257,",",O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84258,as,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84259,recommended,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
84260,.,O,2921.0,"The children used mostly ( semi-)skimmed milk products and non - refined bread and cereals , as recommended ."
85218,Recent,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85219,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85220,by,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85221,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85222,American,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85223,Diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85224,Association,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85225,suggest,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85226,that,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85227,children,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85228,with,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85229,type,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85230,1,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85231,diabetes,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85232,should,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85233,follow,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85234,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85235,recommendations,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85236,for,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85237,age,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85238,",",O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85239,sex,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85240,and,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85241,body,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85242,size,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85243,of,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85244,the,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85245,general,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85246,population,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85247,.,O,2953.0,"Recent recommendations by the American Diabetes Association suggest that children with type 1 diabetes should follow the recommendations for age , sex and body size of the general population ."
85248,In,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85249,the,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85250,case,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85251,of,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85252,being,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85253,overweight,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85254,or,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85255,obese,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85256,",",O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85257,weight,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85258,-,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85259,control,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85260,strategies,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85261,should,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85262,be,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85263,applied,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85264,.,O,2954.0,"In the case of being overweight or obese , weight - control strategies should be applied ."
85590,The,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85591,word,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85592,cacao,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85593,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85594,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85595,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85596,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85597,and,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85598,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85599,subsequent,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85600,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85601,languages,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85602,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85603,kakaw,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85604,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85605,;,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85606,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85607,chocolate,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85608,-,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85609,related,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85610,term,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85611,cacahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85612,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85613,Nahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85614,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85615,Aztec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85616,language,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85617,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85618,",",O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85619,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85620,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85621,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85622,/,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85623,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85624,etymology,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85625,.,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85902,Although,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85903,mushrooms,B,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85904,have,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85905,long,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85906,been,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85907,regarded,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85908,as,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85909,health,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85910,-,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85911,promoting,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85912,foods,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85913,",",O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85914,research,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85915,specific,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85916,to,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85917,their,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85918,role,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85919,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85920,a,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85921,healthful,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85922,diet,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85923,and,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85924,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85925,health,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85926,promotion,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85927,has,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85928,advanced,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85929,in,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85930,the,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85931,past,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85932,decade,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85933,.,O,2976.0,"Although mushrooms have long been regarded as health - promoting foods , research specific to their role in a healthful diet and in health promotion has advanced in the past decade ."
85966,Although,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85967,considered,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85968,a,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85969,vegetable,B,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85970,in,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85971,dietary,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85972,advice,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85973,",",O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85974,mushrooms,B,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85975,are,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85976,fungi,B,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85977,",",O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85978,set,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85979,apart,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85980,by,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85981,vitamin,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85982,B-12,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85983,in,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85984,very,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85985,low,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85986,quantity,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85987,but,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85988,in,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85989,the,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85990,same,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85991,form,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85992,found,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85993,in,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85994,meat,B,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85995,",",O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85996,ergosterol,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85997,converted,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85998,with,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
85999,UV,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86000,light,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86001,to,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86002,vitamin,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86003,D2,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86004,",",O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86005,and,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86006,conjugated,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86007,linoleic,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86008,acid,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86009,.,O,2978.0,"Although considered a vegetable in dietary advice , mushrooms are fungi , set apart by vitamin B-12 in very low quantity but in the same form found in meat , ergosterol converted with UV light to vitamin D2 , and conjugated linoleic acid ."
86172,We,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86173,previously,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86174,have,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86175,shown,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86176,that,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86177,ingested,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86178,beef,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86179,protein,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86180,is,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86181,just,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86182,as,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86183,potent,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86184,as,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86185,glucose,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86186,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86187,stimulating,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86188,a,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86189,rise,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86190,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86191,insulin,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86192,concentration,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86193,in,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86194,type,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86195,II,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86196,diabetic,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86197,patients,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86198,.,O,2985.0,We previously have shown that ingested beef protein is just as potent as glucose in stimulating a rise in insulin concentration in type II diabetic patients .
86407,The,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86408,peripheral,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86409,glucagon,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86410,concentration,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86411,was,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86412,decreased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86413,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86414,ingestion,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86415,of,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86416,glucose,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86417,alone,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86418,and,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86419,increased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86420,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86421,all,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86422,the,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86423,meals,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86424,containing,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86425,protein,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86426,.,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86863,In,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86864,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86865,present,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86866,study,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86867,in,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86868,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86869,same,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86870,animal,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86871,model,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86872,",",O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86873,we,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86874,extended,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86875,these,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86876,observations,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86877,by,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86878,comparing,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86879,camel,B,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86880,milk,I,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86881,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86882,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86883,more,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86884,available,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86885,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86886,widely,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86887,consumed,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86888,bovine,B,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86889,milk,I,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86890,with,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86891,respect,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86892,to,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86893,their,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86894,antidiabetic,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86895,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86896,antithrombotic,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86897,actions,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86898,.,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86950,Diabetic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86951,rats,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86952,developed,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86953,weight,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86954,loss,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86955,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86956,hyperglycemia,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86957,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86958,glucose,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86959,intolerance,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86960,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86961,inhibition,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86962,of,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86963,platelet,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86964,aggregation,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86965,responses,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86966,to,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86967,arachidonic,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86968,acid,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86969,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86970,adenosine,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86971,diphosphate,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86972,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86973,a,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86974,marked,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86975,decrease,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86976,(,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86977,>,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86978,50,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86979,%,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86980,),O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86981,in,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86982,plasma,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86983,fibrinogen,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86984,levels,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86985,",",O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86986,and,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86987,short,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86988,activated,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86989,partial,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86990,thromboplastin,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86991,time,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86992,.,O,3013.0,"Diabetic rats developed weight loss , hyperglycemia , glucose intolerance , inhibition of platelet aggregation responses to arachidonic acid and adenosine diphosphate , a marked decrease ( > 50 % ) in plasma fibrinogen levels , and short activated partial thromboplastin time ."
86993,Treatment,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86994,with,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86995,camel,B,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86996,milk,I,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86997,or,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86998,bovine,B,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86999,milk,I,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87000,reversed,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87001,these,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87002,abnormalities,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87003,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87004,resulting,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87005,in,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87006,weight,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87007,gain,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87008,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87009,decreased,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87010,blood,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87011,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87012,levels,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87013,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87014,and,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87015,improved,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87016,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87017,tolerance,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87018,.,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87048,Long,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87049,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87050,term,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87051,administration,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87052,of,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87053,camel,B,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87054,milk,I,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87055,or,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87056,bovine,B,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87057,milk,I,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87058,counteracted,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87059,streptozotocin,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87060,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87061,induced,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87062,metabolic,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87063,manifestations,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87064,in,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87065,rats,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87066,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87067,maintained,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87068,platelet,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87069,function,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87070,",",O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87071,and,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87072,abolished,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87073,coagulopathy,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87074,-,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87075,associated,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87076,fibrinogen,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87077,consumption,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87078,.,O,3016.0,"Long - term administration of camel milk or bovine milk counteracted streptozotocin - induced metabolic manifestations in rats , maintained platelet function , and abolished coagulopathy - associated fibrinogen consumption ."
87691,Insulin,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87692,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87693,like,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87694,growth,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87695,factor,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87696,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87697,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87698,(,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87699,IGF,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87700,-,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87701,I,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87702,),O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87703,has,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87704,been,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87705,proposed,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87706,as,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87707,the,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87708,link,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87709,between,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87710,diet,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87711,and,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87712,breast,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87713,cancer,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87714,risk,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
87715,.,O,3035.0,Insulin - like growth factor - I ( IGF - I ) has been proposed as the link between diet and breast cancer risk .
88072,Flavanols,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88073,have,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88074,been,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88075,described,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88076,to,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88077,exert,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88078,favorable,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88079,effects,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88080,on,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88081,endothelium,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88082,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88083,derived,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88084,vasodilation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88085,via,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88086,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88087,stimulation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88088,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88089,nitric,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88090,oxide,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88091,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88092,synthase,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88093,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88094,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88095,increased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88096,availability,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88097,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88098,l,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88099,-,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88100,arginine,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88101,",",O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88102,and,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88103,the,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88104,decreased,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88105,degradation,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88106,of,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88107,NO,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88108,.,O,3050.0,"Flavanols have been described to exert favorable effects on endothelium - derived vasodilation via the stimulation of nitric oxide - synthase , the increased availability of l - arginine , and the decreased degradation of NO ."
88136,These,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88137,effects,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88138,are,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88139,associated,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88140,with,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88141,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88142,decrease,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88143,of,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88144,blood,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88145,pressure,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88146,and,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88147,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88148,favorable,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88149,trend,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88150,toward,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88151,a,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88152,reduction,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88153,in,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88154,cardiovascular,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88155,events,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88156,and,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88157,strokes,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
88158,.,O,3052.0,These effects are associated with a decrease of blood pressure and a favorable trend toward a reduction in cardiovascular events and strokes .
89177,Greater,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89178,concentrations,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89179,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89180,monounsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89181,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89182,14.94,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89183,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89184,11.96,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89185,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89186,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89187,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89188,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89189,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89190,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89191,and,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89192,polyunsaturated,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89193,fatty,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89194,acids,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89195,(,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89196,4.53,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89197,vs.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89198,4.03,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89199,g/100,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89200,g,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89201,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89202,milk,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89203,fat,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89204,),O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89205,were,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89206,detected,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89207,in,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89208,the,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89209,milk,B,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89210,of,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89211,goats,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89212,fed,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89213,LRS,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89214,compared,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89215,with,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89216,CON,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89217,.,O,3087.0,Greater concentrations of monounsaturated ( 14.94 vs. 11.96 g/100 g of milk fat ) and polyunsaturated fatty acids ( 4.53 vs. 4.03 g/100 g of milk fat ) were detected in the milk of goats fed LRS compared with CON .
89711,The,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89712,consumption,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89713,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89714,coffee,B,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89715,correlated,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89716,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89717,several,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89718,health,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89719,benefits,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89720,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89721,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89722,reducing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89723,the,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89724,risk,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89725,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89726,human,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89727,chronic,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89728,diseases,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89729,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89730,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89731,inflammation,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89732,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89733,diabetes,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89734,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89735,and,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89736,cardiovascular,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89737,disease,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89738,owing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89739,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89740,its,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89741,antioxidant,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89742,potential,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89743,.,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89865,Some,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89866,relationships,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89867,between,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89868,dough,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89869,rheology,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89870,and,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89871,bread,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89872,characteristics,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89873,were,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89874,established,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89875,to,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89876,identify,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89877,possible,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89878,predictor,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89879,parameters,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
89880,.,O,3113.0,Some relationships between dough rheology and bread characteristics were established to identify possible predictor parameters .
90307,The,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90308,consumption,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90309,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90310,dairy,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90311,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90312,including,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90313,milk,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90314,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90315,cheese,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90316,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90317,yogurt,B,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90318,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90319,has,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90320,been,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90321,associated,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90322,with,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90323,better,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90324,quality,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90325,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90326,diet,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90327,and,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90328,reduced,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90329,risk,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90330,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90331,cardiovascular,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90332,disease,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90333,",",O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90334,the,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90335,leading,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90336,cause,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90337,of,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90338,death,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90339,globally,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90340,.,O,3129.0,"The consumption of dairy , including milk , cheese and yogurt , has been associated with better quality of diet and reduced risk of cardiovascular disease , the leading cause of death globally ."
90341,The,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90342,purpose,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90343,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90344,this,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90345,review,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90346,is,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90347,to,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90348,examine,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90349,recent,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90350,literature,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90351,on,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90352,the,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90353,relationship,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90354,between,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90355,dairy,B,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90356,consumption,I,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90357,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90358,risk,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90359,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90360,cardiovascular,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90361,disease,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90362,incidence,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90363,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90364,mortality,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90365,.,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90874,A,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90875,total,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90876,of,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90877,"31,641",O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90878,(,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90879,86,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90880,%,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90881,),O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90882,participants,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90883,completed,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90884,follow,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90885,-,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90886,up,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90887,",",O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90888,and,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90889,365,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90890,cases,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90891,were,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90892,identified,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90893,.,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
91349,Serum,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91350,cholesterol,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91351,in,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91352,six,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91353,participants,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91354,",",O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91355,previously,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91356,on,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91357,a,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91358,fat,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91359,-,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91360,modified,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91361,diet,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91362,",",O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91363,was,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91364,not,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91365,significantly,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91366,changed,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91367,with,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91368,polyunsaturated,B,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91369,products,I,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91370,.,O,3168.0,"Serum cholesterol in six participants , previously on a fat - modified diet , was not significantly changed with polyunsaturated products ."
91520,One,O,3173.0,One hundred nine subjects also completed a weighed food record .
91521,hundred,O,3173.0,One hundred nine subjects also completed a weighed food record .
91522,nine,O,3173.0,One hundred nine subjects also completed a weighed food record .
91523,subjects,O,3173.0,One hundred nine subjects also completed a weighed food record .
91524,also,O,3173.0,One hundred nine subjects also completed a weighed food record .
91525,completed,O,3173.0,One hundred nine subjects also completed a weighed food record .
91526,a,O,3173.0,One hundred nine subjects also completed a weighed food record .
91527,weighed,O,3173.0,One hundred nine subjects also completed a weighed food record .
91528,food,O,3173.0,One hundred nine subjects also completed a weighed food record .
91529,record,O,3173.0,One hundred nine subjects also completed a weighed food record .
91530,.,O,3173.0,One hundred nine subjects also completed a weighed food record .
92062,Monitoring,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92063,systems,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92064,for,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92065,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92066,-,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92067,farm,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92068,or,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92069,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92070,-,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92071,line,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92072,analysis,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92073,of,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92074,milk,B,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92075,composition,I,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92076,are,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92077,mostly,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92078,based,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92079,on,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92080,infrared,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92081,spectroscopy,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92082,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92083,optical,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92084,methods,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92085,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92086,biosensors,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92087,",",O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92088,or,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92089,sensor,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92090,arrays,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92091,.,O,3191.0,"Monitoring systems for on - farm or on - line analysis of milk composition are mostly based on infrared spectroscopy , optical methods , biosensors , or sensor arrays ."
92479,Yogurt,B,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92480,is,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92481,a,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92482,nutrient,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92483,-,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92484,dense,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92485,food,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92486,that,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92487,may,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92488,benefit,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92489,individuals,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92490,with,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92491,lactose,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92492,intolerance,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92493,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92494,constipation,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92495,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92496,diarrheal,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92497,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92498,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92499,hypertension,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92500,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92501,cardiovascular,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92502,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92503,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92504,diabetes,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92505,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92506,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92507,certain,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92508,types,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92509,of,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92510,cancer,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92511,.,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92618,While,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92619,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92620,evidence,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92621,suggests,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92622,that,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92623,yogurt,B,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92624,consumption,I,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92625,is,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92626,beneficial,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92627,for,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92628,obese,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92629,individuals,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92630,",",O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92631,randomized,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92632,-,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92633,controlled,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92634,trials,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92635,are,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92636,needed,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92637,to,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92638,further,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92639,support,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92640,this,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92641,hypothesis,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92642,.,O,3213.0,"While this evidence suggests that yogurt consumption is beneficial for obese individuals , randomized - controlled trials are needed to further support this hypothesis ."
92856,In,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92857,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92858,domain,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92859,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92860,nutrition,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92861,",",O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92862,exploring,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92863,the,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92864,diet,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92865,-,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92866,health,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92867,linkages,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92868,is,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92869,major,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92870,area,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92871,of,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92872,research,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
92873,.,O,3221.0,"In the domain of nutrition , exploring the diet - health linkages is major area of research ."
93293,This,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93294,association,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93295,was,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93296,observed,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93297,in,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93298,all,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93299,3,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93300,ethnic,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93301,subgroups,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93302,studied,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93303,.,O,3236.0,This association was observed in all 3 ethnic subgroups studied .
93343,In,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93344,addition,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93345,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93346,when,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93347,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93348,consumption,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93349,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93350,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93351,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93352,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93353,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93354,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93355,compared,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93356,to,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93357,that,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93358,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93359,benign,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93360,breast,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93361,patients,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93362,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93363,adjusted,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93364,by,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93365,age,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93366,and,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93367,ethnic,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93368,group,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93369,",",O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93370,a,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93371,diminished,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93372,risk,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93373,was,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93374,found,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93375,(,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93376,odds,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93377,ratio,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93378,for,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93379,BC,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93380,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93381,the,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93382,highest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93383,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93384,of,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93385,methylxanthine,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93386,vs.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93387,lowest,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93388,level,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93389,=,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93390,0.59,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93391,),O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93392,.,O,3238.0,"In addition , when the consumption of methylxanthine of BC patients was compared to that of benign breast patients , adjusted by age and ethnic group , a diminished risk was found ( odds ratio for BC of the highest level of methylxanthine vs. lowest level = 0.59 ) ."
93465,On,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93466,the,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93467,first,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93468,day,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93469,",",O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93470,each,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93471,volunteer,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93472,followed,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93473,their,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93474,selected,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93475,diet,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93476,",",O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93477,and,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93478,an,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93479,overnight,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93480,12,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93481,h,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93482,urine,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93483,sample,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93484,was,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93485,collected,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93486,as,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93487,the,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93488,baseline,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93489,urine,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93490,.,O,3242.0,"On the first day , each volunteer followed their selected diet , and an overnight 12 h urine sample was collected as the baseline urine ."
93536,Urine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93537,volume,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93538,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93539,pH,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93540,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93541,oxalate,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93542,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93543,creatinine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93544,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93545,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93546,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93547,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93548,theobromine,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93549,",",O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93550,and,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93551,a,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93552,uric,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93553,acid,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93554,crystallization,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93555,test,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93556,were,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93557,determined,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93558,for,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93559,each,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93560,sample,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93561,.,O,3245.0,"Urine volume , pH , oxalate , creatinine , uric acid , theobromine , and a uric acid crystallization test were determined for each sample ."
93704,Specific,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93705,IgE,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93706,to,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93707,olive,B,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93708,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93709,grass,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93710,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93711,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93712,weed,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93713,pollens,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93714,were,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93715,10.92,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93716,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93717,6.17,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93718,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93719,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93720,2.4,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93721,AU,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93722,/,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93723,ml,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93724,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93725,respectively,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93726,.,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93800,The,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93801,existence,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93802,of,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93803,monosensitization,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93804,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93805,an,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93806,18,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93807,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93808,kDa,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93809,protein,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93810,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93811,carrot,B,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93812,and,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93813,specific,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93814,IgE,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93815,to,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93816,olive,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93817,pollen,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93818,has,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93819,not,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93820,been,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93821,reported,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93822,in,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93823,the,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93824,celery,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93825,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93826,carrot,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93827,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93828,mugwort,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93829,-,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93830,spice,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93831,syndrome,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93832,.,O,3257.0,The existence of monosensitization to an 18 - kDa protein in carrot and specific IgE to olive pollen has not been reported in the celery - carrot - mugwort - spice syndrome .
93932,Although,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93933,most,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93934,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93935,the,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93936,popular,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93937,botanicals,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93938,have,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93939,a,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93940,long,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93941,history,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93942,in,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93943,folk,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93944,medicine,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93945,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93946,there,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93947,is,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93948,paucity,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93949,of,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93950,data,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93951,regarding,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93952,their,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93953,efficacy,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93954,and,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93955,safety,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93956,",",O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93957,particularly,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93958,as,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93959,it,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93960,relates,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93961,to,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93962,human,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93963,studies,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
93964,.,O,3262.0,"Although most of the popular botanicals have a long history in folk medicine , there is paucity of data regarding their efficacy and safety , particularly as it relates to human studies ."
94154,In,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94155,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94156,first,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94157,study,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94158,",",O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94159,hamsters,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94160,fed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94161,on,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94162,coconut,B,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94163,oil,I,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94164,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94165,150,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94166,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94167,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94168,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94169,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94170,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94171,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94172,cholesterol,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94173,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94174,30,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94175,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94176,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94177,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94178,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94179,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94180,developed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94181,lipid,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94182,-,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94183,rich,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94184,lesions,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94185,in,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94186,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94187,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94188,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94189,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94190,0.28,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94191,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94192,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94193,0.14,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94194,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94195,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94196,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94197,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94198,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94199,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94200,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94201,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94202,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94203,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94204,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94205,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94206,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94207,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94208,after,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94209,4,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94210,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94211,that,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94212,continued,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94213,to,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94214,progress,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94215,over,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94216,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94217,next,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94218,8,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94219,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94220,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94221,0.75,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94222,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94223,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94224,0.41,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94225,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94226,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94227,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94228,0.12,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94229,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94230,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94231,0.11,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94232,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94233,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94234,for,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94235,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94236,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94237,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94238,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94239,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94240,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94241,respectively,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94242,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94243,.,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94800,This,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94801,point,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94802,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94803,especially,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94804,if,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94805,confirmed,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94806,by,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94807,experiments,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94808,with,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94809,more,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94810,frequent,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94811,after,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94812,meal,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94813,measurements,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94814,and,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94815,of,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94816,longer,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94817,duration,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94818,",",O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94819,should,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94820,be,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94821,taken,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94822,into,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94823,account,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94824,in,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94825,defining,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94826,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94827,best,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94828,dietary,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94829,approach,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94830,to,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94831,lower,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94832,plasma,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94833,TG,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94834,levels,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94835,throughout,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94836,the,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94837,whole,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94838,day,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94839,.,O,3288.0,"This point , especially if confirmed by experiments with more frequent after meal measurements and of longer duration , should be taken into account in defining the best dietary approach to lower plasma TG levels throughout the whole day ."
94873,The,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94874,evidence,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94875,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94876,a,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94877,protective,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94878,effect,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94879,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94880,greater,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94881,vegetable,B,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94882,and,I,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94883,fruit,I,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94884,consumption,I,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94885,is,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94886,consistent,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94887,for,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94888,cancers,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94889,of,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94890,the,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94891,stomach,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94892,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94893,esophagus,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94894,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94895,lung,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94896,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94897,oral,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94898,cavity,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94899,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94900,pharynx,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94901,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94902,endometrium,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94903,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94904,pancreas,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94905,",",O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94906,and,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94907,colon,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
94908,.,O,3290.0,"The evidence for a protective effect of greater vegetable and fruit consumption is consistent for cancers of the stomach , esophagus , lung , oral cavity and pharynx , endometrium , pancreas , and colon ."
95205,Scientific,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95206,findings,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95207,indicate,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95208,that,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95209,the,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95210,prevalence,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95211,of,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95212,lactose,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95213,intolerance,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95214,is,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95215,grossly,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95216,overestimated,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95217,.,O,3301.0,Scientific findings indicate that the prevalence of lactose intolerance is grossly overestimated .
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95423,By,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95424,contrast,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95425,",",O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95426,in,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95427,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95428,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95429,-,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95430,mugwort,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95431,sensitive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95432,patients,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95433,(,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95434,n,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95435,=,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95436,6,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95437,),O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95438,the,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95439,celery,B,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95440,RASTs,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95441,with,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95442,heated,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95443,celery,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95444,extracts,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95445,remained,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95446,clearly,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95447,positive,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95448,and,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95449,high,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95450,RAST,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95451,values,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95452,to,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95453,stick,B,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95454,celery,I,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95455,could,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95456,be,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95457,found,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95458,.,O,3308.0,"By contrast , in the celery - mugwort sensitive patients ( n = 6 ) the celery RASTs with heated celery extracts remained clearly positive and high RAST values to stick celery could be found ."
95602,Subjects,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95603,are,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95604,"477,312",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95605,men,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95606,and,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95607,women,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95608,mostly,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95609,aged,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95610,35,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95611,to,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95612,70,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95613,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95614,participating,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95615,in,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95616,the,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95617,EPIC,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95618,cohort,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95619,",",O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95620,including,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95621,683,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95622,gastric,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95623,adenocarcinomas,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95624,with,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95625,11,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95626,years,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95627,of,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95628,follow,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95629,-,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95630,up,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95631,.,O,3313.0,"Subjects are 477,312 men and women mostly aged 35 to 70 years participating in the EPIC cohort , including 683 gastric adenocarcinomas with 11 years of follow - up ."
95891,Most,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95892,regulatory,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95893,agencies,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95894,have,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95895,set,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95896,a,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95897,threshold,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95898,of,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95899,20,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95900,ppm,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95901,gluten,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95902,in,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95903,foods,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95904,labeled,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95905,gluten,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95906,-,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95907,free,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95908,",",O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95909,based,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95910,on,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95911,the,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95912,currently,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95913,available,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95914,ELISA,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95915,methods,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
95916,.,O,3324.0,"Most regulatory agencies have set a threshold of 20 ppm gluten in foods labeled gluten - free , based on the currently available ELISA methods ."
96029,Prolamin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96030,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96031,showed,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96032,higher,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96033,gluten,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96034,recovery,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96035,compared,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96036,to,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96037,their,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96038,respective,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96039,glutelin,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96040,fractions,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96041,.,O,3330.0,Prolamin fractions showed higher gluten recovery compared to their respective glutelin fractions .
96042,Among,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96043,prolamins,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96044,",",O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96045,barley,B,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96046,exhibited,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96047,higher,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96048,recovery,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96049,compared,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96050,to,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96051,wheat,B,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96052,and,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96053,rye,B,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96054,with,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96055,most,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96056,of,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96057,the,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96058,ELISA,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96059,kits,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96060,used,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96061,.,O,3331.0,"Among prolamins , barley exhibited higher recovery compared to wheat and rye with most of the ELISA kits used ."
96182,The,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96183,soil,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96184,with,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96185,high,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96186,average,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96187,uranium,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96188,levels,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96189,(,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96190,64,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96191,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96192,252,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96193,mg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96194,/,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96195,kg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96196,),O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96197,was,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96198,divided,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96199,in,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96200,two,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96201,plots,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96202,",",O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96203,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96204,irrigated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96205,with,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96206,non,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96207,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96208,contaminated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96209,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96210,uranium,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96211,-,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96212,contaminated,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96213,water,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96214,(,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96215,<,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96216,20,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96217,and,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96218,>,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96219,900,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96220,microg,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96221,/,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96222,L,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96223,),O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96224,.,O,3336.0,"The soil with high average uranium levels ( 64 - 252 mg / kg ) was divided in two plots , and irrigated with non - contaminated and uranium - contaminated water ( < 20 and > 900 microg / L ) ."
96274,Although,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96275,uranium,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96276,in,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96277,soil,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96278,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96279,irrigation,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96280,water,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96281,and,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96282,vegetables,B,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96283,was,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96284,high,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96285,",",O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96286,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96287,assessment,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96288,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96289,the,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96290,health,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96291,risk,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96292,based,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96293,on,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96294,hazard,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96295,quotient,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96296,indicates,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96297,that,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96298,consumption,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96299,of,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96300,these,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96301,vegetables,B,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96302,does,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96303,not,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96304,represent,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96305,potential,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96306,adverse,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96307,(,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96308,no,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96309,carcinogenic,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96310,),O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96311,effects,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96312,for,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96313,a,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96314,local,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96315,inhabitant,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96316,during,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96317,lifetime,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
96318,.,O,3338.0,"Although uranium in soil , irrigation water and vegetables was high , the assessment of the health risk based on hazard quotient indicates that consumption of these vegetables does not represent potential adverse ( no carcinogenic ) effects for a local inhabitant during lifetime ."
97163,Many,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97164,lectins,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97165,resist,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97166,digestion,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97167,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97168,survive,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97169,gut,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97170,passage,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97171,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97172,and,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97173,bind,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97174,to,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97175,gastrointestinal,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97176,cells,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97177,and/or,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97178,enter,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97179,the,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97180,circulation,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97181,intact,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97182,",",O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97183,maintaining,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97184,full,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97185,biological,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97186,activity,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97187,.,O,3366.0,"Many lectins resist digestion , survive gut passage , and bind to gastrointestinal cells and/or enter the circulation intact , maintaining full biological activity ."
97644,This,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97645,condition,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97646,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97647,chronic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97648,inflammation,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97649,may,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97650,damage,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97651,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97652,vasculature,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97653,of,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97654,the,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97655,brain,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97656,or,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97657,be,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97658,directly,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97659,neurotoxic,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97660,.,O,3383.0,This condition of chronic inflammation may damage the vasculature of the brain or be directly neurotoxic .
97943,Females,O,3394.0,Females reported FS more often than males .
97944,reported,O,3394.0,Females reported FS more often than males .
97945,FS,O,3394.0,Females reported FS more often than males .
97946,more,O,3394.0,Females reported FS more often than males .
97947,often,O,3394.0,Females reported FS more often than males .
97948,than,O,3394.0,Females reported FS more often than males .
97949,males,O,3394.0,Females reported FS more often than males .
97950,.,O,3394.0,Females reported FS more often than males .
98185,Women,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98186,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98187,both,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98188,ethnic,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98189,groups,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98190,were,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98191,found,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98192,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98193,avoid,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98194,saturated,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98195,fat,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98196,and,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98197,cholesterol,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98198,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98199,a,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98200,greater,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98201,degree,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98202,than,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98203,men,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98204,",",O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98205,scoring,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98206,higher,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98207,on,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98208,five,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98209,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98210,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98211,six,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98212,components,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98213,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98214,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98215,scale,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98216,.,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98347,Evaluation,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98348,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98349,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98350,possible,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98351,anticarcinogenic,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98352,properties,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98353,of,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98354,their,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98355,ingredients,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98356,is,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98357,confounded,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98358,by,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98359,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98360,potential,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98361,increase,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98362,in,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98363,risk,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98364,owing,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98365,to,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98366,the,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98367,high,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98368,temperatures,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98369,at,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98370,which,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98371,these,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98372,beverages,B,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98373,are,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98374,generally,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98375,consumed,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98376,.,O,3408.0,Evaluation of the possible anticarcinogenic properties of their ingredients is confounded by the potential increase in risk owing to the high temperatures at which these beverages are generally consumed .
98377,We,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98378,conducted,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98379,a,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98380,case,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98381,-,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98382,control,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98383,study,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98384,to,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98385,evaluate,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98386,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98387,association,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98388,between,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98389,coffee,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98390,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98391,tea,B,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98392,consumption,I,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98393,and,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98394,the,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98395,risk,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98396,of,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98397,UADT,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98398,cancer,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98399,.,O,3409.0,We conducted a case - control study to evaluate the association between coffee and tea consumption and the risk of UADT cancer .
98514,These,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98515,associations,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98516,were,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98517,evident,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98518,for,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98519,head,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98520,and,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98521,neck,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98522,cancer,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98523,but,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98524,not,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98525,for,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98526,esophageal,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98527,cancer,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98528,.,O,3414.0,These associations were evident for head and neck cancer but not for esophageal cancer .
98859,In,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98860,veal,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98861,calves,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98862,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98863,the,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98864,major,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98865,portion,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98866,of,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98867,digestible,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98868,energy,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98869,intake,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98870,originates,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98871,from,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98872,milk,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98873,replacer,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98874,(,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98875,MR,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98876,),O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98877,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98878,with,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98879,lactose,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98880,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98881,fat,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98882,contributing,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98883,approximately,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98884,45,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98885,and,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98886,35,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98887,%,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98888,",",O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98889,respectively,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98890,.,O,3429.0,"In veal calves , the major portion of digestible energy intake originates from milk replacer ( MR ) , with lactose and fat contributing approximately 45 and 35 % , respectively ."
98955,Therefore,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98956,",",O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98957,an,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98958,experiment,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98959,was,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98960,designed,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98961,to,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98962,compare,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98963,the,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98964,effects,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98965,of,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98966,a,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98967,high,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98968,-,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98969,lactose,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98970,and,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98971,a,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98972,high,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98973,-,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98974,fat,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98975,MR,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98976,on,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98977,glucose,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98978,homeostasis,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98979,and,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98980,insulin,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98981,sensitivity,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98982,in,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98983,veal,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98984,calves,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
98985,.,O,3432.0,"Therefore , an experiment was designed to compare the effects of a high - lactose and a high - fat MR on glucose homeostasis and insulin sensitivity in veal calves ."
99102,Long,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99103,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99104,term,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99105,exposure,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99106,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99107,calves,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99108,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99109,HF,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99110,or,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99111,HL,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99112,MR,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99113,did,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99114,not,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99115,affect,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99116,whole,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99117,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99118,body,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99119,insulin,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99120,sensitivity,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99121,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99122,averaging,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99123,4.2±0.5×10,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99124,During,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99125,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99126,periparturient,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99127,phase,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99128,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99129,cows,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99130,are,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99131,typically,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99132,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99133,an,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99134,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99135,-,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99136,like,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99137,condition,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99138,",",O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99139,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99140,it,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99141,has,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99142,been,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99143,suggested,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99144,that,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99145,inflammation,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99146,associated,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99147,with,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99148,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99149,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99150,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99151,stress,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99152,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99153,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99154,endoplasmic,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99155,reticulum,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99156,(,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99157,ER,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99158,),O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99159,in,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99160,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99161,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99162,contributes,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99163,to,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99164,the,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99165,development,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99166,of,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99167,fatty,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99168,liver,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99169,syndrome,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99170,and,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99171,ketosis,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99172,.,O,3437.0,"Long - term exposure of calves to HF or HL MR did not affect whole - body insulin sensitivity ( averaging 4.2±0.5×10 During the periparturient phase , cows are typically in an inflammation - like condition , and it has been suggested that inflammation associated with the development of stress of the endoplasmic reticulum ( ER ) in the liver contributes to the development of fatty liver syndrome and ketosis ."
99939,Consumption,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99940,of,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99941,olive,B,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99942,oil,I,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99943,within,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99944,the,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99945,Mediterranean,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99946,diet,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99947,has,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99948,been,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99949,long,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99950,known,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99951,to,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99952,have,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99953,many,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99954,health,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99955,benefits,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99956,.,O,3461.0,Consumption of olive oil within the Mediterranean diet has been long known to have many health benefits .
99977,The,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99978,objective,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99979,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99980,this,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99981,review,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99982,was,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99983,to,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99984,give,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99985,an,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99986,overview,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99987,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99988,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99989,state,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99990,of,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99991,art,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99992,epidemiological,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99993,evidence,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99994,concerning,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99995,the,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99996,relationship,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99997,between,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99998,olive,B,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
99999,oil,I,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100000,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100001,key,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100002,public,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100003,health,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100004,outcomes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100005,including,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100006,mortality,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100007,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100008,CVD,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100009,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100010,diabetes,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100011,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100012,metabolic,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100013,syndrome,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100014,(,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100015,MetS,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100016,),O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100017,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100018,obesity,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100019,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100020,cancer,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100021,",",O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100022,with,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100023,a,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100024,particular,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100025,focus,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100026,on,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100027,recent,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100028,results,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100029,from,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100030,cohort,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100031,studies,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100032,and,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100033,dietary,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100034,intervention,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100035,trials,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100036,.,O,3463.0,"The objective of this review was to give an overview of the state of art epidemiological evidence concerning the relationship between olive oil and key public health outcomes including mortality , CVD , diabetes , metabolic syndrome ( MetS ) , obesity and cancer , with a particular focus on recent results from cohort studies and dietary intervention trials ."
100778,Incident,O,3495.0,Incident stroke cases were identified in national registers .
100779,stroke,O,3495.0,Incident stroke cases were identified in national registers .
100780,cases,O,3495.0,Incident stroke cases were identified in national registers .
100781,were,O,3495.0,Incident stroke cases were identified in national registers .
100782,identified,O,3495.0,Incident stroke cases were identified in national registers .
100783,in,O,3495.0,Incident stroke cases were identified in national registers .
100784,national,O,3495.0,Incident stroke cases were identified in national registers .
100785,registers,O,3495.0,Incident stroke cases were identified in national registers .
100786,.,O,3495.0,Incident stroke cases were identified in national registers .
100787,We,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100788,used,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100789,Cox,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100790,proportional,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100791,hazards,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100792,regression,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100793,to,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100794,calculate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100795,associations,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100796,for,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100797,substitutions,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100798,between,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100799,dairy,B,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100800,products,I,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100801,with,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100802,the,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100803,rate,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100804,of,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100805,stroke,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100806,.,O,3496.0,We used Cox proportional hazards regression to calculate associations for substitutions between dairy products with the rate of stroke .
100987,Obesity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100988,is,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100989,associated,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100990,with,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100991,increased,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100992,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100993,of,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100994,the,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100995,renin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100996,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100997,angiotensin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100998,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100999,aldosterone,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101000,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101001,sympathetic,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101002,nervous,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101003,systems,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101004,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101005,possibly,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101006,other,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101007,mineralcorticoid,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101008,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101009,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101010,insulin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101011,resistance,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101012,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101013,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101014,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101015,sensitive,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101016,hypertension,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101017,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101018,excess,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101019,salt,B,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101020,intake,I,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101021,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101022,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101023,reduced,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101024,kidney,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101025,function,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101026,.,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101163,Cancer,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101164,is,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101165,the,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101166,second,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101167,leading,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101168,cause,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101169,of,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101170,death,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101171,in,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101172,developed,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101173,countries,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101174,and,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101175,poor,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101176,diet,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101177,and,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101178,physical,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101179,inactivity,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101180,are,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101181,major,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101182,risk,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101183,factors,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101184,in,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101185,cancer,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101186,-,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101187,related,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101188,deaths,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101189,.,O,3511.0,Cancer is the second leading cause of death in developed countries and poor diet and physical inactivity are major risk factors in cancer - related deaths .
101614,Mean,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101615,per,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101616,capita,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101617,daily,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101618,consumption,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101619,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101620,calcium,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101621,for,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101622,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101623,total,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101624,U.S.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101625,population,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101626,was,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101627,737,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101628,mg,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101629,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101630,varied,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101631,by,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101632,region,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101633,of,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101634,the,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101635,country,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101636,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101637,household,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101638,income,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101639,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101640,ethnic,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101641,group,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101642,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101643,sex,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101644,",",O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101645,and,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101646,age,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101647,.,O,3525.0,"Mean per capita daily consumption of calcium for the total U.S. population was 737 mg and varied by region of the country , household income , ethnic group , sex , and age ."
101648,For,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101649,most,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101650,groups,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101651,of,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101652,females,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101653,",",O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101654,intake,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101655,was,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101656,substantially,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101657,less,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101658,than,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101659,the,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101660,RDA,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101661,.,O,3526.0,"For most groups of females , intake was substantially less than the RDA ."
101759,We,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101760,sought,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101761,to,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101762,determine,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101763,the,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101764,relationship,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101765,between,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101766,chocolate,B,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101767,with,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101768,varying,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101769,combinations,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101770,of,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101771,its,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101772,main,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101773,constituents,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101774,(,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101775,sugar,B,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101776,",",O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101777,cocoa,B,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101778,",",O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101779,and,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101780,fat,B,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101781,),O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101782,and,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101783,its,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101784,psychoactive,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101785,effects,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101786,.,O,3531.0,"We sought to determine the relationship between chocolate with varying combinations of its main constituents ( sugar , cocoa , and fat ) and its psychoactive effects ."
101834,The,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101835,PEQ,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101836,consists,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101837,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101838,questions,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101839,taken,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101840,from,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101841,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101842,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101843,-,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101844,Benzedrine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101845,Group,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101846,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101847,MBG,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101848,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101849,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101850,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101851,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101852,M,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101853,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101854,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101855,and,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101856,Excitement,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101857,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101858,E,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101859,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101860,subscales,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101861,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101862,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101863,Addiction,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101864,Research,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101865,Center,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101866,Inventory,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101867,.,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
102568,High,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102569,salt,B,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102570,intake,I,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102571,is,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102572,a,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102573,major,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102574,risk,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102575,factor,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102576,of,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102577,hypertension,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102578,and,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102579,cardiovascular,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102580,disease,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102581,.,O,3559.0,High salt intake is a major risk factor of hypertension and cardiovascular disease .
102854,These,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102855,findings,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102856,support,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102857,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102858,need,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102859,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102860,education,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102861,campaigns,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102862,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102863,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102864,salt,B,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102865,added,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102866,during,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102867,cooking,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102868,and,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102869,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102870,strategies,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102871,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102872,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102873,salt,B,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102874,content,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102875,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102876,selected,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102877,manufactured,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102878,foods,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102879,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102880,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102881,region,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102882,.,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102927,As,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102928,compared,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102929,to,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102930,controls,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102931,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102932,patients,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102933,showed,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102934,an,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102935,impaired,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102936,fat,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102937,",",O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102938,but,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102939,not,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102940,sugar,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102941,perception,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
102942,.,O,3573.0,"As compared to controls , patients showed an impaired fat , but not sugar perception ."
103406,Reduced,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103407,risks,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103408,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103409,frequent,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103410,consumption,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103411,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103412,2,B,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103413,%,B,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103414,milk,I,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103415,relative,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103416,to,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103417,not,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103418,drinking,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103419,milk,B,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103420,were,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103421,observed,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103422,for,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103423,cancers,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103424,of,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103425,the,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103426,oral,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103427,cavity,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103428,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103429,stomach,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103430,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103431,rectum,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103432,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103433,lung,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103434,",",O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103435,and,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103436,cervix,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103437,.,O,3589.0,"Reduced risks for frequent consumption of 2 % milk relative to not drinking milk were observed for cancers of the oral cavity , stomach , rectum , lung , and cervix ."
103589,Given,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103590,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103591,putative,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103592,relationship,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103593,between,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103594,inflammation,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103595,and,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103596,insulin,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103597,resistance,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103598,",",O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103599,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103600,consumption,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103601,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103602,flavonoids,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103603,or,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103604,flavonoid,B,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103605,-,I,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103606,rich,I,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103607,foods,I,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103608,has,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103609,been,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103610,suggested,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103611,to,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103612,reduce,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103613,the,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103614,risk,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103615,of,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103616,diabetes,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103617,by,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103618,targeting,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103619,inflammatory,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103620,signals,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103621,.,O,3596.0,"Given the putative relationship between inflammation and insulin resistance , the consumption of flavonoids or flavonoid - rich foods has been suggested to reduce the risk of diabetes by targeting inflammatory signals ."
103655,Laboratory,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103656,and,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103657,human,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103658,studies,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103659,on,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103660,the,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103661,activities,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103662,of,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103663,major,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103664,flavonoids,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103665,(,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103666,flavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103667,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103668,isoflavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103669,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103670,flavonols,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103671,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103672,etc,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103673,.,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103857,Changes,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103858,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103859,vitamin,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103860,content,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103861,are,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103862,mainly,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103863,observed,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103864,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103865,fermented,B,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103866,milk,I,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103867,and,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103868,fruits,B,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103869,.,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
104028,CLA,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104029,has,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104030,been,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104031,shown,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104032,to,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104033,inhibit,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104034,chemically,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104035,-,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104036,induced,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104037,skin,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104038,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104039,stomach,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104040,",",O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104041,mammary,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104042,or,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104043,colon,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104044,tumours,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104045,in,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104046,mice,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104047,and,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104048,rats,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104049,.,O,3615.0,"CLA has been shown to inhibit chemically - induced skin , stomach , mammary or colon tumours in mice and rats ."
104264,For,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104265,this,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104266,purpose,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104267,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104268,while,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104269,lockdown,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104270,restrictions,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104271,were,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104272,in,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104273,place,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104274,(,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104275,February,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104276,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104277,April,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104278,2020,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104279,),O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104280,",",O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104281,359,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104282,subjects,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104283,from,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104284,the,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104285,Brisighella,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104286,Heart,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104287,Study,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104288,cohort,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104289,underwent,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104290,a,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104291,phone,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104292,interview,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104293,about,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104294,their,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104295,lifestyle,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104296,habit,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104297,changes,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104298,during,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104299,COVID-19,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104300,-,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104301,related,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104302,quarantine,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104303,.,O,3625.0,"For this purpose , while lockdown restrictions were in place ( February - April 2020 ) , 359 subjects from the Brisighella Heart Study cohort underwent a phone interview about their lifestyle habit changes during COVID-19 - related quarantine ."
104316,Subjects,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104317,significantly,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104318,increased,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104319,daily,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104320,carbohydrates,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104321,consumption,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104322,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104323,all,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104324,fresh,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104325,vegetables,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104326,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104327,healthy,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104328,vegetable,I,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104329,oils,I,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104330,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104331,milk,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104332,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104333,yogurt,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104334,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104335,alcoholic,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104336,drinks,I,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104337,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104338,sugars,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104339,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104340,sweets,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104341,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104342,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104343,coffee,B,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104344,.,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104845,This,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104846,suggests,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104847,the,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104848,existence,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104849,of,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104850,common,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104851,antigenic,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104852,determinants,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104853,among,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104854,these,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104855,allergens,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
104856,.,O,3647.0,This suggests the existence of common antigenic determinants among these allergens .
105450,Although,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105451,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105452,bioactive,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105453,potential,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105454,is,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105455,linked,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105456,to,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105457,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105458,composition,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105459,",",O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105460,that,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105461,is,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105462,variable,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105463,depending,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105464,on,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105465,mainly,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105466,the,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105467,botanical,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105468,origin,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105469,",",O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105470,honey,B,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105471,has,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105472,antioxidant,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105473,and,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105474,anti,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105475,-,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105476,inflammatory,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105477,properties,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105478,.,O,3667.0,"Although the bioactive potential is linked to the composition , that is variable depending on mainly the botanical origin , honey has antioxidant and anti - inflammatory properties ."
105479,Therefore,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105480,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105481,honey,B,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105482,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105483,administered,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105484,alone,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105485,or,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105486,in,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105487,combination,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105488,with,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105489,conventional,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105490,therapy,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105491,",",O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105492,might,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105493,result,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105494,useful,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105495,in,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105496,the,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105497,management,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105498,of,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105499,chronic,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105500,diseases,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105501,that,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105502,are,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105503,commonly,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105504,associated,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105505,with,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105506,oxidative,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105507,stress,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105508,and,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105509,inflammation,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105510,state,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
105511,.,O,3668.0,"Therefore , honey , administered alone or in combination with conventional therapy , might result useful in the management of chronic diseases that are commonly associated with oxidative stress and inflammation state ."
106252,Exploratory,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106253,dietary,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106254,patterns,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106255,were,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106256,derived,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106257,and,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106258,analyzed,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106259,for,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106260,associations,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106261,with,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106262,diet,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106263,and,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106264,nutrition,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106265,measurements,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106266,.,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106305,Sixty,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106306,-,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106307,one,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106308,percent,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106309,of,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106310,men,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106311,and,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106312,51,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106313,%,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106314,of,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106315,women,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106316,were,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106317,overweight,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106318,or,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106319,obese,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106320,.,O,3697.0,Sixty - one percent of men and 51 % of women were overweight or obese .
106412,Biochemical,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106413,evidence,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106414,of,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106415,iron,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106416,and,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106417,vitamin,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106418,A,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106419,deficiency,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106420,was,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106421,also,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106422,low,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106423,.,O,3701.0,Biochemical evidence of iron and vitamin A deficiency was also low .
106790,Dietary,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106791,patterns,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106792,that,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106793,reflect,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106794,a,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106795,Western,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106796,way,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106797,of,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106798,life,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106799,are,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106800,associated,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106801,with,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106802,a,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106803,higher,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106804,risk,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106805,of,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106806,colorectal,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106807,tumors,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106808,.,O,3712.0,Dietary patterns that reflect a Western way of life are associated with a higher risk of colorectal tumors .
106861,Moderately,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106862,elevated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106863,homocysteine,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106864,levels,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106865,may,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106866,be,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106867,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106868,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106869,stroke,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106870,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106871,are,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106872,associated,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106873,with,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106874,deficiency,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106875,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106876,dietary,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106877,intake,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106878,of,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106879,folate,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106880,",",O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106881,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106882,B6,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106883,and,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106884,vitamin,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106885,B12,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106886,.,O,3715.0,"Moderately elevated homocysteine levels may be associated with stroke and are associated with deficiency of dietary intake of folate , vitamin B6 and vitamin B12 ."
106975,There,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106976,is,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106977,also,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106978,evidence,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106979,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106980,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106981,low,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106982,serum,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106983,albumin,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106984,may,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106985,be,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106986,causally,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106987,linked,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106988,to,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106989,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106990,risk,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106991,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106992,outcome,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106993,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106994,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106995,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106996,significant,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106997,number,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106998,of,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106999,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107000,patients,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107001,are,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107002,undernourished,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107003,on,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107004,admission,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107005,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107006,their,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107007,nutritional,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107008,status,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107009,deteriorates,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107010,further,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107011,whilst,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107012,in,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107013,hospital,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107014,.,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107561,Ochratoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107562,A,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107563,(,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107564,OTA,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107565,),O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107566,is,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107567,a,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107568,mycotoxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107569,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107570,or,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107571,fungal,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107572,toxin,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107573,",",O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107574,that,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107575,contaminates,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107576,multiple,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107577,foodstuffs,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107578,worldwide,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
107579,.,O,3739.0,"Ochratoxin A ( OTA ) is a mycotoxin , or fungal toxin , that contaminates multiple foodstuffs worldwide ."
108053,Our,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108054,results,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108055,confirm,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108056,the,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108057,protective,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108058,effect,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108059,of,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108060,high,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108061,fruit,B,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108062,and,I,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108063,vegetables,I,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108064,intake,I,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108065,",",O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108066,and,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108067,show,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108068,a,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108069,differential,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108070,association,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108071,according,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108072,to,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108073,histological,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108074,type,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108075,.,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108076,No,O,3756.0,No effect modification by H. pylori infection was observed .
108077,effect,O,3756.0,No effect modification by H. pylori infection was observed .
108078,modification,O,3756.0,No effect modification by H. pylori infection was observed .
108079,by,O,3756.0,No effect modification by H. pylori infection was observed .
108080,H.,O,3756.0,No effect modification by H. pylori infection was observed .
108081,pylori,O,3756.0,No effect modification by H. pylori infection was observed .
108082,infection,O,3756.0,No effect modification by H. pylori infection was observed .
108083,was,O,3756.0,No effect modification by H. pylori infection was observed .
108084,observed,O,3756.0,No effect modification by H. pylori infection was observed .
108085,.,O,3756.0,No effect modification by H. pylori infection was observed .
108258,These,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108259,results,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108260,demonstrate,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108261,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108262,high,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108263,frequency,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108264,(,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108265,32,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108266,%,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108267,),O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108268,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108269,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108270,association,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108271,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108272,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108273,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108274,egg,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108275,proteins,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108276,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108277,particularly,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108278,egg,B,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108279,yolk,I,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108280,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108281,in,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108282,a,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108283,selected,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108284,population,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108285,of,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108286,patients,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108287,with,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108288,known,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108289,allergy,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108290,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108291,bird,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108292,feathers,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108293,",",O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108294,thus,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108295,suggesting,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108296,that,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108297,in,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108298,some,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108299,patients,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108300,feather,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108301,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108302,could,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108303,trigger,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108304,or,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108305,somehow,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108306,facilitate,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108307,the,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108308,later,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108309,sensitization,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108310,to,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108311,egg,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108312,yolk,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108313,proteins,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108314,.,O,3764.0,"These results demonstrate the high frequency ( 32 % ) of the association of sensitization to egg proteins , particularly egg yolk , in a selected population of patients with known allergy to bird feathers , thus suggesting that in some patients feather sensitization could trigger or somehow facilitate the later sensitization to egg yolk proteins ."
108679,The,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108680,aim,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108681,of,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108682,this,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108683,study,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108684,was,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108685,to,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108686,examine,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108687,replacement,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108688,of,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108689,potatoes,B,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108690,with,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108691,other,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108692,vegetables,B,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108693,or,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108694,subgroups,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108695,of,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108696,other,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108697,vegetables,B,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108698,and,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108699,the,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108700,risk,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108701,of,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108702,MI,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108703,.,O,3777.0,The aim of this study was to examine replacement of potatoes with other vegetables or subgroups of other vegetables and the risk of MI .
108922,This,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108923,study,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108924,supports,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108925,food,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108926,-,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108927,based,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108928,dietary,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108929,guidelines,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108930,recommending,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108931,to,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108932,consume,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108933,a,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108934,variety,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108935,of,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108936,vegetables,B,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108937,from,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108938,all,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108939,subgroups,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
108940,.,O,3788.0,This study supports food - based dietary guidelines recommending to consume a variety of vegetables from all subgroups .
109489,Cases,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109490,and,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109491,controls,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109492,were,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109493,recruited,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109494,at,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109495,the,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109496,University,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109497,Hospital,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109498,"""",O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109499,G.,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109500,Rodolico,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109501,"""",O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109502,of,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109503,Catania,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
109504,.,O,3815.0,"Cases and controls were recruited at the University Hospital "" G. Rodolico "" of Catania ."
110230,This,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110231,paper,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110232,will,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110233,review,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110234,the,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110235,characteristics,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110236,of,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110237,cereal,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110238,anthocyanins,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110239,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110240,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110241,assess,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110242,their,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110243,prevalence,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110244,in,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110245,various,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110246,commercially,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110247,relevant,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110248,crops,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110249,including,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110250,wheat,B,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110251,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110252,barley,B,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110253,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110254,maize,B,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110255,",",O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110256,and,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110257,rice,B,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110258,.,O,3841.0,"This paper will review the characteristics of cereal anthocyanins , and assess their prevalence in various commercially relevant crops including wheat , barley , maize , and rice ."
110338,Previous,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110339,epidemiologic,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110340,studies,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110341,found,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110342,inconsistent,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110343,associations,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110344,between,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110345,vegetables,B,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110346,and,I,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110347,fruit,I,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110348,consumption,I,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110349,and,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110350,the,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110351,risk,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110352,of,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110353,bladder,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110354,cancer,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110355,.,O,3845.0,Previous epidemiologic studies found inconsistent associations between vegetables and fruit consumption and the risk of bladder cancer .
110779,This,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110780,synopsis,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110781,of,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110782,these,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110783,symposia,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110784,describes,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110785,the,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110786,complexity,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110787,of,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110788,dairy,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110789,fat,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110790,and,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110791,the,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110792,effects,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110793,regular,B,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110794,-,I,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110795,fat,I,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110796,dairy,I,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110797,foods,I,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110798,have,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110799,on,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110800,human,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110801,health,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110802,.,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110937,In,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110938,India,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110939,",",O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110940,the,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110941,incidence,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110942,of,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110943,breast,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110944,cancer,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110945,is,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110946,significantly,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110947,higher,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110948,than,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110949,for,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110950,colon,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110951,cancer,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110952,",",O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110953,in,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110954,Japan,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110955,and,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110956,Korea,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110957,colon,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110958,cancer,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110959,exceeds,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110960,by,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110961,far,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110962,the,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110963,rate,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110964,of,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110965,breast,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110966,cancer,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
110967,.,O,3865.0,"In India , the incidence of breast cancer is significantly higher than for colon cancer , in Japan and Korea colon cancer exceeds by far the rate of breast cancer ."
111088,Countries,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111089,with,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111090,discordant,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111091,rates,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111092,of,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111093,colon,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111094,and,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111095,breast,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111096,cancer,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111097,reveal,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111098,a,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111099,similar,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111100,discordance,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111101,between,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111102,meat,B,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111103,and,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111104,milk,B,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111105,product,I,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111106,consumption,I,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111107,of,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111108,dairy,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111109,cattle,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111110,.,O,3871.0,Countries with discordant rates of colon and breast cancer reveal a similar discordance between meat and milk product consumption of dairy cattle .
111239,Water,B,3876.0,Water used for food processing was simultaneously sampled .
111240,used,O,3876.0,Water used for food processing was simultaneously sampled .
111241,for,O,3876.0,Water used for food processing was simultaneously sampled .
111242,food,O,3876.0,Water used for food processing was simultaneously sampled .
111243,processing,O,3876.0,Water used for food processing was simultaneously sampled .
111244,was,O,3876.0,Water used for food processing was simultaneously sampled .
111245,simultaneously,O,3876.0,Water used for food processing was simultaneously sampled .
111246,sampled,O,3876.0,Water used for food processing was simultaneously sampled .
111247,.,O,3876.0,Water used for food processing was simultaneously sampled .
111544,The,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111545,ORs,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111546,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111547,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111548,highest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111549,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111550,relative,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111551,to,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111552,the,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111553,lowest,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111554,quartile,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111555,of,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111556,total,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111557,vegetable,B,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111558,and,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111559,fruit,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111560,intake,I,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111561,were,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111562,0.28,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111563,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111564,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111565,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111566,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111567,0.18,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111568,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111569,0.43,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111570,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111571,and,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111572,0.53,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111573,(,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111574,95,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111575,%,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111576,CI,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111577,0.34,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111578,-,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111579,0.82,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111580,),O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111581,",",O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111582,respectively,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111583,.,O,3891.0,"The ORs of the highest quartile relative to the lowest quartile of total vegetable and fruit intake were 0.28 ( 95 % CI 0.18 - 0.43 ) and 0.53 ( 95 % CI 0.34 - 0.82 ) , respectively ."
111771,Cadmium,O,3900.0,Cadmium group received a single i.p .
111772,group,O,3900.0,Cadmium group received a single i.p .
111773,received,O,3900.0,Cadmium group received a single i.p .
111774,a,O,3900.0,Cadmium group received a single i.p .
111775,single,O,3900.0,Cadmium group received a single i.p .
111776,i.p,O,3900.0,Cadmium group received a single i.p .
111777,.,O,3900.0,Cadmium group received a single i.p .
111981,Here,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111982,",",O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111983,the,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111984,effects,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111985,of,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111986,tofu,B,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111987,(,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111988,soybean,B,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111989,curd,I,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111990,),O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111991,and,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111992,its,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111993,putative,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111994,active,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111995,components,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111996,",",O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111997,protein,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111998,and,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
111999,isoflavone,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112000,",",O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112001,on,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112002,lipid,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112003,metabolism,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112004,in,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112005,male,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112006,rats,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112007,were,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112008,compared,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112009,.,O,3911.0,"Here , the effects of tofu ( soybean curd ) and its putative active components , protein and isoflavone , on lipid metabolism in male rats were compared ."
112056,In,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112057,contrast,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112058,",",O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112059,isoflavone,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112060,supplementation,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112061,had,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112062,little,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112063,effect,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112064,on,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112065,serum,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112066,lipid,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112067,levels,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112068,or,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112069,gene,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112070,expression,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112071,and,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112072,exerted,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112073,no,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112074,synergistic,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112075,effects,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112076,with,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112077,soy,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112078,protein,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112079,or,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112080,tofu,B,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112081,.,O,3913.0,"In contrast , isoflavone supplementation had little effect on serum lipid levels or gene expression and exerted no synergistic effects with soy protein or tofu ."
112641,In,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112642,this,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112643,population,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112644,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112645,EBW,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112646,was,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112647,associated,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112648,with,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112649,larger,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112650,FPS,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112651,of,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112652,11,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112653,of,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112654,the,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112655,30,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112656,food,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112657,groupings,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112658,investigated,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112659,(,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112660,cold,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112661,cuts,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112662,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112663,fried,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112664,snacks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112665,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112666,fruit,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112667,and,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112668,commercial,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112669,juices,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112670,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112671,pizza,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112672,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112673,red,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112674,meat,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112675,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112676,rice,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112677,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112678,salted,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112679,snacks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112680,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112681,soft,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112682,drinks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112683,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112684,soups,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112685,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112686,sugar,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112687,),O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112688,.,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
113221,About,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113222,once,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113223,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113224,day,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113225,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113226,of,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113227,HFCS,B,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113228,-,I,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113229,sweetened,I,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113230,soda,I,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113231,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113232,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113233,49,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113234,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113235,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113236,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113237,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113238,P<0·011,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113239,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113240,",",O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113241,moderate,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113242,apple,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113243,juice,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113244,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113245,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113246,2,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113247,-,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113248,4,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113249,times,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113250,/,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113251,week,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113252,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113253,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113254,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113255,61,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113256,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113257,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113258,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113259,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113260,P<0·007,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113261,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113262,and,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113263,moderate,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113264,fruit,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113265,drink,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113266,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113267,had,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113268,a,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113269,58,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113270,%,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113271,higher,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113272,risk,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113273,(,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113274,P<0·009,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113275,),O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113276,",",O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113277,as,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113278,compared,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113279,with,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113280,never,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113281,/,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113282,seldom,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113283,consumers,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113284,.,O,3946.0,"About once a day consumers of HFCS - sweetened soda had a 49 % higher risk ( P<0·011 ) , moderate apple juice consumers ( 2 - 4 times / week ) had a 61 % higher risk ( P<0·007 ) and moderate fruit drink consumers had a 58 % higher risk ( P<0·009 ) , as compared with never / seldom consumers ."
113391,Further,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113392,research,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113393,regarding,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113394,the,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113395,consequences,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113396,of,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113397,fructose,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113398,malabsorption,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113399,is,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113400,needed,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113401,.,O,3951.0,Further research regarding the consequences of fructose malabsorption is needed .
113508,Nutritional,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113509,epidemiology,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113510,shows,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113511,inverse,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113512,association,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113513,between,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113514,strawberry,B,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113515,consumption,I,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113516,and,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113517,incidence,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113518,of,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113519,hypertension,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113520,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113521,serum,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113522,C,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113523,-,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113524,reactive,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113525,protein,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113526,;,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113527,controlled,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113528,feeding,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113529,studies,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113530,have,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113531,identified,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113532,the,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113533,ability,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113534,of,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113535,strawberries,B,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113536,to,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113537,attenuate,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113538,high,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113539,-,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113540,fat,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113541,diet,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113542,induced,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113543,postprandial,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113544,oxidative,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113545,stress,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113546,and,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113547,inflammation,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113548,",",O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113549,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113550,postprandial,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113551,hyperglycemia,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113552,",",O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113553,or,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113554,hyperlipidemia,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113555,in,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113556,subjects,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113557,with,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113558,cardiovascular,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113559,risk,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113560,factors,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113561,.,O,3955.0,"Nutritional epidemiology shows inverse association between strawberry consumption and incidence of hypertension or serum C - reactive protein ; controlled feeding studies have identified the ability of strawberries to attenuate high - fat diet induced postprandial oxidative stress and inflammation , or postprandial hyperglycemia , or hyperlipidemia in subjects with cardiovascular risk factors ."
113606,These,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113607,health,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113608,effects,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113609,may,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113610,be,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113611,attributed,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113612,to,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113613,the,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113614,synergistic,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113615,effects,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113616,of,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113617,nutrients,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113618,and,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113619,phytochemicals,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113620,in,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113621,strawberries,B,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113622,.,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113744,In,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113745,previous,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113746,studies,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113747,that,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113748,determined,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113749,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113750,PTHrP,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113751,concentrations,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113752,in,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113753,milk,B,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113754,",",O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113755,the,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113756,pretreatments,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113757,and,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113758,diluent,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113759,composition,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113760,were,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113761,not,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113762,standardized,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
113763,.,O,3963.0,"In previous studies that determined the PTHrP concentrations in milk , the pretreatments and diluent composition were not standardized ."
114363,New,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114364,research,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114365,on,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114366,dairy,B,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114367,products,I,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114368,and,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114369,nutrition,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114370,will,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114371,improve,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114372,our,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114373,understanding,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114374,of,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114375,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114376,connections,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114377,between,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114378,these,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114379,products,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114380,",",O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114381,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114382,bioactive,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114383,compounds,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114384,in,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114385,them,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114386,",",O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114387,and,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114388,their,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114389,effects,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114390,on,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114391,the,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114392,human,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114393,body,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114394,.,O,3983.0,"New research on dairy products and nutrition will improve our understanding of the connections between these products , the bioactive compounds in them , and their effects on the human body ."
114797,Poor,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114798,metabolic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114799,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114800,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114801,a,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114802,common,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114803,characteristic,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114804,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114805,overweight,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114806,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114807,obesity,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114808,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114809,aging,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114810,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114811,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114812,is,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114813,the,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114814,forerunner,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114815,of,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114816,T2DM,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114817,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114818,cardiovascular,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114819,disease,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114820,(,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114821,CVD,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114822,),O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114823,",",O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114824,and,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114825,an,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114826,ever,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114827,increasing,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114828,global,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114829,health,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114830,issue,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
114831,.,O,3999.0,"Poor metabolic health is a common characteristic of overweight , obesity and aging , and is the forerunner of T2DM and cardiovascular disease ( CVD ) , and an ever increasing global health issue ."
115082,The,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115083,Mediterranean,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115084,diet,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115085,includes,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115086,the,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115087,consumption,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115088,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115089,large,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115090,amounts,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115091,of,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115092,olive,B,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115093,oil,I,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115094,.,O,4007.0,The Mediterranean diet includes the consumption of large amounts of olive oil .
115095,Olive,B,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115096,oil,I,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115097,is,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115098,a,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115099,source,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115100,of,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115101,at,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115102,least,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115103,30,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115104,phenolic,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115105,compounds,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115106,.,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115169,Typically,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115170,",",O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115171,hydroxytyrosol,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115172,is,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115173,a,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115174,superior,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115175,antioxidant,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115176,and,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115177,radical,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115178,scavenger,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115179,to,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115180,oleuropein,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115181,and,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115182,tyrosol,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115183,.,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115303,Well,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115304,-,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115305,planned,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115306,vegetarian,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115307,diets,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115308,are,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115309,considered,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115310,adequate,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115311,for,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115312,all,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115313,stages,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115314,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115315,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115316,life,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115317,cycle,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115318,",",O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115319,despite,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115320,limited,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115321,data,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115322,on,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115323,the,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115324,zinc,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115325,status,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115326,of,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115327,vegetarians,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115328,during,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115329,early,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115330,childhood,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115331,.,O,4019.0,"Well - planned vegetarian diets are considered adequate for all stages of the life cycle , despite limited data on the zinc status of vegetarians during early childhood ."
115405,However,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115406,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115407,data,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115408,on,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115409,serum,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115410,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115411,concentrations,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115412,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115413,the,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115414,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115415,biomarker,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115416,for,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115417,identifying,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115418,population,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115419,groups,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115420,at,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115421,elevated,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115422,risk,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115423,of,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115424,zinc,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115425,deficiency,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115426,",",O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115427,are,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115428,sparse,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115429,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115430,difficult,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115431,to,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115432,interpret,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115433,because,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115434,recommended,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115435,collection,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115436,and,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115437,analytic,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115438,procedures,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115439,have,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115440,not,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115441,always,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115442,been,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115443,followed,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115444,.,O,4022.0,"However , data on serum zinc concentrations , the recommended biomarker for identifying population groups at elevated risk of zinc deficiency , are sparse and difficult to interpret because recommended collection and analytic procedures have not always been followed ."
115595,Fortified,B,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115596,foods,I,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115597,can,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115598,reduce,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115599,iron,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115600,deficiency,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115601,",",O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115602,but,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115603,whether,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115604,they,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115605,can,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115606,also,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115607,reduce,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115608,zinc,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115609,deficiency,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115610,is,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115611,less,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115612,certain,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115613,.,O,4027.0,"Fortified foods can reduce iron deficiency , but whether they can also reduce zinc deficiency is less certain ."
115614,Supplements,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115615,may,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115616,be,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115617,necessary,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115618,for,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115619,vegetarian,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115620,children,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115621,following,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115622,very,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115623,restricted,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115624,vegan,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115625,diets,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115626,.,O,4028.0,Supplements may be necessary for vegetarian children following very restricted vegan diets .
115683,To,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115684,investigate,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115685,this,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115686,possibility,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115687,",",O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115688,we,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115689,studied,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115690,dietary,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115691,data,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115692,from,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115693,participants,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115694,in,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115695,the,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115696,Nurses,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115697,',O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115698,Health,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115699,Study,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115700,.,O,4030.0,"To investigate this possibility , we studied dietary data from participants in the Nurses ' Health Study ."
115983,A,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115984,total,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115985,of,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115986,219,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115987,consumers,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115988,participated,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115989,in,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115990,this,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115991,study,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115992,and,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115993,rated,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115994,overall,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115995,liking,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115996,and,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115997,sensory,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115998,attributes,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115999,.,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
116656,The,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116657,intake,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116658,of,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116659,several,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116660,minerals,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116661,found,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116662,in,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116663,milk,B,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116664,has,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116665,been,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116666,demonstrated,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116667,to,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116668,have,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116669,an,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116670,inverse,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116671,relationship,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116672,with,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116673,blood,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116674,pressure,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116675,.,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116715,More,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116716,recent,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116717,data,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116718,indicate,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116719,that,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116720,a,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116721,dietary,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116722,pattern,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116723,that,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116724,is,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116725,low,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116726,in,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116727,fat,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116728,",",O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116729,with,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116730,fruits,B,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116731,",",O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116732,vegetables,B,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116733,",",O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116734,and,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116735,low,B,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116736,fat,I,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116737,dairy,I,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116738,products,I,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116739,can,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116740,significantly,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116741,reduce,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116742,blood,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116743,pressure,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116744,and,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116745,lower,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116746,risk,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116747,of,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116748,developing,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116749,high,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116750,blood,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116751,pressure,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116752,.,O,4072.0,"More recent data indicate that a dietary pattern that is low in fat , with fruits , vegetables , and low fat dairy products can significantly reduce blood pressure and lower risk of developing high blood pressure ."
116949,By,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116950,virtue,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116951,of,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116952,their,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116953,unique,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116954,composition,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116955,",",O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116956,nuts,B,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116957,are,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116958,likely,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116959,to,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116960,beneficially,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116961,impact,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116962,health,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116963,outcomes,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116964,.,O,4080.0,"By virtue of their unique composition , nuts are likely to beneficially impact health outcomes ."
116989,Limited,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116990,evidence,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116991,also,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116992,suggests,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116993,beneficial,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116994,effects,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116995,on,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116996,hypertension,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116997,",",O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116998,cancer,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
116999,",",O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
117000,and,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
117001,inflammation,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
117002,.,O,4082.0,"Limited evidence also suggests beneficial effects on hypertension , cancer , and inflammation ."
117043,Blood,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117044,pressure,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117045,",",O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117046,visceral,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117047,adiposity,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117048,and,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117049,the,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117050,metabolic,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117051,syndrome,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117052,also,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117053,appear,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117054,to,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117055,be,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117056,positively,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117057,influenced,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117058,by,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117059,nut,B,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117060,consumption,I,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117061,.,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117249,Pasta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117250,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117251,rice,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117252,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117253,the,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117254,major,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117255,sources,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117256,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117257,starch,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117258,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117259,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117260,polenta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117261,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117262,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117263,porridge,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117264,made,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117265,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117266,maize,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117267,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117268,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117269,ham,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117270,were,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117271,positively,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117272,related,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117273,with,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117274,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117275,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117276,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117277,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117278,whereas,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117279,green,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117280,vegetables,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117281,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117282,fresh,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117283,fruit,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117284,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117285,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117286,whole,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117287,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117288,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117289,specifically,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117290,citrus,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117291,fruit,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117292,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117293,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117294,selected,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117295,fibre,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117296,-,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117297,rich,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117298,aliments,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117299,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117300,such,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117301,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117302,whole,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117303,-,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117304,grain,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117305,bread,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117306,or,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117307,pasta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117308,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117309,showed,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117310,protective,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117311,effects,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117312,on,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117313,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117314,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117315,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117316,.,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117595,Direct,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117596,effects,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117597,in,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117598,the,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117599,gastrointestinal,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117600,tract,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117601,include,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117602,prevention,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117603,of,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117604,constipation,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117605,and,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117606,possibly,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117607,colon,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117608,cancer,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117609,.,O,4101.0,Direct effects in the gastrointestinal tract include prevention of constipation and possibly colon cancer .
117695,Histamine,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117696,release,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117697,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117698,HR,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117699,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117700,studies,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117701,were,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117702,performed,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117703,in,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117704,40,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117705,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117706,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117707,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117708,allergic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117709,patients,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117710,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117711,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117712,case,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117713,history,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117714,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117715,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117716,SPT,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117717,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117718,positive,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117719,birch,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117720,pollen,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117721,-,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117722,specific,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117723,serum,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117724,IgE,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117725,:,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117726,RAST,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117727,>,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117728,or,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117729,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117730,3,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117731,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117732,with,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117733,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117734,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117735,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117736,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117737,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117738,A,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117739,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117740,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117741,without,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117742,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117743,n,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117744,=,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117745,20,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117746,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117747,B,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117748,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117749,fruit,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117750,hypersensitivity,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117751,",",O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117752,and,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117753,10,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117754,nonatopic,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117755,volunteers,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117756,(,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117757,C,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117758,),O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117759,.,O,4105.0,"Histamine release ( HR ) studies were performed in 40 birch pollen - allergic patients ( positive case history , positive SPT , positive birch pollen - specific serum IgE : RAST > or = 3 ) with ( n = 20 , A ) and without ( n = 20 , B ) fruit hypersensitivity , and 10 nonatopic volunteers ( C ) ."
117760,Several,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117761,fruit,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117762,allergens,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117763,were,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117764,used,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117765,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117766,characterized,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117767,by,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117768,protein,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117769,determination,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117770,and,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117771,immunoblot,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117772,techniques,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117773,.,O,4106.0,Several fruit allergens were used and characterized by protein determination and immunoblot techniques .
117832,Strong,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117833,correlations,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117834,between,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117835,the,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117836,mediator,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117837,response,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117838,induced,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117839,by,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117840,several,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117841,fruits,B,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117842,indicate,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117843,common,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117844,allergens,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117845,within,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117846,the,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117847,extracts,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
117848,.,O,4109.0,Strong correlations between the mediator response induced by several fruits indicate common allergens within the extracts .
118009,A,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118010,considerable,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118011,amount,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118012,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118013,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118014,was,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118015,mobilized,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118016,from,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118017,raw,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118018,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118019,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118020,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118021,digestion,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118022,process,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118023,(,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118024,on,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118025,average,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118026,85,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118027,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118028,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118029,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118030,gastric,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118031,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118032,and,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118033,69,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118034,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118035,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118036,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118037,gastrointestinal,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118038,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118039,),O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118040,",",O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118041,which,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118042,could,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118043,be,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118044,attributed,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118045,to,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118046,a,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118047,high,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118048,uptake,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118049,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118050,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118051,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118052,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118053,growth,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118054,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118055,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118056,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118057,.,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118477,The,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118478,present,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118479,comprehensive,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118480,review,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118481,summarized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118482,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118483,latest,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118484,studies,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118485,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118486,shellfish,B,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118487,consumption,I,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118488,and,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118489,synthesized,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118490,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118491,available,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118492,evidence,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118493,on,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118494,the,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118495,potential,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118496,health,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118497,benefits,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118498,or,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118499,risks,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118500,of,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118501,shellfish,B,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118502,consumption,I,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118503,.,O,4132.0,The present comprehensive review summarized the latest studies on shellfish consumption and synthesized the available evidence on the potential health benefits or risks of shellfish consumption .
118656,A,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118657,population,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118658,-,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118659,based,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118660,cross,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118661,-,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118662,sectional,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118663,study,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118664,was,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118665,carried,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118666,out,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118667,on,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118668,a,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118669,low,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118670,-,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118671,income,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118672,neighbourhood,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118673,in,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118674,the,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118675,Rio,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118676,de,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118677,Janeiro,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118678,metropolitan,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118679,area,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118680,",",O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118681,and,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118682,1009,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118683,subjects,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118684,between,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118685,20,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118686,and,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118687,65,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118688,years,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118689,of,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118690,age,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118691,completed,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118692,an,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118693,FFQ,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
118694,.,O,4139.0,"A population - based cross - sectional study was carried out on a low - income neighbourhood in the Rio de Janeiro metropolitan area , and 1009 subjects between 20 and 65 years of age completed an FFQ ."
119307,Determinants,O,4159.0,Determinants of DED did not vary by the calculation method used .
119308,of,O,4159.0,Determinants of DED did not vary by the calculation method used .
119309,DED,O,4159.0,Determinants of DED did not vary by the calculation method used .
119310,did,O,4159.0,Determinants of DED did not vary by the calculation method used .
119311,not,O,4159.0,Determinants of DED did not vary by the calculation method used .
119312,vary,O,4159.0,Determinants of DED did not vary by the calculation method used .
119313,by,O,4159.0,Determinants of DED did not vary by the calculation method used .
119314,the,O,4159.0,Determinants of DED did not vary by the calculation method used .
119315,calculation,O,4159.0,Determinants of DED did not vary by the calculation method used .
119316,method,O,4159.0,Determinants of DED did not vary by the calculation method used .
119317,used,O,4159.0,Determinants of DED did not vary by the calculation method used .
119318,.,O,4159.0,Determinants of DED did not vary by the calculation method used .
119619,The,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119620,source,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119621,of,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119622,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119623,fatty,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119624,acids,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119625,was,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119626,butter,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119627,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119628,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119629,A,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119630,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119631,lard,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119632,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119633,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119634,B,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119635,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119636,coconut,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119637,oil,I,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119638,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119639,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119640,C,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119641,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119642,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119643,butter,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119644,or,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119645,lard,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119646,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119647,Expt,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119648,D.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119649,Generally,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119650,",",O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119651,olive,B,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119652,oil,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119653,-,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119654,fed,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119655,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119656,received,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119657,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119658,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119659,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119660,tended,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119661,to,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119662,have,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119663,more,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119664,cholesterol,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119665,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119666,VLDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119667,and,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119668,less,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119669,in,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119670,LDL,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119671,compared,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119672,with,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119673,groups,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119674,receiving,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119675,saturated,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119676,fat,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
119677,.,O,4170.0,"The source of saturated fatty acids was butter in Expt A , lard in Expt B , coconut oil in Expt C , and butter or lard in Expt D. Generally , olive oil - fed groups received more cholesterol and tended to have more cholesterol in VLDL and less in LDL compared with groups receiving saturated fat ."
120008,After,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120009,adjustment,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120010,for,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120011,demographic,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120012,and,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120013,dietary,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120014,characteristics,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120015,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120016,there,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120017,was,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120018,no,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120019,association,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120020,between,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120021,pancreatic,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120022,cancer,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120023,risk,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120024,and,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120025,the,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120026,intake,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120027,of,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120028,coffee,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120029,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120030,beer,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120031,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120032,red,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120033,wine,I,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120034,",",O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120035,hard,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120036,liquor,I,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120037,or,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120038,all,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120039,alcohol,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120040,combined,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120041,;,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120042,a,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120043,slight,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120044,reduction,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120045,in,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120046,risk,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120047,was,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120048,seen,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120049,among,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120050,those,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120051,consuming,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120052,white,B,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120053,wine,I,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120054,daily,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
120055,.,O,4182.0,"After adjustment for demographic and dietary characteristics , there was no association between pancreatic cancer risk and the intake of coffee , beer , red wine , hard liquor or all alcohol combined ; a slight reduction in risk was seen among those consuming white wine daily ."
121402,Blood,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121403,glucose,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121404,and,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121405,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121406,levels,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121407,were,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121408,used,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121409,for,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121410,the,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121411,homoeostasis,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121412,model,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121413,assessment,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121414,of,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121415,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121416,resistance,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121417,(,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121418,HOMA,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121419,-,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121420,IR,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121421,),O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121422,.,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121822,Only,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121823,interventions,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121824,that,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121825,investigated,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121826,concentrated,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121827,",",O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121828,isolated,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121829,or,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121830,hydrolysed,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121831,forms,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121832,of,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121833,dietary,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121834,protein,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121835,were,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121836,included,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
121837,.,O,4242.0,"Only interventions that investigated concentrated , isolated or hydrolysed forms of dietary protein were included ."
122023,d,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122024,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122025,],O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122026,",",O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122027,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122028,2.6,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122029,mol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122030,/,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122031,L,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122032,ethanol,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122033,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122034,E,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122035,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122036,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122037,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122038,or,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122039,water,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122040,(,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122041,W,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122042,-,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122043,PE,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122044,),O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122045,as,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122046,their,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122047,respective,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122048,controls,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122049,.,O,4251.0,"d ) ] , or 2.6 mol / L ethanol ( E - PE ) or water ( W - PE ) as their respective controls ."
122149,Liver,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122150,glutathione,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122151,peroxidase,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122152,activity,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122153,was,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122154,67,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122155,%,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122156,greater,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122157,in,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122158,the,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122159,group,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122160,receiving,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122161,PE,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122162,in,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122163,water,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122164,compared,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122165,with,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122166,the,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122167,group,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122168,given,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122169,water,B,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122170,;,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122171,there,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122172,was,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122173,no,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122174,effect,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122175,when,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122176,PE,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122177,was,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122178,given,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122179,in,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122180,ethanol,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122181,relative,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122182,to,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122183,its,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122184,control,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122185,.,O,4256.0,Liver glutathione peroxidase activity was 67 % greater in the group receiving PE in water compared with the group given water ; there was no effect when PE was given in ethanol relative to its control .
122424,Specific,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122425,fluids,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122426,related,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122427,to,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122428,bladder,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122429,cancer,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122430,risk,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122431,were,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122432,milk,B,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122433,intake,I,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122434,(,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122435,OR,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122436,=,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122437,0.64,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122438,),O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122439,and,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122440,caffeinated,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122441,coffee,B,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122442,intake,I,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122443,(,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122444,OR,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122445,=,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122446,1.60,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122447,),O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122448,.,O,4265.0,Specific fluids related to bladder cancer risk were milk intake ( OR = 0.64 ) and caffeinated coffee intake ( OR = 1.60 ) .
122479,Alcohol,B,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122480,increased,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122481,risk,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122482,only,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122483,when,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122484,consumed,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122485,at,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122486,high,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122487,levels,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122488,(,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122489,over,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122490,3.64,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122491,ounces,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122492,or,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122493,103,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122494,g,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122495,per,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122496,week,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122497,),O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122498,by,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122499,people,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122500,who,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122501,never,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122502,smoked,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122503,cigarettes,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122504,(,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122505,OR,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122506,=,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122507,2.37,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122508,),O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
122509,.,O,4267.0,Alcohol increased risk only when consumed at high levels ( over 3.64 ounces or 103 g per week ) by people who never smoked cigarettes ( OR = 2.37 ) .
123541,However,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123542,",",O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123543,if,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123544,the,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123545,pH,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123546,was,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123547,adjusted,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123548,to,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123549,pH,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123550,7,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123551,after,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123552,spiking,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123553,and,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123554,extraction,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123555,",",O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123556,the,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123557,recovery,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123558,was,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123559,only,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123560,11.1%+/-,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123561,1.7,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123562,%,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123563,.,O,4308.0,"However , if the pH was adjusted to pH 7 after spiking and extraction , the recovery was only 11.1%+/- 1.7 % ."
123841,After,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123842,allowance,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123843,for,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123844,the,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123845,reciprocal,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123846,confounding,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123847,effect,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123848,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123849,various,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123850,dietary,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123851,habits,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123852,",",O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123853,only,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123854,frequent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123855,intake,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123856,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123857,milk,B,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123858,seemed,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123859,to,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123860,be,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123861,a,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123862,significant,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123863,independent,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123864,indicator,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123865,of,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123866,prostatic,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123867,cancer,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123868,risk,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
123869,.,O,4317.0,"After allowance for the reciprocal confounding effect of various dietary habits , only frequent intake of milk seemed to be a significant independent indicator of prostatic cancer risk ."
124226,Proteins,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124227,from,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124228,red,B,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124229,",",B,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124230,rosé,I,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124231,",",B,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124232,and,I,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124233,white,I,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124234,wines,I,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124235,were,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124236,enriched,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124237,by,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124238,dialysis,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124239,and,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124240,lyophilization,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124241,followed,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124242,by,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124243,separation,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124244,by,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124245,SDS,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124246,-,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124247,PAGE,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124248,.,O,4331.0,"Proteins from red , rosé , and white wines were enriched by dialysis and lyophilization followed by separation by SDS - PAGE ."
124281,In,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124282,German,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124283,Portugieser,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124284,red,B,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124285,wine,I,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124286,",",O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124287,a,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124288,total,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124289,of,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124290,121,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124291,tryptic,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124292,peptides,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124293,were,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124294,identified,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124295,",",O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124296,which,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124297,were,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124298,attributed,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124299,to,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124300,12,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124301,grape,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124302,proteins,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124303,and,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124304,6,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124305,proteins,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124306,derived,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124307,from,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124308,yeast,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124309,.,O,4333.0,"In German Portugieser red wine , a total of 121 tryptic peptides were identified , which were attributed to 12 grape proteins and 6 proteins derived from yeast ."
124402,Olive,B,4338.0,Olive oil reportedly has cardioprotective effects .
124403,oil,I,4338.0,Olive oil reportedly has cardioprotective effects .
124404,reportedly,O,4338.0,Olive oil reportedly has cardioprotective effects .
124405,has,O,4338.0,Olive oil reportedly has cardioprotective effects .
124406,cardioprotective,O,4338.0,Olive oil reportedly has cardioprotective effects .
124407,effects,O,4338.0,Olive oil reportedly has cardioprotective effects .
124408,.,O,4338.0,Olive oil reportedly has cardioprotective effects .
124409,We,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124410,examined,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124411,the,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124412,influence,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124413,of,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124414,olive,B,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124415,oil,I,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124416,consumption,I,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124417,on,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124418,cardiovascular,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124419,risk,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124420,factors,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124421,in,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124422,FM,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124423,.,O,4339.0,We examined the influence of olive oil consumption on cardiovascular risk factors in FM .
124497,Red,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124498,blood,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124499,cell,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124500,count,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124501,and,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124502,erythrocyte,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124503,sedimentation,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124504,rate,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124505,(,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124506,ESR,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124507,;,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124508,both,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124509,The,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124510,role,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124511,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124512,various,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124513,life,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124514,style,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124515,factors,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124516,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124517,including,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124518,dietary,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124519,habits,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124520,",",O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124521,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124522,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124523,etiology,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124524,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124525,non,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124526,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124527,Hodgkin,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124528,'s,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124529,lymphoma,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124530,was,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124531,investigated,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124532,using,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124533,data,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124534,from,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124535,a,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124536,case,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124537,-,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124538,control,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124539,study,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124540,conducted,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124541,in,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124542,the,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124543,northeastern,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124544,part,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124545,of,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124546,Italy,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
124547,.,O,4343.0,"Red blood cell count and erythrocyte sedimentation rate ( ESR ; both The role of various life style factors , including dietary habits , in the etiology of non - Hodgkin 's lymphoma was investigated using data from a case - control study conducted in the northeastern part of Italy ."
125170,During,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125171,a,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125172,median,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125173,follow,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125174,-,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125175,up,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125176,of,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125177,13·6,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125178,years,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125179,",",O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125180,we,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125181,identified,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125182,656,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125183,female,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125184,and,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125185,1694,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125186,male,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125187,cases,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125188,.,O,4367.0,"During a median follow - up of 13·6 years , we identified 656 female and 1694 male cases ."
125357,Sorghum,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125358,is,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125359,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125360,fifth,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125361,cereal,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125362,most,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125363,produced,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125364,in,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125365,the,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125366,world,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125367,after,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125368,wheat,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125369,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125370,rice,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125371,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125372,maize,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125373,",",O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125374,and,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125375,barley,B,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125376,.,O,4374.0,"Sorghum is the fifth cereal most produced in the world after wheat , rice , maize , and barley ."
125591,Findings,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125592,of,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125593,epidemiologic,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125594,studies,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125595,on,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125596,the,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125597,relationship,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125598,between,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125599,fruit,B,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125600,and,I,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125601,vegetable,I,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125602,consumption,I,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125603,and,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125604,renal,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125605,cell,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125606,carcinoma,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125607,(,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125608,RCC,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125609,),O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125610,risk,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125611,have,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125612,been,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125613,inconclusive,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125614,.,O,4380.0,Findings of epidemiologic studies on the relationship between fruit and vegetable consumption and renal cell carcinoma ( RCC ) risk have been inconclusive .
125878,Frequent,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125879,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125880,of,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125881,salad,B,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125882,vegetables,I,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125883,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125884,once,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125885,or,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125886,more,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125887,per,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125888,day,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125889,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125890,decreased,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125891,the,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125892,risk,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125893,by,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125894,40,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125895,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125896,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125897,RR,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125898,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125899,0.60,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125900,;,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125901,95,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125902,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125903,CI,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125904,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125905,0.30,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125906,-,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125907,1.22,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125908,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125909,",",O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125910,in,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125911,comparison,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125912,to,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125913,no,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125914,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125915,.,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125956,We,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125957,examined,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125958,these,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125959,associations,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125960,with,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125961,risk,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125962,of,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125963,incident,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125964,rectal,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125965,cancer,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125966,in,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125967,a,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125968,population,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125969,-,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125970,based,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125971,case,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125972,-,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125973,control,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125974,study,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125975,of,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125976,952,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125977,cases,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125978,and,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125979,"1,205",O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125980,controls,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125981,living,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125982,in,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125983,northern,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125984,California,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125985,and,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125986,Utah,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
125987,.,O,4393.0,"We examined these associations with risk of incident rectal cancer in a population - based case - control study of 952 cases and 1,205 controls living in northern California and Utah ."
126334,To,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126335,evaluate,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126336,the,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126337,associations,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126338,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126339,changes,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126340,in,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126341,diet,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126342,during,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126343,adult,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126344,life,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126345,with,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126346,adenoma,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126347,risk,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126348,",",O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126349,data,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126350,from,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126351,a,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126352,case,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126353,-,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126354,control,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126355,study,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126356,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126357,146,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126358,colorectal,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126359,adenomas,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126360,and,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126361,226,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126362,controls,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126363,were,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126364,analyzed,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126365,.,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126673,Intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126674,in,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126675,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126676,morning,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126677,is,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126678,associated,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126679,with,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126680,a,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126681,reduction,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126682,in,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126683,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126684,total,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126685,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126686,for,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126687,the,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126688,day,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126689,",",O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126690,while,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126691,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126692,at,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126693,night,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126694,is,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126695,associated,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126696,with,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126697,greater,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126698,overall,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126699,daily,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126700,intake,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126701,.,O,4411.0,"Intake in the morning is associated with a reduction in the total intake for the day , while intake at night is associated with greater overall daily intake ."
126795,The,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126796,intakes,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126797,of,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126798,twenty,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126799,-,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126800,four,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126801,different,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126802,types,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126803,of,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126804,foods,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126805,and,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126806,seven,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126807,different,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126808,drinks,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126809,occurring,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126810,during,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126811,the,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126812,morning,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126813,(,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126814,04.00,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126815,-,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126816,10.29,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126817,hours,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126818,),O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126819,",",O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126820,afternoon,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126821,(,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126822,10.30,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126823,-,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126824,16.59,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126825,hours,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126826,),O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126827,and,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126828,evening,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126829,(,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126830,17.00,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126831,-,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126832,02.00,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126833,hours,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126834,),O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126835,were,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126836,identified,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126837,and,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126838,related,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126839,to,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126840,overall,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126841,daily,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126842,intakes,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126843,.,O,4415.0,"The intakes of twenty - four different types of foods and seven different drinks occurring during the morning ( 04.00 - 10.29 hours ) , afternoon ( 10.30 - 16.59 hours ) and evening ( 17.00 - 02.00 hours ) were identified and related to overall daily intakes ."
126968,The,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126969,increasing,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126970,prevalence,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126971,of,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126972,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126973,obesity,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126974,is,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126975,a,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126976,serious,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126977,public,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126978,health,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126979,problem,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126980,associated,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126981,with,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126982,co,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126983,-,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126984,morbidities,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126985,in,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126986,adulthood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126987,",",O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126988,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126989,well,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126990,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126991,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126992,.,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
127135,The,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127136,cMetS,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127137,was,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127138,calculated,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127139,based,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127140,on,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127141,waist,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127142,circumference,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127143,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127144,triglycerides,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127145,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127146,high,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127147,-,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127148,density,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127149,lipoprotein,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127150,cholesterol,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127151,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127152,glucose,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127153,",",O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127154,and,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127155,mean,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127156,arterial,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127157,blood,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127158,pressure,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127159,.,O,4424.0,"The cMetS was calculated based on waist circumference , triglycerides , high - density lipoprotein cholesterol , glucose , and mean arterial blood pressure ."
127229,At,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127230,follow,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127231,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127232,up,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127233,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127234,sugar,B,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127235,intake,I,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127236,from,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127237,fruit,B,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127238,at,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127239,baseline,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127240,was,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127241,still,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127242,negatively,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127243,associated,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127244,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127245,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127246,above,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127247,outcomes,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127248,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127249,but,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127250,only,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127251,the,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127252,relationship,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127253,with,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127254,BMI,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127255,z,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127256,-,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127257,scores,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127258,retained,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127259,statistical,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127260,significance,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127261,(,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127262,β,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127263,=,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127264,-0.08,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127265,",",O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127266,p,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127267,<,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127268,0.05,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127269,),O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127270,.,O,4426.0,"At follow - up , sugar intake from fruit at baseline was still negatively associated with the above outcomes , but only the relationship with BMI z - scores retained statistical significance ( β = -0.08 , p < 0.05 ) ."
127271,There,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127272,was,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127273,a,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127274,significant,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127275,positive,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127276,relationship,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127277,between,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127278,consumption,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127279,of,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127280,sugar,B,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127281,from,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127282,SSBs,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127283,and,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127284,cMetS,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127285,at,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127286,baseline,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127287,(,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127288,β,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127289,=,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127290,0.04,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127291,",",O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127292,p,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127293,=,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127294,0.02,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127295,),O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127296,",",O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127297,but,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127298,that,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127299,relationship,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127300,was,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127301,not,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127302,observed,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127303,at,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127304,follow,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127305,-,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127306,up,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127307,(,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127308,p,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127309,=,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127310,0.83,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127311,),O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127312,.,O,4427.0,"There was a significant positive relationship between consumption of sugar from SSBs and cMetS at baseline ( β = 0.04 , p = 0.02 ) , but that relationship was not observed at follow - up ( p = 0.83 ) ."
127372,This,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127373,paper,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127374,studied,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127375,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127376,possible,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127377,effect,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127378,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127379,folic,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127380,acid,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127381,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127382,fortified,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127383,Baladi,B,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127384,bread,I,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127385,on,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127386,the,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127387,prevention,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127388,of,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127389,colon,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127390,cancer,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127391,development,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127392,in,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127393,rats,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127394,.,O,4431.0,This paper studied the possible effect of folic acid in fortified Baladi bread on the prevention of colon cancer development in rats .
127768,In,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127769,addition,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127770,",",O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127771,effective,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127772,and,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127773,respectful,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127774,communication,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127775,with,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127776,patients,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127777,around,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127778,NHP,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127779,use,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127780,and,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127781,collaboration,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127782,with,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127783,various,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127784,health,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127785,-,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127786,care,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127787,providers,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127788,are,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127789,essential,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127790,in,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127791,the,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127792,patient,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127793,care,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127794,process,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
127795,.,O,4448.0,"In addition , effective and respectful communication with patients around NHP use and collaboration with various health - care providers are essential in the patient care process ."
128593,Approximately,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128594,half,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128595,of,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128596,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128597,patients,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128598,had,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128599,symptoms,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128600,(,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128601,especially,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128602,oral,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128603,allergy,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128604,syndrome,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128605,),O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128606,after,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128607,eating,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128608,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128609,products,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128610,.,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128611,We,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128612,also,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128613,found,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128614,an,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128615,easy,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128616,extraction,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128617,procedure,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128618,(,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128619,juice,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128620,extract,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128621,),O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128622,suitable,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128623,for,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128624,apple,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128625,skin,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128626,prick,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128627,testing,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128628,",",O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128629,superior,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128630,even,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128631,to,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128632,freeze,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128633,-,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128634,dried,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128635,extraction,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128636,or,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128637,the,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128638,low,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128639,-,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128640,temperature,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128641,acetone,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128642,powder,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128643,technique,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128644,.,O,4472.0,"We also found an easy extraction procedure ( juice extract ) suitable for apple skin prick testing , superior even to freeze - dried extraction or the low - temperature acetone powder technique ."
128683,However,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128684,",",O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128685,recent,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128686,human,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128687,studies,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128688,have,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128689,proven,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128690,that,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128691,chocolate,B,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128692,has,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128693,beneficial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128694,effects,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128695,on,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128696,some,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128697,pathogenic,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128698,mechanisms,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128699,of,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128700,heart,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128701,disease,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128702,such,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128703,as,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128704,endothelial,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128705,function,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128706,and,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128707,blood,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128708,pressure,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128709,.,O,4475.0,"However , recent human studies have proven that chocolate has beneficial effects on some pathogenic mechanisms of heart disease such as endothelial function and blood pressure ."
128764,In,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128765,the,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128766,U.S.,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128767,diet,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128768,chocolate,B,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128769,is,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128770,the,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128771,third,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128772,highest,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128773,daily,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128774,per,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128775,capita,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128776,antioxidant,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128777,source,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
128778,.,O,4478.0,In the U.S. diet chocolate is the third highest daily per capita antioxidant source .
129014,Many,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129015,people,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129016,believe,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129017,that,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129018,plant,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129019,-,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129020,based,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129021,diets,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129022,are,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129023,healthy,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129024,because,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129025,they,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129026,are,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129027,low,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129028,in,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129029,fat,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129030,.,O,4487.0,Many people believe that plant - based diets are healthy because they are low in fat .
129571,Although,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129572,acute,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129573,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129574,show,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129575,reductions,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129576,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129577,postprandial,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129578,glycemia,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129579,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129580,healthy,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129581,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129582,ingesting,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129583,60,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129584,to,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129585,90,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129586,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129587,almonds,B,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129588,",",O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129589,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129590,have,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129591,not,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129592,been,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129593,conducted,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129594,using,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129595,a,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129596,single,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129597,serving,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129598,of,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129599,almonds,B,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129600,(,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129601,28,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129602,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129603,),O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129604,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129605,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129606,with,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129607,type,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129608,2,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129609,diabetes,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129610,mellitus,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129611,.,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129995,Frequent,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129996,consumption,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129997,of,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129998,fruit,B,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129999,was,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130000,also,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130001,inversely,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130002,associated,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130003,with,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130004,this,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130005,cancer,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130006,.,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130420,Peroral,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130421,challenges,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130422,with,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130423,spices,B,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130424,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130425,gelatin,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130426,capsules,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130427,were,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130428,negative,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130429,in,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130430,20,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130431,nonselected,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130432,patients,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130433,.,O,4536.0,Peroral challenges with spices in gelatin capsules were negative in 20 nonselected patients .
130434,Oral,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130435,and,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130436,external,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130437,dosing,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130438,methods,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130439,replicating,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130440,field,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130441,exposure,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130442,were,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130443,developed,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130444,using,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130445,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130446,double,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130447,crested,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130448,cormorant,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130449,(,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130450,DCCO,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130451,),O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130452,to,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130453,test,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130454,the,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130455,toxicity,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130456,of,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130457,artificially,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130458,weathered,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130459,Deepwater,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130460,Horizon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130461,Mississippi,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130462,Canyon,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130463,252,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130464,oil,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130465,.,O,4537.0,Oral and external dosing methods replicating field exposure were developed using the double crested cormorant ( DCCO ) to test the toxicity of artificially weathered Deepwater Horizon Mississippi Canyon 252 oil .
130655,Conversely,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130656,",",O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130657,birds,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130658,orally,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130659,dosed,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130660,with,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130661,oil,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130662,experienced,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130663,hypothermia,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130664,and,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130665,consumed,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130666,less,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130667,fish,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130668,compared,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130669,to,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130670,control,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130671,birds,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130672,.,O,4545.0,"Conversely , birds orally dosed with oil experienced hypothermia and consumed less fish compared to control birds ."
130773,We,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130774,have,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130775,mainly,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130776,focused,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130777,on,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130778,several,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130779,phytochemicals,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130780,like,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130781,resveratrol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130782,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130783,red,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130784,grapes,I,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130785,and,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130786,peanuts,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130787,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130788,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130789,allicin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130790,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130791,garlic,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130792,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130793,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130794,lycopene,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130795,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130796,tomato,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130797,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130798,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130799,indole-3,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130800,-,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130801,carbinol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130802,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130803,cruciferous,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130804,vegetables,I,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130805,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130806,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130807,vitamin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130808,C,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130809,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130810,citrus,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130811,fruits,I,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130812,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130813,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130814,[,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130815,6]-gingerol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130816,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130817,ginger,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130818,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130819,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130820,emodin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130821,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130822,aloe,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130823,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130824,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130825,natural,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130826,antioxidant,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130827,mixture,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130828,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130829,spinach,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130830,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130831,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130832,beta,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130833,carotenoids,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130834,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130835,carrots,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130836,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130837,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130838,sulphoraphane,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130839,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130840,mustard,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130841,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130842,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130843,ellagic,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130844,acid,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130845,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130846,pomegranate,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130847,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130848,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130849,myrecitin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130850,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130851,cranberry,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130852,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130853,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130854,carnosol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130855,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130856,rosemary,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130857,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130858,",",O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130859,vanillin,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130860,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130861,vanilla,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130862,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130863,and,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130864,eugenol,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130865,(,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130866,cloves,B,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130867,),O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130868,.,O,4550.0,"We have mainly focused on several phytochemicals like resveratrol ( red grapes and peanuts ) , allicin ( garlic ) , lycopene ( tomato ) , indole-3 - carbinol ( cruciferous vegetables ) , vitamin C ( citrus fruits ) , [ 6]-gingerol ( ginger ) , emodin ( aloe ) , natural antioxidant mixture ( spinach ) , beta carotenoids ( carrots ) , sulphoraphane ( mustard ) , ellagic acid ( pomegranate ) , myrecitin ( cranberry ) , carnosol ( rosemary ) , vanillin ( vanilla ) and eugenol ( cloves ) ."
130924,Critical,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130925,knowledge,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130926,on,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130927,these,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130928,compounds,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130929,and,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130930,their,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130931,signaling,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130932,pathways,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130933,may,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130934,help,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130935,in,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130936,formulation,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130937,of,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130938,effective,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130939,anticancer,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130940,drugs,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130941,.,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
131333,Histone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131334,deacetylase,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131335,inhibitors,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131336,(,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131337,HDACi,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131338,),O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131339,regulate,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131340,the,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131341,activity,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131342,of,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131343,HDACs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131344,and,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131345,are,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131346,being,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131347,used,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131348,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131349,cancer,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131350,treatment,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131351,either,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131352,alone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131353,or,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131354,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131355,combination,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131356,with,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131357,other,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131358,chemotherapeutic,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131359,drugs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131360,/,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131361,radiotherapy,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131362,.,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131395,Several,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131396,other,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131397,HDACi,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131398,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131399,natural,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131400,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131401,synthetic,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131402,origin,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131403,are,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131404,under,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131405,clinical,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131406,trial,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131407,for,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131408,the,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131409,evaluation,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131410,of,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131411,efficiency,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131412,and,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131413,side,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131414,-,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131415,effects,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131416,.,O,4568.0,Several other HDACi of natural and synthetic origin are under clinical trial for the evaluation of efficiency and side - effects .
131622,The,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131623,effects,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131624,of,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131625,the,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131626,presence,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131627,of,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131628,hydrocolloids,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131629,and,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131630,the,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131631,substitution,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131632,of,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131633,the,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131634,flour,B,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131635,basis,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131636,by,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131637,flour,B,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131638,or,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131639,proteins,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131640,from,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131641,different,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131642,sources,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131643,were,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131644,studied,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
131645,.,O,4574.0,The effects of the presence of hydrocolloids and the substitution of the flour basis by flour or proteins from different sources were studied .
